SVM-light Version V5.01-TK-1.5
5 # kernel type
3 # kernel parameter -d 
1 # kernel parameter -g 
1 # kernel parameter -s 
1 # kernel parameter -r 
empty# kernel parameter -u 
0.4 # kernel parameter -L 
1 # kernel parameter -T 
T # kernel parameter -C 
1 # kernel parameter -F 
1 # kernel parameter -S 
0.400000 # kernel parameter -M 
3 # kernel parameter -N 
S # kernel parameter -V 
S # kernel parameter -W 
0 # kernel parameter -U 
60 # highest feature index 
178 # number of training documents 
178 # number of support vectors plus 1 
-0.23260016 # threshold b, each following line is a SV (starting with alpha*y)
-1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (PRP$ (Our))(NNS (findings)))(VP (VBP (indicate))(SBAR (IN (that))(S (NP (JJ (canakinumab))(CD (150))(NN (mg)))(VP (VP (VBZ (provides))(NP (JJ (rapid))(CC (and))(JJ (sustained))(NN (pain))(NN (relief)))(PP (IN (in))(NP (NP (NNS (patients)))(PP (IN (with))(NP (JJ (acute))(JJ (gouty))(NN (arthritis)))))))(, (,))(CC (and))(VP (ADVP (RB (significantly)))(VBZ (reduces))(NP (NP (DT (the))(NN (risk)))(PP (IN (of))(NP (NP (JJ (recurrent))(NNS (flares)))(PP (VBN (compared))(PP (IN (with))(NP (JJ (triamcinolone))(NN (acetonide))))))))))))))(. (.)))) |ET|  |BV| 1:-0.70107085 2:-0.67142344 3:-0.99821794 4:-0.27082878 5:0.96723515 6:-0.90341014 7:-0.21741243 8:0.17161171 9:0.18283898 10:0.35798311 11:-0.3414588 12:-0.28059736 13:-0.21575037 14:0.80553985 15:-0.29131484 16:0.31853765 17:-0.01406425 18:-0.62460804 19:-2.1282365 20:-0.86754268 21:-0.5073027 22:-0.46654549 23:-0.19207969 24:-0.18477006 25:0.48602673 26:0.0095923962 27:-0.15957986 28:-0.66272211 29:-0.11714134 30:-0.083451219 31:-0.2927314 32:-0.002590975 33:0.99936646 34:0.77390444 35:0.61782748 36:0.65482217 37:0.43461204 38:-0.63503081 39:0.77378172 40:0.27871394 41:-0.23816001 42:0.49596485 43:0.24029925 44:0.34273428 45:-0.10382351 46:0.1243526 47:0.22147045 48:-0.12639189 49:0.085527204 50:0.10854711 51:-0.05201349 52:0.33668953 53:-0.027487827 54:0.24325944 55:-0.12473096 56:-0.14732218 57:0.414942 58:0.085233316 59:0.43200132 60:-0.074566804  |EV| 
-0.81741506558620136146942058985587  |BT| (ROOT (S (NP (DT (The))(NN (plasma))(NN (lipid))(NN (peroxidation)))(VP (VP (VBD (was))(VP (VBN (determined))(CC (and))(VBN (reported))(PP (IN (as))(NP (JJ (thiobarbituric))(NN (acid))(NN (reactive))(NN (substance))))))(CC (and))(VP (VBD (was))(ADJP (ADJP (ADJP (RB (significantly))(JJ (increased)))(PRN (-LRB- (-LRB-))(NP (CD (+21))(NN (%)))(-RRB- (-RRB-))))(, (,))(SBAR (IN (whereas))(S (NP (NP (DT (the))(NNS (activities)))(PP (IN (of))(NP (NP (DT (the))(JJ (erythrocyte))(JJ (antioxidant))(NNS (enzymes))(NN (glutathione)))(ADJP (JJ (peroxidase))(, (,))(JJ (catalase))(, (,))(CC (and))(JJ (superoxide))(JJ (dismutase))))))(VP (VBD (were))(ADVP (RB (significantly)))(VP (VBN (decreased))(PRN (-LRB- (-LRB-))(NP (NP (NP (CD (-32))(NN (%)))(, (,))(NP (CD (-14))(NN (%)))(CC (and))(NP (CD (-31))(NN (%))))(, (,))(ADVP (RB (respectively))))(-RRB- (-RRB-))))))))(PP (IN (in))(NP (JJ (amphetamine))(NNS (users))))))(. (.)))) |ET|  |BV| 1:-0.51009583 2:-0.56838346 3:0.018959643 4:-0.80733913 5:-0.028113127 6:-0.51623201 7:0.14834246 8:-0.50347131 9:0.91042084 10:0.16682194 11:0.37457371 12:-0.095307551 13:0.23110786 14:-0.50809145 15:-0.5548557 16:-0.40123346 17:0.65094382 18:-0.02916215 19:0.42906675 20:1.1775618 21:-2.1319661 22:1.0506796 23:0.8612175 24:-0.52978295 25:-0.84027267 26:-0.48896053 27:-0.34385866 28:0.59534967 29:-0.29902795 30:0.96731508 31:0.075172231 32:0.12474465 33:1.6130536 34:0.37658465 35:-0.24996969 36:-1.5141646 37:-1.6431141 38:-0.34250835 39:0.28368518 40:-1.1796204 41:0.36493894 42:-0.12623131 43:0.23646332 44:-0.0021588178 45:-0.22519679 46:-0.017826512 47:-0.76105434 48:-0.16577321 49:0.093279012 50:-0.21217889 51:0.42986286 52:0.47051576 53:0.11429661 54:-0.94374698 55:-0.17818514 56:0.49227211 57:0.39937896 58:0.26278988 59:-0.57860619 60:0.089267962  |EV| 
-0.74266375944521589858027255104389  |BT| (ROOT (S (NP (NP (NNS (Millions)))(PP (IN (of))(NP (NNS (individuals)))))(VP (VBP (are))(VP (VBN (prescribed))(S (NP (NP (JJ (platelet))(NNS (inhibitors)))(, (,))(PP (JJ (such))(IN (as))(NP (NN (aspirin))(CC (and))(NN (clopidogrel))))(, (,)))(VP (TO (to))(VP (VB (reduce))(NP (NP (PRP$ (their))(NN (risk)))(PP (IN (of))(NP (JJ (thrombosis-related))(JJ (clinical))(NNS (events))))))))))(. (.)))) |ET|  |BV| 1:-0.15856889 2:0.3293196 3:-0.6357854 4:-0.037901204 5:0.4094055 6:0.16079946 7:-0.40807116 8:-0.96301061 9:0.22807567 10:0.12053797 11:-0.31293467 12:0.17092253 13:0.28423032 14:0.14488637 15:-0.22898345 16:1.0369015 17:-0.058853254 18:-0.22417794 19:0.88311076 20:0.051908705 21:-0.45031631 22:0.15654109 23:-0.14055742 24:0.57517284 25:0.1998097 26:-0.003260914 27:-0.33045915 28:-0.79845482 29:0.2162341 30:-0.19117653 31:-0.26789901 32:0.13184972 33:0.5689823 34:-0.53675497 35:-0.25804719 36:0.65332514 37:-0.48971584 38:-0.86091042 39:0.14939134 40:-0.01000188 41:-0.13894668 42:0.14867257 43:0.25275663 44:-0.074380524 45:0.30145276 46:0.16982481 47:-0.15957671 48:-0.15784621 49:0.24943964 50:0.31978816 51:0.12373658 52:0.019082075 53:-0.40232769 54:-0.062541299 55:0.2235852 56:0.38597289 57:0.33574659 58:0.14232403 59:0.31984273 60:-0.35995016  |EV| 
-1  |BT| (ROOT (S (S (NP (DT (The))(JJ (cyclooxygenase))(NN (inhibitor))(NN (indomethacin)))(VP (VBD (normalized))(NP (DT (this))(NN (response)))))(, (,))(CC (and))(S (NP (NP (DT (the))(NN (concentration)))(PP (IN (of))(NP (NP (DT (the))(JJ (stable))(NN (metabolite)))(PP (IN (of))(NP (NP (NN (prostacyclin)))(PP (IN (in))(NP (NP (DT (the))(NN (aorta)))(PP (IN (of))(NP (NNP (CLP))(NNS (rats)))))))))))(VP (VBD (increased))(PP (PP (IN (in))(NP (JJ (basal))(NNS (conditions))))(CC (and))(PP (IN (after))(NP (NN (stimulation)))))(PP (IN (with))(NP (NN (acetylcholine))))))(. (.)))) |ET|  |BV| 1:-0.6964218 2:0.36328217 3:0.839136 4:-0.91466933 5:-0.27204117 6:-0.37875962 7:0.44033417 8:0.29511434 9:0.8904736 10:-0.26710111 11:0.88625318 12:-0.29589823 13:0.97394598 14:-0.12877832 15:-0.10586167 16:0.56494546 17:0.2942304 18:0.2748687 19:0.5583688 20:-0.16265568 21:-0.26775089 22:-0.17085113 23:-0.28042009 24:-0.11034966 25:-0.097754493 26:0.26364118 27:0.064379074 28:-0.10352088 29:0.47721407 30:0.8950026 31:-0.43930519 32:-0.32465222 33:-0.036774006 34:-0.44432601 35:-0.21733296 36:-0.36880413 37:-0.047921028 38:-0.76586854 39:-0.049508598 40:0.055001814 41:-0.42306143 42:-0.21677443 43:0.13826723 44:-0.37169611 45:0.14014922 46:-0.23866676 47:-0.11636898 48:-0.23296531 49:0.15913241 50:0.11641513 51:0.020793764 52:-0.3296493 53:0.1054501 54:-0.60931742 55:0.15935853 56:0.15040198 57:-0.23283552 58:-0.036179513 59:-0.10597014 60:0.35070109  |EV| 
-1  |BT| (ROOT (S (S (NP (NNP (Plasma))(NNP (calcium)))(VP (VBD (did))(RB (not))(VP (VB (change)))))(, (,))(CC (but))(S (NP (NNS (concentrations)))(VP (ADVP (IN (of)))(VBZ (insulin))(-LRB- (-LRB-))(NP (NNP (P)))))(. (?)))) |ET|  |BV| 1:-0.76733154 2:0.2460794 3:-0.36372909 4:-0.26238525 5:-0.33067521 6:-0.33500141 7:-0.089534409 8:0.13414255 9:0.37700409 10:0.26008978 11:-0.075949982 12:-0.24670501 13:0.17961161 14:-0.15187471 15:-1.0580264 16:-0.25400683 17:-0.31937048 18:0.033552781 19:0.48308486 20:-0.69982004 21:0.11782391 22:-0.11326382 23:-0.45559829 24:0.23644729 25:0.76049387 26:-0.59329844 27:0.54228014 28:0.41613418 29:0.040011354 30:-0.32132769 31:0.92303711 32:0.70906955 33:-0.073625803 34:0.061595749 35:0.56586367 36:0.75466645 37:-0.81484872 38:-0.17582589 39:0.64058375 40:-0.051477093 41:-0.16284072 42:-0.36576149 43:0.41856998 44:0.28824455 45:-0.011221407 46:0.47739005 47:-0.45349297 48:-0.14012027 49:-0.14517677 50:-0.03136408 51:0.28500482 52:-0.091129169 53:0.27687401 54:-0.34755701 55:-0.0070933066 56:0.38126776 57:0.81831282 58:0.048237447 59:0.50520217 60:0.33657447  |EV| 
1  |BT| (ROOT (S (NP (NP (NP (NN (Monitoring))(NNS (patients)))(PP (IN (for))(NP (JJ (adverse))(NNS (events)))))(, (,))(NP (NP (DT (the))(NN (need)))(PP (IN (for))(NP (NN (dose))(NNS (adjustments)))))(, (,))(CC (or))(NP (NP (DT (both)))(PP (IN (during))(NP (NP (NN (coadministration)))(PP (IN (with))(NP (NN (posaconazole))))))))(VP (MD (may))(VP (VB (be))(VP (VBN (warranted))(PP (IN (in))(NP (NP (NNS (patients)))(VP (VBG (being))(VP (VBN (treated))(PP (IN (with))(NP (NP (NNS (benzodiazepines)))(SBAR (WHNP (WDT (that)))(S (VP (VBP (are))(ADVP (RB (predominantly)))(VP (VBN (metabolized))(PP (IN (through))(NP (NNP (CYP3A4))))))))(PRN (-LRB- (-LRB-))(NP (NP (NN (eg)))(, (,))(NP (NN (midazolam))))(-RRB- (-RRB-))))))))))))(. (.)))) |ET|  |BV| 1:-0.78979158 2:-0.58866102 3:-0.50207615 4:0.22971973 5:1.023483 6:0.78828704 7:-0.15948094 8:-0.00097798009 9:0.73214215 10:-0.26119983 11:-1.1348884 12:0.0080271913 13:0.31622371 14:0.38099229 15:-0.98981839 16:-0.18961744 17:-0.79919237 18:-0.2080963 19:0.25636631 20:-0.37937513 21:-0.33319581 22:-0.9960075 23:-0.36023229 24:-0.92181027 25:0.70081371 26:0.13029915 27:-1.0233551 28:-0.3117902 29:-0.06793651 30:-0.072507545 31:0.083184622 32:-0.49804565 33:-0.0906666 34:-0.08099328 35:-0.43621778 36:0.82062733 37:-0.23244357 38:-0.10020839 39:0.24677145 40:-1.4766077 41:-0.16772039 42:0.27030492 43:0.035899766 44:-0.2042307 45:0.058817174 46:0.32141963 47:0.53227121 48:-0.34179607 49:0.23373675 50:0.39511076 51:0.062264528 52:0.5808931 53:0.009949795 54:0.80117011 55:-0.15728521 56:-0.39057025 57:0.083487339 58:0.54840708 59:0.52147019 60:-0.56140709  |EV| 
1  |BT| (ROOT (S (NP (NP (NP (NNS (CONCLUSIONS)))(: (:))(NP (NP (NP (JJ (High))(NN (clonidine))(NN (dose)))(PRN (-LRB- (-LRB-))(NP (CD (75))(NN (microg)))(-RRB- (-RRB-))))(VP (VBN (associated))(PP (TO (to))(NP (JJ (hyperbaric))(NN (bupivacaine))))(PP (IN (during))(NP (JJ (high-level))(JJ (spinal))(NN (anesthesia)))))))(PRN (-LRB- (-LRB-))(NP (NNP (T4)))(-RRB- (-RRB-))))(VP (VP (VBZ (induces))(NP (NP (DT (a))(JJR (higher))(NN (incidence)))(PP (IN (of))(NP (JJ (arterial))(NN (hypotension))))))(CC (but))(VP (VBZ (prolongs))(NP (NP (JJ (sensory))(NN (block))(CC (and))(NN (postoperative))(NN (analgesia)))(ADJP (JJ (similar))(PP (TO (to))(NP (JJR (lower))(NN (clonidine))(NN (dose)))))(PRN (-LRB- (-LRB-))(NP (CD (45))(NN (microg)))(-RRB- (-RRB-))))(PP (IN (during))(NP (JJ (upper))(JJ (spinal))(NN (anesthesia))))))(. (.)))) |ET|  |BV| 1:-0.34696582 2:-0.0097431345 3:-0.23105963 4:-0.50302809 5:-0.020926366 6:0.2870712 7:-0.036876835 8:-0.00093980529 9:0.57171631 10:-0.061133616 11:0.5594151 12:-0.38323382 13:0.034318916 14:-0.24120934 15:-0.67039001 16:0.42504683 17:0.50754982 18:0.30065629 19:-0.016009297 20:-0.086647823 21:-0.8905074 22:-0.068780981 23:-0.47116345 24:-0.32579431 25:-0.21974571 26:-0.086479373 27:0.31466416 28:-0.11319269 29:0.079392374 30:0.18790373 31:0.23570172 32:-0.12637585 33:0.10259232 34:-0.49600062 35:-0.2559278 36:0.32329068 37:0.42616135 38:0.28018206 39:-0.7610113 40:0.10418049 41:-0.76491618 42:0.24518801 43:0.17853083 44:-0.23840232 45:0.34070531 46:-0.064233221 47:-0.65283954 48:0.11207738 49:0.090207815 50:-0.27262828 51:-0.45396826 52:-0.46814615 53:-0.5591079 54:0.023902979 55:-0.26819465 56:-0.20253927 57:-0.18586649 58:0.19122948 59:-0.16243209 60:0.14149334  |EV| 
1  |BT| (ROOT (S (S (VP (VBG (Examining))(NP (NP (DT (the))(NNS (details)))(PP (IN (of))(NP (NP (DT (the))(JJ (temporal))(NNS (features)))(PP (IN (of))(NP (DT (the))(JJ (evoked))(NNS (profiles)))))))))(VP (VBZ (reveals))(NP (NP (DT (no))(JJ (clear))(NN (evidence)))(PP (IN (for))(NP (NP (JJ (long-distance))(NN (diffusion)))(PP (IN (of))(NP (NP (NN (dopamine)))(PP (IN (between))(NP (ADJP (JJ (fast))(CC (and))(JJ (slow)))(NNS (domains)))))))))(, (,))(SBAR (RB (even))(IN (though))(S (NP (NP (JJ (uptake))(NN (inhibition)))(PP (IN (by))(NP (NN (nomifensine)))))(VP (ADVP (RB (clearly)))(VBZ (prolongs))(NP (DT (the))(NN (time)))(SBAR (IN (that))(S (NP (NN (dopamine)))(VP (VBZ (resides))(PP (IN (in))(NP (DT (the))(NN (extracellular))(NN (space)))))))))))(. (.)))) |ET|  |BV| 1:-1.4352882 2:0.23550102 3:0.28739452 4:-1.6928145 5:-0.10965688 6:-0.60174739 7:0.74265701 8:-0.91238713 9:0.85570979 10:0.393821 11:0.48118779 12:-0.74184155 13:1.2862357 14:-0.52537066 15:0.68416065 16:0.93611735 17:0.4934338 18:0.52505773 19:-0.21933049 20:1.0926528 21:-0.52288628 22:0.064634569 23:0.43291721 24:-0.5993492 25:0.067319103 26:-0.54065132 27:0.75569421 28:0.22499478 29:0.7509374 30:0.50299102 31:0.66871351 32:-0.46396655 33:0.70376694 34:0.35963044 35:0.027474603 36:0.40848967 37:0.32412928 38:-0.051923949 39:0.47423962 40:0.30214891 41:-0.18680191 42:0.031823594 43:-0.066329129 44:-0.16584101 45:0.43341047 46:-0.64443189 47:0.049082715 48:0.018523032 49:-0.28769046 50:0.57131511 51:-0.10905656 52:0.061138332 53:0.10274614 54:-0.22704844 55:-0.087608151 56:0.10404284 57:0.34588921 58:0.22590666 59:-0.4927125 60:0.060855482  |EV| 
1  |BT| (ROOT (S (NP (NNP (Chlordiazepoxide)))(VP (VBD (produced))(NP (JJ (significant))(NNS (decreases)))(PP (PP (IN (in))(NP (NP (JJ (food-maintained))(VBG (responding)))(CC (and))(NP (NP (DT (the))(NN (dose)))(PP (IN (of))(NP (NP (NN (ethanol)))(VP (VBN (presented))))))))(, (,))(CONJP (CC (but))(RB (only)))(PP (IN (at))(NP (NP (DT (the))(JJS (highest))(NN (dose)))(VP (VBN (tested)))))))(. (.)))) |ET|  |BV| 1:-0.18262425 2:-0.27455565 3:-0.63187039 4:-0.20303082 5:-0.49805775 6:-0.36358526 7:-0.67585135 8:-0.18507487 9:0.57143605 10:-0.13132448 11:0.033105545 12:0.39477274 13:0.01403023 14:-0.085290499 15:0.069696143 16:0.078646556 17:-0.2542069 18:-0.099925838 19:0.45036244 20:0.57571846 21:-1.1399069 22:-0.051731899 23:-1.3472413 24:-0.11247903 25:0.35895267 26:-0.78500241 27:-1.8944215 28:0.49661213 29:1.8387921 30:0.36294636 31:-0.65767848 32:0.029336948 33:0.013183736 34:0.34426984 35:-0.32096601 36:-0.17584008 37:0.018173909 38:0.39964738 39:0.34451035 40:0.53582203 41:-0.22235754 42:-0.35752195 43:0.10931377 44:0.3466202 45:0.19532886 46:-0.18904051 47:0.20533572 48:-0.43493101 49:-0.43030122 50:-0.039110955 51:0.17364885 52:0.36153713 53:0.076109618 54:0.093946531 55:-0.16439913 56:0.091444574 57:0.72916645 58:0.14645554 59:0.23365995 60:0.29246813  |EV| 
1  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(NP (NP (DT (The))(NN (combination)))(PP (IN (of))(NP (NP (JJ (chronic))(ADJP (JJ (amiodarone))(CC (and))(JJ (acute)))(NN (ranolazine)))(SBAR (S (VP (VBZ (produces))(NP (NP (DT (a))(JJ (synergistic))(JJ (use-dependent))(NN (depression)))(PP (IN (of))(NP (NP (PRP (I)))(PRN (-LRB- (-LRB-))(NP (NNP (Na)))(-RRB- (-RRB-))))))))))))(: (-))(NP (NP (JJ (dependent))(NNS (parameters)))(PP (IN (in))(NP (JJ (isolated))(JJ (canine))(NN (atria)))))(, (,))(VP (VBG (leading))(PP (TO (to))(NP (NP (DT (a))(JJ (potent))(NN (effect)))(PP (IN (of))(NP (DT (the))(NN (drug))(NN (combination))))))(S (VP (TO (to))(VP (VB (prevent))(NP (NP (DT (the))(NN (induction)))(PP (IN (of))(NP (JJ (atrial))(NN (fibrillation)))))))))(. (.)))) |ET|  |BV| 1:-0.16469966 2:0.022516429 3:-0.73193413 4:0.045193154 5:0.4222194 6:0.036796849 7:0.2352435 8:-0.27031907 9:0.41419598 10:0.20313478 11:-0.29296407 12:-0.33279586 13:0.23716505 14:-0.20832293 15:-0.14375141 16:-0.043305229 17:-0.10976048 18:-0.43185729 19:0.685583 20:0.18347895 21:-0.50797927 22:0.22242394 23:-0.58503681 24:-1.1161242 25:0.29811209 26:-0.20458293 27:0.28309065 28:-0.53003603 29:1.2892283 30:1.1058322 31:-0.64361739 32:-1.1454899 33:-0.1349261 34:0.29871371 35:-0.53236902 36:-0.15928262 37:-0.58320421 38:-0.17344429 39:0.83502084 40:-0.2206724 41:-0.6961236 42:-0.22058751 43:0.068752035 44:-0.25931942 45:0.30157036 46:-0.22566921 47:0.26623222 48:0.11536221 49:0.32593679 50:-0.13486694 51:-0.054787338 52:-0.90097779 53:0.12251316 54:0.44120902 55:0.020446632 56:0.27535501 57:0.22570048 58:0.21483344 59:0.18371722 60:-0.27874658  |EV| 
-0.847073662740129185166892966663  |BT| (ROOT (S (NP (NP (DT (The))(NN (purpose)))(PP (IN (of))(NP (DT (this))(NN (study)))))(VP (VBD (was))(S (VP (TO (to))(VP (VB (evaluate))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (NP (NP (NN (lamivudine)))(PRN (-LRB- (-LRB-))(NP (NNP (LAM)))(-RRB- (-RRB-))))(PP (IN (versus))(NP (NP (NN (telbivudine)))(PRN (-LRB- (-LRB-))(NP (NNP (LdT)))(-RRB- (-RRB-))))))))(PP (IN (in))(NP (NP (DT (the))(NN (treatment)))(PP (IN (of))(NP (JJ (chronic))(NNP (hepatitis))(NNP (B))(PRN (-LRB- (-LRB-))(NP (NNP (CHB)))(-RRB- (-RRB-)))))))))))(. (.)))) |ET|  |BV| 1:0.21777214 2:-0.48387641 3:-0.78525078 4:0.066077396 5:-0.2437056 6:0.50630271 7:0.45234659 8:-0.72379816 9:0.11202154 10:1.3632783 11:-0.27164024 12:0.62322271 13:-0.63029885 14:1.0705799 15:-0.82747239 16:0.73803794 17:-0.62852734 18:-0.7533195 19:-0.038409524 20:-0.18720534 21:0.23779199 22:-1.6707587 23:0.010241315 24:-0.12289868 25:-0.35425296 26:1.0315037 27:0.74759912 28:0.13548201 29:-0.56741869 30:0.92076725 31:0.26983118 32:0.18860863 33:-0.27637884 34:0.73069203 35:-1.13779 36:0.32787588 37:-0.94376045 38:-0.91430557 39:0.36018893 40:-1.2165726 41:-0.024095088 42:-0.20915298 43:0.26553917 44:-0.046438165 45:-0.22937129 46:-0.028843738 47:0.251798 48:-0.029212222 49:-0.14888071 50:-0.092224009 51:0.011975461 52:-0.32317951 53:-0.16132723 54:0.58817178 55:-0.19626126 56:0.41344604 57:0.2396934 58:0.19986278 59:-0.090092249 60:-0.12889434  |EV| 
-0.62587018746919120815164205851033  |BT| (ROOT (S (NP (NP (JJ (Dexmedetomidine))(NN (infusion)))(PP (IN (without))(NP (DT (a))(NNS (bolus)))))(VP (VBZ (appears))(S (VP (TO (to))(VP (VB (be))(NP (DT (an))(JJ (effective))(NN (adjunct))(S (VP (TO (to))(VP (VB (fentanyl))(NP (NP (NN (anesthesia)))(PP (IN (in))(NP (NP (NN (control)))(PP (IN (of))(NP (JJ (hemodynamic))(NNS (responses)))))))(PP (TO (to))(NP (NP (NN (surgery)))(PP (IN (for))(NP (NP (NN (repair)))(PP (IN (of))(NP (NNP (CHD))))))))(PP (IN (in))(NP (NNS (children))))))))))))(. (.)))) |ET|  |BV| 1:-0.77053291 2:-0.48575148 3:-0.84432662 4:-1.0948236 5:0.79077691 6:-0.38421625 7:-0.094402462 8:-0.76336622 9:-0.38017043 10:0.042292215 11:-0.44345054 12:-0.75959682 13:-0.44020325 14:-0.11750142 15:0.36356458 16:1.1747187 17:0.36346835 18:0.23654294 19:-0.10545375 20:-0.92121631 21:-0.5965603 22:-0.60173035 23:-0.5637145 24:-0.742405 25:0.11047246 26:-0.63334364 27:-0.39095229 28:-0.11231483 29:0.08078523 30:0.339479 31:0.24232866 32:-0.4889521 33:0.044322167 34:-0.77776569 35:-0.32153225 36:0.4958865 37:0.6283139 38:-0.012034352 39:-0.66721821 40:-1.0869571 41:0.034788929 42:0.1428165 43:-0.15560913 44:0.034237575 45:0.36357898 46:-0.43612674 47:-0.54494858 48:-0.4042058 49:0.23585364 50:0.0031713275 51:-0.4113718 52:-0.087790638 53:-0.45852062 54:0.012386788 55:-0.44590914 56:-0.43328649 57:0.41290116 58:-0.16389251 59:-0.031090358 60:-0.19744091  |EV| 
-0.83788099334336840762205156352138  |BT| (ROOT (S (NP (NP (DT (The))(JJ (cysteine))(NN (prodrug))(NN (N-acetylcysteine)))(PRN (-LRB- (-LRB-))(NP (NNP (NAC)))(-RRB- (-RRB-))))(VP (VBZ (has))(VP (VBN (been))(VP (VBN (shown))(S (VP (TO (to))(VP (VB (reduce))(NP (NP (NN (reinstatement)))(PP (IN (of))(NP (NP (NN (cocaine)))(VP (VBG (seeking))(PP (IN (by))(NP (NP (NN (normalization)))(PP (IN (of))(NP (JJ (glutamatergic))(NN (tone))))))))))))))))(. (.)))) |ET|  |BV| 1:0.04645972 2:-0.243412 3:-0.12847507 4:-0.020735495 5:0.046708986 6:-0.63118833 7:-0.37865597 8:-0.77093482 9:0.74587637 10:-0.46059707 11:0.0066282842 12:-0.22267382 13:-0.17692463 14:-0.36518228 15:-0.20190102 16:0.29322821 17:-0.080923498 18:-0.18870497 19:0.15922587 20:0.54918379 41:0.062842861 42:-0.33100313 43:0.066658333 44:-0.22510052 45:0.47421774 46:-0.48099273 47:-0.53954118 48:-0.15290162 49:0.10567547 50:0.27469495 51:0.12800848 52:-0.040627558 53:0.053304292 54:0.30889568 55:0.15100461 56:0.25580519 57:0.25999257 58:-0.26079535 59:0.57520294 60:0.28164241  |EV| 
1  |BT| (ROOT (S (NP (NP (JJ (Several))(NNS (drugs)))(, (,))(PP (VBG (including))(NP (NP (NN (sucralfate)))(, (,))(NP (NN (acarbose)))(, (,))(NP (JJ (cytotoxic))(NNS (agents)))(, (,))(CC (and))(NP (JJ (enzyme))(NNS (inducers)))))(, (,)))(VP (MD (can))(VP (VB (reduce))(NP (JJ (digoxin))(NN (plasma))(NNS (concentrations)))))(. (.)))) |ET|  |BV| 1:-1.0121845 2:0.14595585 3:0.44600824 4:-0.25769731 5:-0.37429839 6:0.023680463 7:0.67091608 8:0.20296322 9:1.6607677 10:0.61272508 11:-0.86790186 12:0.55626851 13:0.33811837 14:-1.0848907 15:-0.81710273 16:0.16831641 17:-0.089263283 18:-0.56630611 19:0.69577777 20:-0.74892586 21:-0.60551023 22:0.79024237 23:-1.4789503 24:-0.063694231 25:0.52428079 26:0.011539915 27:-0.44888067 28:-0.2874338 29:1.0391918 30:0.14282526 31:-0.64101034 32:0.20663229 33:0.57818228 34:-0.28894764 35:-0.11183441 36:0.23218049 37:0.074597076 38:-0.25530753 39:0.13733175 40:-0.53306454 41:-0.31519055 42:-0.1250736 43:0.45796633 44:0.46528739 45:0.23173526 46:0.20864008 47:-0.029604094 48:-0.35758504 49:0.55659491 50:0.073550396 51:0.41324598 52:0.21355695 53:0.028693797 54:-0.14827161 55:0.2351398 56:0.043548752 57:0.13677995 58:0.40026498 59:0.22347628 60:-0.27246344  |EV| 
0.71978066210920055301158981819754  |BT| (ROOT (S (NP (DT (A))(JJ (recent))(NN (study)))(VP (VBD (reported))(SBAR (IN (that))(S (NP (NN (resveratrol)))(VP (VP (ADVP (RB (directly)))(VBZ (inhibits))(NP (JJ (cyclic))(JJ (adenosine))(JJ (monophosphate-specific))(NNS (phosphodiesterases))))(CC (and))(VP (ADVP (RB (then)))(VBZ (activates))(NP (JJ (5cyclic))(JJ (adenosine))(JJ (monophosphate-specific))(NNS (phosphodiesterases)))))))))) |ET|  |BV| 1:-0.58411968 2:-0.47265872 3:-0.15236552 4:-0.015359038 5:0.10891268 6:-1.0250098 7:-1.6109728 8:1.0500451 9:0.05216353 10:0.89534938 11:-0.62225813 12:-0.0080696652 13:0.03575068 14:1.3001171 15:-1.4801602 16:0.8895095 17:-0.50203562 18:-0.24404615 19:-0.24035545 20:-1.487729 21:-0.30830941 22:-0.31597814 23:-0.25802624 24:-0.078292951 25:-0.31885257 26:-0.063564442 27:0.36135384 28:0.29760718 29:0.16068318 30:-0.050796911 31:0.11653323 32:-0.021431386 33:0.75684661 34:0.10787389 35:-0.20611054 36:-0.0290264 37:0.26027101 38:0.0347443 39:0.19359428 40:0.22078773 41:0.0084029417 42:0.017400514 43:0.012152082 44:-0.020999137 45:0.014177808 46:0.020954652 47:-0.0048795589 48:-0.0010717437 49:-0.0050756452 50:-0.011515853 51:0.01602816 52:0.018754518 53:-0.023977019 54:0.0090801353 55:-0.0075581134 56:0.022889582 57:0.0042083976 58:0.017112264 59:-0.00077992986 60:-0.021568734  |EV| 
1  |BT| (ROOT (FRAG (NP (NNP (Conclusion)))(: (:))(S (S (NP (NNP (Etanercept))(CC (and))(NN (anakinra))(NNS (efficiently))(CC (and))(NN (dose-dependently)))(VP (VBP (prevent))(NP (JJ (cytokine-induced))(NN (bone))(NN (growth))(NN (impairment)))))(, (,))(CC (and))(S (NP (NP (NN (combination)))(PP (IN (with))(NP (NNP (IGF-I)))))(VP (ADVP (RBR (further)))(VBZ (improves))(NP (NN (bone))(NN (growth))))))(. (.)))) |ET|  |BV| 1:-0.9448337 2:-1.1720799 3:-0.21976928 4:0.053598132 5:-1.6204743 6:-1.8191205 7:-0.45569769 8:-0.55438995 9:-0.76254988 10:-0.47779968 11:0.20224361 12:-0.88376659 13:0.32213646 14:1.1307764 15:-0.023874465 16:0.9223147 17:-0.80786711 18:-0.86718744 19:0.15088288 20:-0.25309196 21:-1.596894 22:-0.78697842 23:-1.510949 24:0.5172174 25:-1.4647456 26:-0.55207968 27:-0.41307622 28:-1.0079505 29:0.016854065 30:-0.058697954 31:-0.034399349 32:-1.0416425 33:0.41075316 34:0.81969017 35:0.35323617 36:1.1244911 37:-0.28098848 38:-0.24923591 39:0.20871326 40:0.1986725 41:-0.3441565 42:-0.2785342 43:0.10139197 44:0.11196058 45:0.27015987 46:-0.24094439 47:-0.078733921 48:-0.32805887 49:0.025581963 50:-0.0038116053 51:0.29081509 52:0.068547443 53:0.64466673 54:0.50583422 55:0.35711536 56:0.030563382 57:0.50197816 58:0.52946103 59:-0.18454069 60:-0.63856828  |EV| 
-0.76261964082057986935581084253499  |BT| (ROOT (S (NP (NNP (Bosutinib)))(ADVP (RB (effectively)))(VP (VBZ (inhibits))(NP (NP (JJ (wild-type))(NNS (BCR-ABL)))(CC (and))(NP (ADJP (RBS (most))(JJ (imatinib-resistant)))(JJ (BCR-ABL))(NNS (mutations))))(PP (IN (except))(PP (IN (for))(NP (NNP (V299L))(CC (and))(NNP (T315I))))))(. (.)))) |ET|  |BV| 1:-1.4150195 2:-0.75379562 3:-0.30274698 4:0.41086516 5:0.87304497 6:-0.13760939 7:-0.1161086 8:0.54664403 9:0.4185783 10:-1.0666376 11:0.37693745 12:0.044920638 13:-0.58525449 14:1.8035409 15:-0.19468595 16:0.43577275 17:-0.24823987 18:-0.38447586 19:0.87542605 20:-0.57449919 21:-0.33851308 22:-1.7168829 23:0.14864606 24:-0.79962552 25:0.091452621 26:0.71990466 27:-0.19070913 28:1.004841 29:0.15158902 30:-0.040196452 31:-0.73503423 32:0.24747746 33:1.0172499 34:0.75858974 35:0.045884404 36:0.86002636 37:-0.5267238 38:0.35932794 39:0.27222681 40:-0.44760516 41:-0.36382547 42:-0.41348338 43:0.14345749 44:-0.148377 45:0.22420827 46:0.0034748192 47:-0.12785278 48:-0.28102565 49:0.17195584 50:0.44904375 51:0.066136934 52:0.048695061 53:-0.46924067 54:0.35670757 55:-0.11258142 56:-0.0038496205 57:0.37719911 58:0.36941379 59:-0.39937991 60:0.34766871  |EV| 
-0.73530013286055462273793636995833  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (SBAR (IN (In))(NN (order))(S (VP (TO (to))(VP (VB (prevent))(NP (NN (rebound))(CC (or))(NN (relapse)))))))(, (,))(NP (JJ (various))(NNS (approaches)))(VP (VBP (are))(ADJP (JJ (available)))(, (,))(PP (VBG (including))(NP (JJ (cyclosporine))(, (,))(JJ (methotrexate))(CC (and))(JJ (biologic))(NNS (therapies))))))(. (.)))) |ET|  |BV| 1:0.024814399 2:-0.24871032 3:-0.10679194 4:-0.10794007 5:-0.59986538 6:-0.27684015 7:0.73448992 8:-0.19402602 9:-0.28890821 10:0.75778615 11:-0.25642815 12:-0.42810559 13:-0.66437232 14:-0.12065995 15:0.10851625 16:0.92460924 17:-0.29851535 18:-0.28599888 19:0.86515802 20:-0.39470315 21:0.22973515 22:0.19648084 23:0.55181855 24:0.1875837 25:0.38749653 26:0.022247471 27:0.38784403 28:-0.22101809 29:-0.2505368 30:0.63505775 31:-0.84504056 32:-0.38331211 33:-0.28157818 34:0.26864225 35:-0.5905841 36:0.14444742 37:0.25645807 38:-0.067241907 39:-0.22094773 40:-0.84235156 41:0.17405927 42:-0.20791538 43:0.18546791 44:0.12403602 45:0.27035078 46:-0.35232466 47:0.30350289 48:-0.31708738 49:0.19726326 50:0.11050511 51:0.29948801 52:0.050592054 53:-0.32458326 54:0.30495605 55:0.30676445 56:-0.087085158 57:0.20142482 58:-0.026089739 59:0.19592059 60:0.21563217  |EV| 
-1  |BT| (ROOT (S (NP (NP (NNP (Tiagabine)))(PRN (-LRB- (-LRB-))(NP (NNP (Gabitril)))(-RRB- (-RRB-))))(VP (VBZ (is))(NP (NP (DT (an))(JJ (anticonvulsive))(NN (drug)))(SBAR (WHNP (WDT (that)))(S (VP (VP (VBZ (binds))(ADVP (RB (selectively)))(PP (TO (to))(NP (NNP (GABA))(CD (transporter-1)))))(CC (and))(VP (ADVP (RB (thereby)))(VBZ (inhibits))(NP (NNP (GABA))(NN (uptake)))))))))(. (.)))) |ET|  |BV| 1:-0.83241612 2:-1.1449342 3:0.95080703 4:-1.0274135 5:0.22716926 6:-0.14663307 7:0.78738421 8:-0.55017918 9:2.0051949 10:-0.043764744 11:0.29244024 12:0.74981308 13:0.57963634 14:-0.47093388 15:0.61563385 16:-0.25871527 17:-0.69366622 18:-1.0949746 19:0.0025397066 20:0.61486751 21:-0.27307969 22:-0.63439894 23:0.67877787 24:-0.37401637 25:0.30667624 26:0.0076121525 27:0.36643663 28:0.4661926 29:0.9620142 30:-0.15649326 31:0.58691895 32:0.85801345 33:-0.23444062 34:-0.29673785 35:-0.33163401 36:0.12373613 37:-0.59513187 38:-1.4145489 39:0.45294952 40:0.48181862 41:0.13987552 42:-0.12864909 43:0.25546247 44:-0.28174827 45:-0.041111976 46:-0.32483268 47:-0.029574873 48:0.14357752 49:-0.061583485 50:0.24860196 51:0.01839046 52:0.12885794 53:0.30713049 54:-0.26737991 55:0.033892825 56:0.34236515 57:0.13177383 58:0.1335682 59:-0.26608232 60:-0.13616437  |EV| 
1  |BT| (ROOT (S (NP (NP (DT (The))(NN (attenuation)))(PP (IN (of))(NP (NP (JJ (mossy))(NN (fiber))(NN (LTP)))(PP (IN (by))(NP (JJ (tail))(NN (suspension)))))))(VP (VBD (was))(ADVP (RB (completely)))(VP (VBN (restored))(SBAR (WHADVP (WRB (when)))(S (NP (NNS (rats)))(VP (VBD (were))(VP (VBN (pretreated))(PP (IN (with))(NP (NN (clioquinol))(PRN (-LRB- (-LRB-))(NP (CD (30))(NN (mg/kg)))(-RRB- (-RRB-)))(S (VP (TO (to))(VP (VB (block))(NP (NP (DT (the))(NN (action)))(PP (IN (of))(NP (JJ (chelatable))(NN (zinc))))))))))))))))(. (.)))) |ET|  |BV| 1:-0.09793371 2:-0.60528225 3:-0.024483999 4:-0.40964469 5:0.93276751 6:-0.79760659 7:0.40149951 8:0.029675951 9:0.12886706 10:0.73275822 11:-0.0099219996 12:0.40133649 13:-0.091869988 14:-0.28844568 15:-0.39580074 16:-0.78840023 17:0.068280049 18:0.14598976 19:0.33837888 20:0.084088556 21:0.11782391 22:-0.11326382 23:-0.45559829 24:0.23644729 25:0.76049387 26:-0.59329844 27:0.54228014 28:0.41613418 29:0.040011354 30:-0.32132769 31:0.92303711 32:0.70906955 33:-0.073625803 34:0.061595749 35:0.56586367 36:0.75466645 37:-0.81484872 38:-0.17582589 39:0.64058375 40:-0.051477093 41:-0.44955367 42:-0.30030286 43:0.11882168 44:-0.45189169 45:0.010749685 46:-0.8219229 47:-0.029807638 48:-0.17772147 49:-0.25201723 50:0.24559647 51:0.016874924 52:0.083186172 53:0.3055582 54:-0.30730185 55:-0.28739202 56:-0.17966278 57:-0.56990087 58:0.10578173 59:-0.00016746538 60:0.014165998  |EV| 
1  |BT| (ROOT (S (NP (PRP (We)))(VP (VBD (found))(SBAR (IN (that))(S (NP (NN (memantine)))(VP (VBZ (blocks))(NP (NP (JJ (extrasynaptic))(JJ (NMDAR-mediated))(NNS (currents)))(VP (VBN (induced))(PP (IN (by))(NP (NP (NN (bath))(NN (application)))(PP (IN (of))(NP (CD (100))(JJ (microM))(NNP (NMDA/10))(NN (microM))(NN (glycine))))))(PP (IN (with))(NP (NP (DT (a))(ADJP (RB (twofold))(JJR (higher)))(NN (potency)))(PP (IN (than))(NP (NP (PRP$ (its))(NN (blockade)))(PP (IN (of))(NP (NP (DT (the))(JJ (NMDAR))(NN (component)))(PP (IN (of))(NP (NP (NP (JJ (evoked))(NNS (EPSCs)))(-LRB- (-LRB-))(NP (NNP (EPSCs)))(PRN (-LRB- (-LRB-))(NP (NNP (NMDAR)))(-RRB- (-RRB-)))(-RRB- (-RRB-)))(: (;))(S (NP (DT (this))(NN (effect)))(VP (VBZ (persists))(PP (IN (under))(NP (NP (NNS (conditions)))(PP (IN (of))(NP (JJ (pathological))(NN (depolarization))))))(PP (IN (in))(NP (NP (DT (the))(NN (presence)))(PP (IN (of))(NP (CD (1))(NN (mm))(NN (extracellular))(NNS (Mg))))))))))))))(PRN (-LRB- (-LRB-))(NP (QP (CD (2))(CD (+))))(-RRB- (-RRB-)))))))))))(. (.)))) |ET|  |BV| 1:0.037619635 2:-1.3707722 3:-0.78813481 4:0.11216474 5:-0.087420791 6:0.39344969 7:0.66902333 8:-0.39446059 9:0.6078822 10:1.2609564 11:0.59104782 12:0.5495742 13:-0.17848748 14:-0.89857042 15:-0.0059450157 16:0.21829332 17:-0.33531234 18:-0.43005264 19:0.40840954 20:-0.71890801 21:-1.219892 22:0.22954351 23:0.34183744 24:-0.32787293 25:-0.34051555 26:-0.81820977 27:1.0950845 28:0.30548695 29:0.53864843 30:-0.17523772 31:0.33607841 32:0.44189683 33:0.075850949 34:0.20910802 35:-1.0593969 36:0.53212762 37:-0.25781393 38:-0.43844366 39:1.098778 40:-0.21287422 41:-0.24275327 42:0.23940989 43:0.16326427 44:-0.68348515 45:-0.45819315 46:-0.7039308 47:0.064832881 48:-0.44956934 49:-0.080455489 50:-0.076916426 51:0.58827525 52:-0.026850931 53:0.30010059 54:-0.070069924 55:-0.47175941 56:0.3185094 57:-0.036001243 58:0.034302302 59:0.0715013 60:0.070368357  |EV| 
1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSIONS)))(: (:))(S (NP (PRP$ (Our))(NNS (findings)))(ADVP (RB (further)))(VP (VP (VBP (support))(NP (DT (the))(NNS (hypothesis)))(SBAR (IN (that))(S (NP (NP (DT (the))(JJ (synergistic))(NN (effect)))(PP (IN (of))(NP (NP (NN (olanzapine))(CC (and))(NN (fluoxetine)))(PP (IN (on))(NP (NP (JJ (prefrontal))(JJ (cortical))(NNS (levels)))(PP (IN (of))(NP (NN (norepinephrine))(CC (and))(NN (dopamine)))))))))(VP (MD (might))(VP (VB (be))(NP (NP (DT (an))(VBG (underlying))(NN (mechanism)))(PP (IN (for))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (NP (JJ (olanzapine-fluoxetine))(NN (combination)))(PP (IN (in))(NP (NP (DT (the))(NN (treatment)))(PP (IN (of))(NP (JJ (treatment-resistant))(NN (depression))))))))))))))))(CC (and))(VP (PRN (, (,))(SBAR (IN (if))(FRAG (ADJP (JJ (replicated)))))(, (,)))(MD (may))(VP (VB (form))(NP (NP (DT (a))(NN (basis)))(SBAR (WHPP (IN (on))(WHNP (WDT (which))))(S (NP (NP (NN (response)))(PP (TO (to))(NP (NP (JJ (olanzapine-fluoxetine))(NN (combination)))(PP (IN (versus))(NP (JJ (continued))(NN (fluoxetine)))))))(VP (MD (can))(VP (VB (be))(VP (VBN (predicted))(PP (VBN (based))(PP (IN (on))(NP (NP (NNS (variants)))(PP (IN (in))(NP (NNP (SLC6A2)))))))))))))))))(. (.)))) |ET|  |BV| 1:0.13194823 2:0.34916896 3:-0.7530095 4:-0.43338528 5:0.26798153 6:1.1201754 7:0.013825226 8:-0.61208022 9:0.21881662 10:0.5256815 11:0.8308621 12:1.0212096 13:0.50689417 14:0.013927326 15:-0.75837433 16:-0.09899047 17:0.54053074 18:-0.78683519 19:0.3812432 20:0.087259933 21:-0.18715255 22:0.066955015 23:-0.46771184 24:-0.07208021 25:1.0176843 26:-0.45238835 27:-0.38410947 28:-0.28686091 29:0.14154397 30:0.53410459 31:0.60740608 32:-0.097546875 33:0.41103497 34:0.25003383 35:0.22044036 36:0.19254863 37:-0.37296125 38:-0.78279614 39:0.89931923 40:-0.091693178 41:-0.18657164 42:0.18919772 43:-0.018889196 44:-0.015345511 45:0.45200348 46:-0.095505856 47:-0.35578388 48:0.32600135 49:-0.11797196 50:0.57004982 51:0.093005627 52:-0.31196856 53:-0.039651092 54:0.38389194 55:-0.14716217 56:0.20236784 57:-0.18913902 58:0.084636077 59:-0.10934187 60:-0.023350189  |EV| 
-1  |BT| (ROOT (S (NP (NP (DT (The))(NNS (pharmacokinetics))(CC (and))(NNS (pharmacodynamics)))(PP (IN (of))(NP (JJ (porcine))(NN (insulin))(NN (zinc))(NN (suspension)))))(VP (VBD (were))(VP (VP (VBN (studied))(PP (IN (in))(NP (NP (NP (CD (eight))(NNS (dogs)))(PP (IN (with))(NP (JJ (spontaneous))(NN (diabetes))(NNS (mellitus)))))(CC (and))(NP (NP (DT (a))(NN (lack)))(PP (IN (of))(NP (JJ (endogenous))(NN (insulin))))))))(, (,))(VP (VBN (demonstrated))(PP (IN (by))(NP (NP (DT (the))(NN (lack)))(PP (IN (of))(NP (NN (insulin))(NN (secretion))))))(PP (IN (after))(NP (NP (DT (an))(NN (injection)))(PP (IN (of))(NP (NN (glucagon)))))))(CC (and))(VP (VBN (confirmed))(PP (IN (by))(NP (NP (NN (measurement)))(PP (IN (of))(NP (NP (DT (the))(NN (concentration)))(PP (IN (of))(NP (NNP (C-peptide))))))))(PP (IN (during))(NP (DT (the))(JJ (pharmacokinetic))(NNS (assessments)))))))(. (.)))) |ET|  |BV| 1:0.20189296 2:0.27777377 3:-0.60384792 4:0.37231353 5:0.19332364 6:-0.32141238 7:0.44214949 8:0.12248313 9:0.49692559 10:0.21804628 11:0.72888732 12:0.6371491 13:-0.18561436 14:0.35771164 15:-0.11597318 16:0.55502707 17:-0.78332585 18:-0.25377184 19:0.27052855 20:-0.13939533 21:-1.4067736 22:0.40916508 23:-0.93048185 24:-0.90124398 25:-1.139022 26:-0.90997916 27:-0.1367933 28:-0.45856705 29:0.20126998 30:0.44320375 31:0.17076015 32:0.13942185 33:0.59822404 34:0.28471127 35:0.47598884 36:-0.066112466 37:-1.2346281 38:0.26826265 39:0.56514877 40:-0.93853712 41:-0.24873205 42:-0.37741387 43:-0.13749911 44:-0.16866711 45:-0.02013343 46:-0.26543555 47:-0.11520155 48:-0.60198617 49:-0.21114011 50:0.502029 51:-0.20637487 52:-0.65794069 53:-0.16405942 54:-0.16070814 55:-0.26654825 56:0.12435222 57:0.47522637 58:0.022032019 59:0.42957374 60:-0.0071422169  |EV| 
-0.63212225300481827972021164896432  |BT| (ROOT (S (PP (IN (In))(NP (NP (CD (one))(JJ (36-month))(NN (trial)))(PP (IN (of))(NP (NP (JJ (teriparatide))(NN (vs))(NN (alendronate)))(PP (IN (for))(NP (NP (NNP (GIOP)))(PP (IN (in))(NP (NNS (men))(CC (and))(NNS (women))))))))))(, (,))(NP (DT (the))(JJ (anabolic))(NN (agent)))(VP (VP (VBD (led))(PP (TO (to))(NP (NP (DT (a))(JJR (greater))(NN (increase)))(PP (IN (in))(NP (NN (bone))(NN (density)))))))(CC (and))(VP (VBD (was))(VP (VBN (associated))(PP (IN (with))(NP (NP (DT (a))(JJR (lower))(NN (incidence)))(PP (IN (of))(NP (JJ (morphologic))(JJ (vertebral))(NNS (fractures)))))))))(. (.)))) |ET|  |BV| 1:1.8555552 2:-1.2722206 3:-0.18031485 4:-0.79166538 5:-0.22769068 6:1.0953016 7:0.30920225 8:-0.21043386 9:0.39473754 10:0.42890215 11:0.5085026 12:0.30641097 13:1.6130884 14:0.42426801 15:-0.6740852 16:0.42879158 17:-0.2468079 18:-0.49778593 19:-0.23895197 20:-0.21471269 21:0.14559665 22:-0.96536797 23:-0.049320791 24:0.10797343 25:0.3003158 26:0.05989844 27:-0.20600575 28:-0.39199704 29:0.19992818 30:0.15507546 31:-0.0048865797 32:-0.33889413 33:0.55883229 34:-0.001611074 35:-0.50033373 36:-0.18548341 37:-0.46428102 38:-0.25024152 39:-0.046396352 40:-0.39793542 41:0.22779979 42:0.46281523 43:-0.13679771 44:0.27378795 45:0.13634209 46:0.070162185 47:0.0026049456 48:-0.30956495 49:-0.050599065 50:-0.0066138832 51:-0.036921434 52:-0.13931668 53:-0.062929444 54:0.18466379 55:0.16199456 56:-0.20060647 57:0.28610405 58:0.15790328 59:0.082400203 60:-0.14728466  |EV| 
-1  |BT| (ROOT (S (ADVP (RB (Interestingly)))(, (,))(NP (NP (DT (the))(NN (action)))(PP (IN (of))(NP (NN (amiodarone)))))(VP (VBZ (is))(ADJP (JJ (additive))(PP (IN (with))(NP (NP (DT (the))(NN (one)))(PP (IN (of))(NP (NP (NN (chloroquine)))(, (,))(NP (NP (DT (a))(VBN (known))(NN (inhibitor)))(PP (IN (of))(NP (NNP (ABC-transporters)))))))))))(. (.)))) |ET|  |BV| 1:-0.44465402 2:-0.32230401 3:-0.045599494 4:0.39940435 5:0.65570676 6:-0.75953043 7:-0.077495389 8:0.46600577 9:0.02426268 10:0.39012048 11:-1.4777908 12:0.13325724 13:0.47489363 14:0.99156183 15:-1.030862 16:0.12335151 17:-0.30270708 18:-0.059895068 19:-0.040842503 20:-0.3289873 21:-0.16469966 22:0.022516429 23:-0.73193413 24:0.045193154 25:0.4222194 26:0.036796849 27:0.2352435 28:-0.27031907 29:0.41419598 30:0.20313478 31:-0.29296407 32:-0.33279586 33:0.23716505 34:-0.20832293 35:-0.14375141 36:-0.043305229 37:-0.10976048 38:-0.43185729 39:0.685583 40:0.18347895 41:-0.10938887 42:-0.38245955 43:0.14321519 44:0.044857524 45:0.3669782 46:-0.29872188 47:0.23523457 48:0.17176935 49:0.098058701 50:0.28258982 51:0.40256479 52:0.017722167 53:-0.021063194 54:0.001281107 55:0.15073901 56:0.33263028 57:0.16956863 58:0.33415374 59:0.18496469 60:0.15551123  |EV| 
1  |BT| (ROOT (S (NP (NNP (Addition)))(VP (ADVP (IN (of)))(VBZ (L-NAME))(-LRB- (-LRB-))(NP (CD (10))))(. (?)))) |ET|  |BV| 1:-0.29991701 2:-0.32896069 3:-0.69324625 4:-1.0911616 5:0.35399058 6:-0.10250002 7:0.39163858 8:-0.35641289 9:0.19815752 10:0.13153271 11:0.585962 12:-0.79918879 13:-0.1041747 14:-0.49502534 15:0.46688238 16:0.2814571 17:-0.51942658 18:-0.21242213 19:-0.45488372 20:-0.35163856 21:-0.74559247 22:-0.92662257 23:-0.094804794 24:-1.0139915 25:-0.31690508 26:-0.21768261 27:0.49653453 28:0.90447181 29:0.071511663 30:-0.20202994 31:0.063019894 32:-0.83182251 33:-0.51941019 34:0.37375233 35:-0.06491974 36:-0.22771221 37:-0.74174893 38:-0.23774406 39:-0.24274755 40:-0.076648839 41:-0.5185281 42:-0.7219348 43:-0.26535568 44:-0.33659416 45:0.35703728 46:-0.56103665 47:-0.096939683 48:-0.013583369 49:-0.63936836 50:0.16969082 51:0.32175457 52:0.13346069 53:0.072000608 54:-0.037328582 55:0.0084037492 56:0.050877023 57:0.81833345 58:0.40231639 59:-0.10890339 60:0.091367833  |EV| 
1  |BT| (ROOT (S (NP (NP (NNP (Pretreatment)))(PP (IN (with))(NP (DT (the))(ADJP (ADJP (JJ (poly)))(PRN (-LRB- (-LRB-))(NP (NNP (ADP-ribose)))(-RRB- (-RRB-))))(NN (polymerase))(PRN (-LRB- (-LRB-))(NP (NNP (PARP)))(-RRB- (-RRB-)))(JJ (inhibitor))(NN (nicotinamide)))))(VP (VBD (was))(ADJP (JJ (able))(S (VP (TO (to))(VP (VB (prevent))(NP (CD (HCN2))(NN (cell))(NN (death))))))))(. (.)))) |ET|  |BV| 1:-1.1993157 2:0.053196605 3:0.1224883 4:-1.9055474 5:-0.92909217 6:-0.64883864 7:0.30231109 8:1.3207569 9:-0.42110953 10:-0.78424996 11:-0.56691229 12:-0.42819503 13:0.48882344 14:0.77929699 15:-0.079202443 16:0.58030307 17:-1.0447642 18:0.72934699 19:0.48482397 20:-1.1021204 21:-0.16018865 22:-0.20164067 23:0.48393661 24:-0.3548536 25:-0.29586497 26:-0.69610828 27:0.59243101 28:0.71105278 29:-0.2180766 30:-0.076776206 31:0.18077846 32:0.11973686 33:-0.23570934 34:1.1153556 35:-0.10737976 36:0.15242311 37:-0.40505868 38:0.15672459 39:-0.11915537 40:-0.34048092 41:-0.18662667 42:-0.46376848 43:0.062977754 44:-0.4639048 45:0.15059537 46:-0.092401959 47:0.25971705 48:0.0075230338 49:0.0033323055 50:-0.32721618 51:0.19921748 52:0.028093984 53:0.11199475 54:0.16654766 55:-0.083239749 56:0.34423569 57:0.61986649 58:0.013610451 59:-0.0072255651 60:-0.14489049  |EV| 
1  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(S (NP (NNP (Celecoxib)))(VP (MD (can))(VP (VB (be))(VP (VBN (used))(ADVP (ADVP (RB (effectively)))(CC (and))(ADVP (RB (safely))))(S (VP (TO (to))(VP (VB (prevent))(NP (JJ (capecitabine-related))(NN (HFS))))))))))(. (.)))) |ET|  |BV| 1:-0.56679702 2:-0.62543494 3:-0.5860247 4:-0.072349876 5:0.2914542 6:0.039748844 7:0.12966907 8:-0.46064526 9:0.56549722 10:0.089931421 11:-0.20305611 12:0.38930008 13:0.12347036 14:-0.012362192 15:-0.31148207 16:0.74294347 17:0.21108854 18:-0.91415018 19:-0.47628018 20:-1.0190288 21:-0.32796666 22:-0.25613049 23:-0.52632725 24:0.24094534 25:-0.26407838 26:-0.0081087351 27:-0.25522965 28:-0.014294713 29:0.8821184 30:-0.31850836 31:-0.75686383 32:1.0172775 33:0.68566597 34:-0.8547563 35:-0.31067047 36:0.78766519 37:0.16948181 38:-1.0481271 39:-0.16115592 40:-0.68791288 41:-0.22668482 42:0.12565137 43:-0.1324587 44:0.0024048779 45:0.26116794 46:-0.24280791 47:-0.20895852 48:-0.51180321 49:-0.079732776 50:0.092892893 51:0.31995887 52:-0.010705335 53:-0.14677839 54:0.42625371 55:0.28632826 56:-0.25836739 57:0.35476696 58:-0.16922681 59:-0.16634247 60:-0.11811004  |EV| 
-1  |BT| (ROOT (S (NP (NN (Tobramycin))(CC (and))(NN (gentamicin)))(VP (MD (can))(ADVP (RB (safely)))(VP (VB (be))(VP (VBN (given))(PP (IN (by))(NP (JJ (slow))(NN (push)))))))(. (.)))) |ET|  |BV| 1:-0.90144736 2:-0.77357274 3:-0.98598629 4:0.32056946 5:0.56900829 6:-0.34711796 7:0.099613249 8:-0.91540295 9:-0.10529343 10:0.9992407 11:-1.3118937 12:0.25720066 13:-0.73304844 14:-0.50897765 15:-0.20677987 16:-0.022683533 17:-0.53631645 18:-0.83129674 19:-0.71905071 20:0.53638476 21:-0.22913231 22:-1.2405342 23:-0.30050904 24:-0.14356558 25:0.29575044 26:0.11060968 27:0.20454697 28:0.017117478 29:0.074474417 30:0.250958 31:-0.43201312 32:-0.99625641 33:-0.28138539 34:0.76117563 35:-0.12153184 36:-0.056398768 37:-0.64857173 38:-0.27979827 39:-0.59806585 40:0.59601575 41:-0.13940489 42:-0.13985452 43:-0.037979092 44:-0.085790396 45:0.016450102 46:-0.58741885 47:0.060406182 48:-0.28220025 49:0.08495187 50:0.093223758 51:0.14306502 52:0.085696876 53:0.00018746342 54:0.40823203 55:0.35357884 56:-0.25287384 57:0.26182187 58:-0.045700382 59:-0.43640217 60:-0.43985346  |EV| 
-1  |BT| (ROOT (S (NP (PRP (It)))(VP (VBD (was))(VP (VBN (concluded))(SBAR (SBAR (IN (that))(S (NP (DT (all))(NNS (protocols)))(VP (VBD (provided))(NP (JJ (adequate))(NN (analgesia))))))(CC (and))(SBAR (WHADVP (WRB (when)))(S (S (VP (VBN (used))(PP (IN (with))(NP (NN (midazolam-medetomidine-ketamine))))))(VP (VBP (are))(ADJP (JJ (effective))(PP (IN (for))(NP (JJ (routine))(JJ (feline))(NN (ovariohysterectomy)))))))))))(. (.)))) |ET|  |BV| 1:-0.11668429 2:-0.74165034 3:-1.0241296 4:-0.74730933 5:0.10768051 6:-0.027183697 7:-0.3724331 8:0.063145764 9:0.61295736 10:0.35496283 11:0.77447647 12:-0.23379371 13:0.25274378 14:-0.1552559 15:-0.41261145 16:0.58029056 17:0.033387862 18:0.43734667 19:-0.18863106 20:-0.29837921 21:-0.33319581 22:-0.9960075 23:-0.36023229 24:-0.92181027 25:0.70081371 26:0.13029915 27:-1.0233551 28:-0.3117902 29:-0.06793651 30:-0.072507545 31:0.083184622 32:-0.49804565 33:-0.0906666 34:-0.08099328 35:-0.43621778 36:0.82062733 37:-0.23244357 38:-0.10020839 39:0.24677145 40:-1.4766077 41:-0.54253477 42:-0.099288113 43:0.35640484 44:0.086138047 45:0.17721993 46:-0.15654343 47:-0.10916232 48:0.1159996 49:0.39309952 50:0.26952156 51:0.12959385 52:0.4050242 53:-0.15491019 54:0.25288731 55:-0.1877137 56:-0.47574008 57:0.037227448 58:0.02224724 59:-0.22766301 60:0.068437144  |EV| 
-0.9867169898572910602396746071463  |BT| (ROOT (S (NP (PRP (It)))(VP (MD (may))(VP (VB (be))(VP (VBN (concluded))(SBAR (IN (that))(S (NP (NP (CD (40))(NN (mg))(NN (enalapril)))(CC (or))(NP (CD (200))(NN (mg))(NN (losartan))))(VP (VBP (are))(RB (not))(ADJP (JJ (sufficient))(S (VP (TO (to))(VP (VB (reduce))(NP (NN (proteinuria))(CC (and))(NN (blood))(NN (pressure)))(ADVP (RB (significantly)))(PP (IN (in))(NP (NP (ADJP (NN (type))(CD (2)))(JJ (proteinuric))(NNS (diabetics)))(PP (IN (with))(NP (JJ (renal))(NN (dysfunction))))))))))(SBAR (IN (although))(S (NP (DT (both))(NNS (drugs)))(VP (VBD (were))(ADVP (RB (well)))(VP (VBN (tolerated))(PP (IN (at))(NP (JJ (high))(NNS (doses))))))))))))))(. (.)))) |ET|  |BV| 1:-0.44045794 2:-0.20210637 3:-0.66858321 4:-0.20488085 5:0.19160648 6:-0.085578531 7:-0.041856848 8:0.2172731 9:-0.22746991 10:0.76215541 11:-0.25301582 12:-0.95776105 13:0.62736779 14:0.17984417 15:-0.50206578 16:-0.37004891 17:-0.029559879 18:-0.37207043 19:0.013137033 20:-0.36919877 21:-0.11989374 22:0.02275284 23:0.096252784 24:-0.10840993 25:0.091117181 26:0.54770023 27:-0.28366002 28:0.15614185 29:-0.042302072 30:1.256332 31:0.33538967 32:-0.49246866 33:0.067063369 34:0.1227378 35:-0.69925517 36:0.54223621 37:-1.0732445 38:-0.16988181 39:-0.29746479 40:-0.29228118 41:-0.4951438 42:-0.016866246 43:0.27956626 44:0.040818717 45:-0.14349174 46:-0.01564648 47:-0.48963043 48:0.21600883 49:0.1900941 50:0.14878403 51:0.19369347 52:-0.16875175 53:0.15268704 54:0.24139041 55:0.51968884 56:-0.28463146 57:-0.23024626 58:0.48723248 59:-0.22559986 60:-0.13642505  |EV| 
1  |BT| (ROOT (FRAG (NP (NNP (RESULTS)))(: (:))(S (NP (NP (DT (The))(JJS (highest))(NN (dose)))(PP (IN (of))(NP (NP (NN (estradiol)))(PP (IN (in))(NP (NP (NN (combination)))(PP (IN (with))(NP (NN (progesterone)))))))))(VP (VBD (was))(VP (VBN (associated))(PP (PP (IN (with))(NP (DT (the))(ADJP (RBS (most))(JJ (pronounced)))(NN (symptom))(NN (recurrence))))(, (,))(CC (both))(PP (IN (in))(NP (NP (NN (comparison)))(PP (IN (with))(NP (NP (DT (a))(JJR (lower))(NN (dose)))(PP (IN (of))(NP (NN (estradiol))))))))(ADVP (RB (together))))(PP (IN (with))(NP (JJ (progesterone))(CC (and))(JJ (estradiol-only))(NN (treatment)))))))(. (.)))) |ET|  |BV| 1:-0.85465068 2:-0.1223867 3:0.039865397 4:-0.019043626 5:0.45820934 6:-0.23349798 7:-0.055019416 8:-0.62751144 9:0.28472161 10:0.22962189 11:0.65343541 12:0.033011775 13:0.56688863 14:0.29359838 15:0.41499624 16:0.37236989 17:-0.36746573 18:0.17696653 19:0.45934385 20:0.74600995 21:-0.70291984 22:0.10596521 23:0.40353924 24:-0.0082024643 25:0.51516557 26:-0.4248296 27:0.15003122 28:0.1239915 29:0.20275137 30:0.48732561 31:0.47781709 32:-0.14894189 33:0.51152009 34:0.33163288 35:-0.5908134 36:0.57499492 37:0.029747412 38:0.11391607 39:0.40241897 40:0.6374259 41:-0.054782338 42:0.008420324 43:-0.086031243 44:0.35578576 45:0.33762404 46:-0.059868045 47:-0.62654752 48:-0.12100456 49:-0.034663845 50:0.26551086 51:0.038700636 52:-0.22988118 53:0.26230201 54:0.20914651 55:-0.28321511 56:0.20418559 57:0.98321259 58:0.61721301 59:0.22644742 60:-0.17938238  |EV| 
1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSIONS)))(: (:))(S (NP (NP (DT (The))(NN (addition)))(PP (IN (of))(NP (NP (NN (dexamethasone)))(PP (TO (to))(NP (NN (mepivacaine)))))))(VP (VP (VBZ (prolongs))(NP (NP (DT (the))(NN (duration)))(PP (IN (of))(NP (NN (analgesia))))))(CC (but))(VP (VBZ (does))(RB (not))(VP (VB (reduce))(NP (NP (DT (the))(NN (onset)))(PP (IN (of))(NP (NP (JJ (sensory))(CC (and))(NN (motor))(NN (blockade)))(PP (IN (after))(NP (JJ (ultrasound-guided))(NN (supraclavicular))(NN (block)))))))(PP (VBN (compared))(PP (IN (with))(NP (NN (mepivacaine)))(ADVP (RB (alone)))))))))(. (.)))) |ET|  |BV| 1:-0.10846969 2:-1.1248966 3:-2.2123501 4:-0.45427525 5:-0.0025391362 6:-0.71695 7:0.98120749 8:0.085808828 9:-0.018116614 10:0.24273001 11:0.28299728 12:0.87854862 13:0.55519456 14:-0.51021361 15:0.35845408 16:0.48307443 17:1.2435056 18:0.4753606 19:0.85673851 20:0.015080235 21:-0.37860355 22:-0.77694696 23:0.15381135 24:-0.30914474 25:0.1739258 26:-0.038748726 27:-0.1213993 28:-0.30365685 29:-0.37887204 30:0.97536069 31:-0.10927109 32:-0.26525721 33:0.15702246 34:-0.080765247 35:0.04058389 36:0.47821069 37:-0.2975603 38:-0.32002869 39:-0.079881735 40:0.0094199497 41:-0.0069700577 42:0.62894666 43:-0.11931515 44:-0.095916934 45:0.6696977 46:-0.52859932 47:-0.38847485 48:-0.2709077 49:-0.022042869 50:0.079710484 51:-0.27185559 52:-0.3044467 53:-0.33029908 54:-0.063711867 55:-0.30507949 56:0.09436854 57:0.46872929 58:-0.17002775 59:-0.27465081 60:0.083312295  |EV| 
0.95661466710521958489721328078303  |BT| (ROOT (S (S (NP (NP (CD (One))(NN (interpretation)))(PP (IN (of))(NP (DT (the))(NNS (findings)))))(VP (VBZ (is))(SBAR (IN (that))(S (NP (NN (caffeine)))(VP (VBZ (reduces))(NP (NP (DT (the))(NN (binding)))(PP (IN (of))(NP (NN (calcium)))))(PP (DT (both))(PP (IN (in))(NP (DT (the))(NN (membrane))))(CC (and))(PP (IN (in))(NP (DT (the))(NN (myoplasm))))))))))(: (;))(S (NP (DT (this)))(VP (VBZ (increases))(NP (NP (NP (DT (the))(`` (``))(NN (permeability))('' ('')))(PP (TO (to))(NP (NN (calcium)))))(CC (and))(NP (NP (DT (the))(JJ (ionic))(NN (activity)))(PP (IN (of))(NP (NP (NN (calcium)))(PP (IN (in))(NP (NN (muscle))))))))))(. (.)))) |ET|  |BV| 1:-0.76733154 2:0.2460794 3:-0.36372909 4:-0.26238525 5:-0.33067521 6:-0.33500141 7:-0.089534409 8:0.13414255 9:0.37700409 10:0.26008978 11:-0.075949982 12:-0.24670501 13:0.17961161 14:-0.15187471 15:-1.0580264 16:-0.25400683 17:-0.31937048 18:0.033552781 19:0.48308486 20:-0.69982004 21:-0.2271708 22:-0.49435622 23:-0.40642983 24:-0.10535501 25:-0.27241275 26:0.051554579 27:-0.072615057 28:-0.48675424 29:0.82784843 30:0.19380833 31:0.63382119 32:0.076453894 33:-0.12286576 34:-0.33363119 35:-0.37121943 36:-0.018839749 37:0.16713631 38:0.24557871 39:0.4215138 40:0.49096838 41:-0.11066132 42:0.0085656494 43:0.36054519 44:0.40146816 45:-0.28329161 46:-0.017671164 47:-0.31622526 48:0.061480086 49:0.048572283 50:0.37426037 51:-0.18462184 52:0.25033173 53:-0.040978748 54:-0.098860085 55:-0.082847297 56:0.17607558 57:-0.36613628 58:0.16977058 59:-0.75163603 60:-0.013338619  |EV| 
-1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (NP (DT (Both)))(ADJP (JJ (atropine))(CC (and))(JJ (labetalol))))(VP (VBD (were))(ADJP (JJ (able))(S (VP (TO (to))(VP (VB (lower))(NP (NP (DT (the))(NN (frequency)))(PP (IN (of))(NP (NN (bradycardia)))))))))))(. (.)))) |ET|  |BV| 1:-0.67935634 2:-0.76576102 3:-0.22106758 4:-0.57372367 5:0.28197569 6:0.20814733 7:0.15986425 8:-0.027409209 9:0.26356155 10:0.089581832 11:0.42520076 12:-0.090538852 13:0.23981953 14:-0.41005591 15:-0.60331243 16:0.26125708 17:0.019843308 18:-0.055050366 19:-0.095602602 20:-0.014820319 21:-0.58098125 22:-0.40042359 23:-1.5038909 24:-0.86171508 25:-0.49340943 26:0.017316615 27:0.43960094 28:-0.049376938 29:0.36283317 30:0.74861336 31:0.4021062 32:-0.69954503 33:0.42344731 34:-0.44488522 35:-0.40955183 36:0.91399258 37:-0.059419192 38:0.32290283 39:0.011256274 40:-0.64895022 41:-0.33024085 42:0.095193006 43:0.13546225 44:0.10700334 45:-0.020409832 46:-0.27642927 47:-0.40872547 48:-0.34815118 49:0.047458958 50:-0.034340546 51:0.090304479 52:0.013966616 53:-0.33480132 54:-0.064863056 55:-0.24053223 56:-0.16270885 57:0.16170947 58:0.17324926 59:-0.15239599 60:-0.17294192  |EV| 
-1  |BT| (ROOT (S (NP (PRP$ (Our))(NNS (studies)))(ADVP (RB (further)))(VP (VBP (support))(NP (DT (the))(NN (notion)))(SBAR (SBAR (IN (that))(S (NP (NP (JJ (1-phenylpropane-1))(CD (,2)))(: (-))(NP (NP (NN (dione)))(CC (and))(NP (-LRB- (-LRB-))(NNP (S))(-RRB- (-RRB-))))(: (-)))(ADVP (RB (cathinone)))(VP (VBP (are))(NP (NP (JJ (biosynthetic))(NNS (precursors)))(PP (IN (of))(NP (NP (DT (the))(JJ (ephedrine))(NNS (alkaloids)))(PP (IN (in))(NP (NP (NNP (E.))(NNP (sinica)))(VP (VBZ (stems)))))))))))(CC (and))(SBAR (IN (that))(S (NP (NP (DT (the))(NN (activity)))(PP (IN (of))(NP (NP (-LRB- (-LRB-))(NNP (S))(-RRB- (-RRB-)))(: (-))(NP (JJ (cathinone))(NNS (reductases))))))(VP (VBZ (directs))(CC (and))(VBZ (determines))(NP (NP (DT (the))(JJ (stereochemical))(NN (branching)))(PP (IN (of))(NP (DT (the))(NN (pathway))))))))))(. (.)))) |ET|  |BV| 21:-1.108264 22:-0.6469155 23:-0.76749939 24:-0.76419538 25:0.58523953 26:0.084061302 27:0.76048017 28:0.22806706 29:-0.064313509 30:0.57709318 31:0.2053308 32:0.34237215 33:-0.79073209 34:0.2953113 35:-0.21772186 36:0.94173443 37:0.2466367 38:-0.031097014 39:-0.45997047 40:-0.41981825 41:-0.35839799 42:-0.06994307 43:0.079077519 44:0.19737177 45:-0.23435576 46:-0.01649498 47:0.033517227 48:-0.02881957 49:0.1992152 50:0.069139674 51:0.24089955 52:0.13287215 53:0.15652777 54:0.034178816 55:-0.47532448 56:0.3159157 57:-0.011261834 58:-0.26447919 59:0.40172455 60:-0.061112583  |EV| 
-1  |BT| (ROOT (S (PP (IN (After))(S (VP (VBG (having))(VP (VBN (experienced))(NP (DT (a))(JJ (significant))(NN (stress)))(PP (IN (on))(NP (DT (a))(NN (job))))))))(NP (DT (the))(NN (patient)))(VP (VBD (ingested))(NP (NP (JJ (huge))(NN (amount)))(PP (IN (of))(NP (NP (NN (pregabalin)))(PRN (-LRB- (-LRB-))(NP (QP (CD (4,2))(CD (r))))(-RRB- (-RRB-))))))(PP (ADVP (RB (together)))(IN (with))(NP (NP (NN (bromazepam)))(PRN (-LRB- (-LRB-))(NP (QP (CD (21))(CD (mg))))(-RRB- (-RRB-)))(CC (and))(NP (NN (chlorimipramine)))(PRN (-LRB- (-LRB-))(NP (QP (CD (125))(CD (mg))))(-RRB- (-RRB-))))))(. (.)))) |ET|  |BV| 1:-0.3715277 2:0.87690616 3:-0.67786133 4:-1.0895817 5:-0.32238093 6:-0.30310103 7:0.74545997 8:1.0689116 9:-0.084735177 10:-0.13898903 11:-0.45417902 12:1.5356567 13:-1.1514781 14:0.3972005 15:-0.16190478 16:0.024553267 17:-1.1329116 18:0.32390153 19:0.3422752 20:-0.23198044 21:-0.15756521 22:-0.73500854 23:0.27732077 24:-1.1033922 25:-0.84908271 26:0.099410497 27:0.61854541 28:1.0471468 29:-0.79155123 30:1.0137994 31:-0.1654882 32:1.7841874 33:-0.058538508 34:-0.20666136 35:0.24202348 36:0.050779529 37:-0.47508377 38:0.21666744 39:0.5929929 40:-0.34812191 41:-0.27601537 42:-0.008309924 43:-0.18264793 44:-0.086053051 45:0.19646661 46:0.1656806 47:0.096765384 48:0.44792366 49:-0.010487107 50:-0.45661753 51:0.11046581 52:0.48861441 53:0.10922129 54:-0.11300386 55:-0.073537484 56:-0.08435002 57:0.72861916 58:0.090702914 59:0.074953854 60:-0.16789076  |EV| 
1  |BT| (ROOT (S (ADVP (RB (Therefore)))(, (,))(NP (NNS (clinicians)))(VP (MD (should))(VP (VB (be))(ADJP (JJ (aware))(PP (IN (of))(NP (NP (DT (the))(ADJP (RB (potentially))(JJ (severe)))(JJ (adverse))(NNS (reactions)))(SBAR (WHNP (WDT (that)))(S (VP (MD (might))(VP (VB (occur))(PP (IN (during))(NP (JJ (concomitant))(NN (treatment))))(PP (IN (with))(NP (NN (fluvoxamine))(CC (and))(NN (topiramate)))))))))))))(. (.)))) |ET|  |BV| 1:-0.40733424 2:0.088755883 3:0.10718788 4:0.013866344 5:1.3555768 6:0.27399254 7:0.03464178 8:-0.6104272 9:0.8449223 10:1.2903489 11:-0.54146254 12:0.1041882 13:0.42105645 14:-0.415142 15:0.24828853 16:0.62464571 17:0.32119453 18:-0.5138095 19:0.29288891 20:0.75004053 21:-0.60522342 22:0.27817166 23:-0.90040553 24:-0.31354764 25:0.31086519 26:-0.032624342 27:-0.59054387 28:-0.83233339 29:1.3101377 30:0.5389362 31:0.28208524 32:0.10082465 33:1.5436033 34:0.41065362 35:0.59445727 36:0.13318267 37:0.30581635 38:-1.0496583 39:0.307877 40:0.63569981 41:0.033959888 42:0.027510187 43:0.32678607 44:0.22634886 45:0.2587229 46:-0.077155985 47:0.068695538 48:-0.2624152 49:0.17027704 50:0.05064458 51:0.1582194 52:-0.51965088 53:-0.40854359 54:0.26124856 55:0.27135313 56:0.064434551 57:0.5344246 58:0.24181905 59:0.085832022 60:0.21217079  |EV| 
1  |BT| (ROOT (S (NP (NNP (Adenosine))(NNP (A2A))(NN (receptor))(NNS (activation)))(VP (VBZ (reduces))(NP (NN (recurrence))(CC (and))(NN (mortality)))(PP (IN (from))(NP (NP (NNP (Clostridium))(NN (difficile))(NN (infection)))(PP (IN (in))(NP (NP (NNS (mice)))(PP (VBG (following))(NP (NN (vancomycin))(NN (treatment)))))))))(. (.)))) |ET|  |BV| 1:-0.29975867 2:-0.90835148 3:-0.35928813 4:-0.40498751 5:-0.070239365 6:-0.54183668 7:-0.41281372 8:0.56097722 9:-0.59817785 10:0.68011802 11:-1.0664285 12:-0.33847964 13:-0.050172817 14:1.0202811 15:-0.51219434 16:0.73061973 17:-0.31654057 18:-0.64519918 19:-0.52202326 20:0.20618306 21:-0.6597845 22:-0.31617564 23:0.6121586 24:-0.20507358 25:-0.38477787 26:0.017386394 27:1.0120741 28:0.55528861 29:0.72523844 30:0.13058755 31:0.55353308 32:-0.43569505 33:1.548465 34:0.40420932 35:-0.14122428 36:0.4070124 37:0.362838 38:-0.28290966 39:0.32303816 40:-0.16674691 41:0.060000814 42:-0.26570427 43:0.29985878 44:0.32654765 45:0.082037985 46:-0.042080514 47:-0.31069604 48:-0.058550201 49:-0.54371661 50:0.34423864 51:-0.19239713 52:0.069108181 53:0.18452632 54:0.065499023 55:0.12032666 56:0.072963931 57:0.38348359 58:0.28043589 59:-0.10032836 60:-0.055832706  |EV| 
1  |BT| (ROOT (S (NP (NP (NNS (Suggestions)))(PP (IN (for))(NP (JJ (clinical))(NNS (trials)))))(VP (VBP (are))(VP (VBN (provided))(PP (IN (for))(NP (NP (NP (JJ (oral))(JJ (high-dose))(NN (dextromethorphan)))(CC (and))(NP (NNP (Nuedexta))))(PRN (-LRB- (-LRB-))(NP (NP (NN (dextromethorphan)))(VP (VBN (combined))(PP (IN (with))(NP (NN (quinidine))))(S (VP (TO (to))(VP (VB (block))(NP (NN (metabolism)))(PP (TO (to))(NP (NN (dextrorphan)))))))(, (,))(S (ADVP (RB (thereby)))(VP (VBG (increasing))(NP (JJ (dextromethorphan))(NN (plasma))(NNS (concentrations)))))))(-RRB- (-RRB-)))))))(. (.)))) |ET|  |BV| 1:-1.1707729 2:0.012263766 3:-0.84103411 4:-0.76736891 5:0.44781983 6:-0.33082962 7:1.1540477 8:0.75352329 9:0.52853262 10:-0.61968285 11:-0.39778149 12:0.53033823 13:1.3973336 14:-1.0261741 15:0.025873467 16:0.64448971 17:0.70441997 18:-0.43234247 19:1.7754222 20:-0.80212051 21:-1.0970409 22:0.2492929 23:-0.47835976 24:-0.75830764 25:0.21095426 26:-0.51516789 27:0.80864805 28:-0.71112651 29:0.26558745 30:0.61124283 31:0.57490146 32:-0.90374875 33:0.90670896 34:-0.12755761 35:-0.79162866 36:-0.15326242 37:0.75029796 38:-0.83412212 39:0.7489388 40:-0.039337046 41:0.25539193 42:-0.26039508 43:0.009961904 44:-0.085021324 45:0.019663984 46:0.077245846 47:-0.38111502 48:-0.58264321 49:0.089632101 50:-0.21255884 51:-0.070178941 52:-0.11987563 53:-0.0622679 54:-0.16256726 55:0.39346334 56:0.42196533 57:-0.33701015 58:0.02348353 59:0.031497933 60:0.00622425  |EV| 
-1  |BT| (ROOT (NP (NP (NNP (CONCLUSION)))(: (:))(NP (NP (NNP (Exposure)))(PP (TO (to))(NP (NP (NP (NN (ethanol)))(PP (IN (during))(NP (NN (pregnancy))(NNS (increases))(NNP (IGF-I))(CC (and))(NNP (IGF-II)))))(CC (and))(NP (NP (NNS (decreases)))(VP (VBN (leptin))(PP (IN (during))(NP (JJ (early))(NN (childhood)))))))))(. (.)))) |ET|  |BV| 1:-1.1923358 2:0.36651093 3:0.14956017 4:-0.25442144 5:-0.74738133 6:0.29904133 7:0.63527578 8:0.27886191 9:0.45418373 10:0.062229525 11:0.63828611 12:-0.17143264 13:0.40124375 14:0.10097073 15:0.77508128 16:-0.08437378 17:-1.0932121 18:0.10228246 19:1.0465006 20:-0.54566127 21:-0.18262425 22:-0.27455565 23:-0.63187039 24:-0.20303082 25:-0.49805775 26:-0.36358526 27:-0.67585135 28:-0.18507487 29:0.57143605 30:-0.13132448 31:0.033105545 32:0.39477274 33:0.01403023 34:-0.085290499 35:0.069696143 36:0.078646556 37:-0.2542069 38:-0.099925838 39:0.45036244 40:0.57571846 41:-0.055515446 42:-0.080653176 43:-0.070444487 44:0.22189337 45:0.13441584 46:0.095493071 47:0.12557183 48:-0.69311935 49:-0.11840862 50:0.16673094 51:0.16080832 52:0.23540422 53:0.26769853 54:0.20856482 55:0.022768565 56:0.3142567 57:0.6107133 58:0.19407818 59:-0.12783302 60:0.14827177  |EV| 
-1  |BT| (ROOT (S (NP (NP (NP (NNS (Studies)))(PP (IN (of))(NP (NP (VBN (combined))(NN (therapy)))(PP (IN (with))(NP (NN (pemetrexed)))))))(, (,))(CC (and))(NP (NP (NN (bevacizumab)))(PP (IN (beyond))(NP (NN (progression)))))(, (,)))(VP (VBP (are))(ADJP (JJ (ongoing))))(. (.)))) |ET|  |BV| 1:-1.3908824 2:-0.11869227 3:0.231677 4:0.20158879 5:0.51931131 6:0.15928105 7:-0.94721961 8:-0.71603251 9:0.53037298 10:0.30137166 11:-1.0751276 12:0.034899134 13:0.29326963 14:0.06090232 15:-0.11565398 16:0.021296026 17:0.44529137 18:-0.70981979 19:-0.15477675 20:-1.3002903 21:-1.2117177 22:-0.36075294 23:0.064280353 24:-0.16516033 25:0.2985073 26:-0.075363375 27:0.017898917 28:-0.7093007 29:0.69164449 30:0.64934754 31:-1.8740338 32:-0.71959877 33:1.7490357 34:-0.78083962 35:-0.57003623 36:1.059317 37:0.36552858 38:-0.48745784 39:0.57645863 40:-1.8443197 41:0.10336014 42:0.11610208 43:-0.12481127 44:0.21785234 45:-0.060024712 46:-0.078616686 47:-0.1064215 48:-0.18285896 49:0.29520079 50:0.21553503 51:0.39706475 52:0.045637619 53:0.073875763 54:-0.042854551 55:0.40837374 56:-0.060209844 57:0.16769862 58:0.05472903 59:0.21526819 60:-0.52857339  |EV| 
-1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (NNP (Exenatide)))(VP (MD (can))(VP (VB (reduce))(NP (JJ (glycemic))(NN (variability)))(PP (VBN (compared))(PP (IN (with))(NP (NN (glimepiride)))))(, (,))(S (VP (VBG (providing))(NP (NP (JJ (additional))(JJ (beneficial))(NNS (effects)))(PP (IN (in))(NP (VBG (controlling))(NN (glucose))(NNS (homeostasis))))))))))(. (.)))) |ET|  |BV| 1:-0.93116724 2:0.16165628 3:-0.29050761 4:0.41528583 5:0.9210614 6:0.96246243 7:-0.45994931 8:-0.49726835 9:0.5069015 10:1.0611229 11:0.89072293 12:1.0179569 13:0.63718492 14:-0.57090878 15:-0.45598295 16:0.94798738 17:-0.31631407 18:0.37501788 19:-0.19825248 20:0.23595335 21:-0.81246877 22:0.21673532 23:-0.84179485 24:-0.22898389 25:0.069351196 26:0.11475291 27:-0.43084851 28:-0.72749895 29:-0.44754124 30:1.1456863 31:0.49666786 32:0.32925326 33:0.086216025 34:0.7848776 35:-0.070442803 36:1.7741995 37:-0.4424713 38:-0.19110917 39:-0.51957941 40:-0.075366549 41:-0.11285566 42:0.33559066 43:0.31283709 44:-0.093589649 45:0.060787041 46:-0.013190156 47:0.054832309 48:-0.85783446 49:0.038858727 50:-0.02937685 51:0.26014236 52:0.1090735 53:-0.091011293 54:-0.056013148 55:-0.099395066 56:0.46729338 57:0.30824614 58:0.16248286 59:0.2276943 60:0.404715  |EV| 
1  |BT| (ROOT (S (NP (NP (NN (Darifenacin))(, (,))(NN (oxybutynin))(, (,))(NN (tolterodine))(, (,))(CC (and))(NN (solifenacin)))(PRN (-LRB- (-LRB-))(NP (QP (CD (1))(CD (µM))))(-RRB- (-RRB-))))(ADVP (RB (all))(RB (significantly)))(VP (VBD (depressed))(NP (DT (the))(NN (frequency))(NNS (responses)))(PP (TO (to))(NP (NP (NN (carbachol)))(PRN (-LRB- (-LRB-))(NP (QP (CD (1))(CD (µM))))(-RRB- (-RRB-))))))(. (.)))) |ET|  |BV| 1:-0.96398121 2:-0.72986817 3:0.78382325 4:-0.23221229 5:-0.74379468 6:0.24420521 7:0.19699882 8:0.51081872 9:0.50388843 10:-0.3647604 11:0.34553966 12:-0.4490515 13:0.22615537 14:0.035029516 15:-0.70427251 16:0.34291399 17:-0.75787491 18:-0.66681296 19:0.059181526 20:-1.1488304 21:-0.65054059 22:-0.21124956 23:0.17133197 24:-0.061776195 25:-0.37753147 26:-0.6811325 27:0.42972559 28:-0.13692035 29:0.10174469 30:-0.54913765 31:0.49487802 32:-0.135359 33:-0.27002528 34:-0.52904797 35:-0.31652325 36:0.14843516 37:0.20821591 38:0.50349724 39:0.40614331 40:0.028209951 41:-0.46176362 42:0.22227135 43:-0.26102078 44:-0.22920193 45:0.33080167 46:-0.10427046 47:-0.11518118 48:-0.062471207 49:-0.30371645 50:0.15643853 51:0.74717689 52:0.003257195 53:0.11749375 54:-0.23312649 55:-0.39839873 56:0.11162661 57:0.53589153 58:0.10688544 59:0.21737665 60:-0.38508812  |EV| 
1  |BT| (ROOT (S (NP (NNP (Naltrexone)))(VP (VBD (was))(VP (VBN (given))(S (VP (TO (to))(VP (VB (block))(NP (NP (DT (the))(JJ (opioid))(NNS (effects)))(PP (IN (of))(NP (NN (fentanyl))))))))))(. (.)))) |ET|  |BV| 1:-0.27463067 2:-0.91500187 3:-0.21062799 4:-0.80729401 5:0.75264245 6:-0.25265709 7:0.50812238 8:0.20771764 9:0.71180749 10:0.92224193 11:0.66304022 12:0.29768577 13:0.93442696 14:-0.63969117 15:-0.16151166 16:0.83217007 17:-0.069254249 18:-0.27093816 19:0.50270307 20:-0.37011161 21:-0.5965603 22:-0.60173035 23:-0.5637145 24:-0.742405 25:0.11047246 26:-0.63334364 27:-0.39095229 28:-0.11231483 29:0.08078523 30:0.339479 31:0.24232866 32:-0.4889521 33:0.044322167 34:-0.77776569 35:-0.32153225 36:0.4958865 37:0.6283139 38:-0.012034352 39:-0.66721821 40:-1.0869571 41:0.042391594 42:-0.087760322 43:0.21589287 44:-0.41139197 45:0.39889482 46:-0.0051261294 47:0.20188522 48:-0.16193476 49:-0.25689802 50:0.11044021 51:-0.16737477 52:0.14578173 53:0.034244936 54:0.060563523 55:-0.15279594 56:-0.013212064 57:-0.074377649 58:-0.049110953 59:-0.17898455 60:0.091567568  |EV| 
0.68776771135348269137210763801704  |BT| (ROOT (S (SBAR (IN (As))(S (NP (DT (the))(NN (TOFR)))(VP (VBD (was))(NP (NP (CD (1.44)))(SBAR (WHADVP (WRB (when)))(S (NP (DT (the))(NN (surgery)))(VP (VBD (completed)))))))))(, (,))(NP (DT (the))(NN (trachea)))(VP (VBD (was))(VP (VBN (extubated))(PP (IN (without))(S (VP (VBG (giving))(ADJP (JJ (neostigmine))(S (VP (TO (to))(VP (VB (antagonize))(NP (NP (DT (the))(NN (effect)))(PP (IN (of))(NP (NN (vecuronium))))))))))))))(. (.)))) |ET|  |BV| 1:-0.73282301 2:-0.62496716 3:-0.55196631 4:-0.59960639 5:0.041034617 6:-0.34943715 7:0.12115459 8:0.74872983 9:0.71173537 10:-0.54305732 11:0.92430598 12:-0.20378846 13:0.71527505 14:-0.89005417 15:-1.0758097 16:1.0591766 17:-0.083953075 18:0.84651631 19:-0.49481836 20:-0.20741776 21:-0.68614113 22:-0.65829486 23:-0.00013987023 24:-0.69458354 25:0.96579355 26:-0.39681914 27:0.070516728 28:0.88442427 29:2.4594264 30:0.64080501 31:-0.21193583 32:0.46229142 33:-0.40535548 34:-1.1348872 35:-0.20699725 36:0.71404099 37:0.092942588 38:1.1456379 39:0.64754295 40:0.24682903 41:-0.39083207 42:0.25195426 43:0.088800497 44:-0.087418184 45:0.35853833 46:0.13507693 47:-0.085344456 48:-0.06275928 49:-0.059664588 50:0.45961237 51:0.08794494 52:0.11617428 53:-0.28607452 54:-0.26028624 55:-0.46931139 56:-0.28569847 57:0.084914111 58:-0.12482747 59:-0.0028960989 60:-0.42502385  |EV| 
-1  |BT| (ROOT (S (PP (IN (During))(NP (NP (DT (the))(NN (period)))(PP (IN (of))(NP (NN (retention))))))(NP (NP (DT (the))(NN (chlorine))(NN (content)))(PP (IN (of))(NP (DT (the))(NN (blood)))))(VP (VBZ (is))(ADJP (RB (distinctly))(JJR (lower)))(SBAR (IN (than))(S (S (ADVP (RB (normally)))(, (,))(NP (DT (the))(NN (calcium))(NN (content)))(VP (VBZ (is))(ADVP (RB (apparently)))(ADJP (RB (slightly))(JJR (lower)))))(, (,))(CC (and))(S (NP (DT (the))(NN (magnesium))(NN (content)))(VP (VBZ (tends))(ADVP (RB (also)))(S (VP (TO (to))(VP (VB (be))(ADJP (NP (DT (a))(RB (little)))(JJR (lower)))))))))))(. (.)))) |ET|  |BV| 1:-0.76733154 2:0.2460794 3:-0.36372909 4:-0.26238525 5:-0.33067521 6:-0.33500141 7:-0.089534409 8:0.13414255 9:0.37700409 10:0.26008978 11:-0.075949982 12:-0.24670501 13:0.17961161 14:-0.15187471 15:-1.0580264 16:-0.25400683 17:-0.31937048 18:0.033552781 19:0.48308486 20:-0.69982004 21:-0.69870472 22:-0.24796677 23:-0.81360668 24:-0.010563116 25:0.23021409 26:-0.49103528 27:-0.12774047 28:0.32772008 29:-0.10109277 30:0.37758282 31:-0.10246789 32:-0.17838542 33:-0.41387382 34:-0.30004424 35:-0.10441614 36:0.11705339 37:-0.5140717 38:0.68735868 39:0.66774976 40:-0.36981764 41:-0.33053035 42:0.32286009 43:-0.31099394 44:-0.041827079 45:-0.089347117 46:0.24733691 47:-0.19805221 48:-0.01455935 49:0.14183567 50:-0.12761287 51:0.18701932 52:-0.47131419 53:0.40048292 54:-0.44303295 55:0.38636225 56:0.11848532 57:0.25722757 58:0.085567869 59:0.30996332 60:0.12313284  |EV| 
-1  |BT| (ROOT (S (NP (PRP (We)))(VP (VBD (found))(SBAR (IN (that))(S (NP (DT (the))(JJ (antihypertensive))(NN (drug))(NN (Prazosin)))(VP (VBZ (inhibits))(NP (JJ (endocytic))(VBG (sorting)))(PP (IN (by))(NP (NP (DT (an))(JJ (off-target))(NN (perturbation)))(PP (IN (of))(NP (NP (NP (DT (the))(NNP (G))(JJ (protein-coupled))(NN (receptor))(NN (dopamine))(NN (receptor))(NNP (D)))(PRN (-LRB- (-LRB-))(NP (CD (3)))(-RRB- (-RRB-))))(PRN (-LRB- (-LRB-))(NP (NNP (DRD3)))(-RRB- (-RRB-)))))))))))(. (.)))) |ET|  |BV| 1:-0.14506224 2:-0.28481072 3:-0.59362674 4:-0.25439376 5:0.38625631 6:-0.046137732 7:-0.35386601 8:0.65320385 9:-0.16809134 10:0.57964814 11:0.1303789 12:-0.61583757 13:0.31949565 14:0.45095748 15:-0.93978143 16:0.63066709 17:0.063957803 18:-0.89659083 19:0.36688527 20:-0.13719878 21:-0.52288628 22:0.064634569 23:0.43291721 24:-0.5993492 25:0.067319103 26:-0.54065132 27:0.75569421 28:0.22499478 29:0.7509374 30:0.50299102 31:0.66871351 32:-0.46396655 33:0.70376694 34:0.35963044 35:0.027474603 36:0.40848967 37:0.32412928 38:-0.051923949 39:0.47423962 40:0.30214891 41:-0.082409658 42:-0.15337348 43:0.12433288 44:0.019588588 45:0.12490033 46:-0.20622849 47:-0.27082387 48:-0.16096747 49:-0.17234598 50:0.13388297 51:0.34869686 52:-0.39368239 53:0.12837291 54:-0.28345147 55:-0.074015379 56:0.18608488 57:0.29153109 58:0.25861481 59:0.11662579 60:-0.46507797  |EV| 
-1  |BT| (ROOT (S (PP (IN (On))(NP (DT (the))(JJ (seventh))(NN (postoperative))(NN (day))))(, (,))(NP (NP (DT (the))(NNS (amplitudes)))(PP (IN (of))(NP (DT (the))(NNP (ERG))(NNS (b-waves)))))(VP (VBD (were))(ADJP (ADJP (RB (significantly))(JJR (lower)))(PP (IN (in))(NP (DT (the))(NN (vehicle))(NN (group)))))(PP (IN (than))(IN (in))(NP (NP (DT (the))(NNS (groups)))(VP (VBN (pretreated))(PP (IN (with))(NP (NN (captopril))(CC (or))(NN (candesartan))))))))(. (.)))) |ET|  |BV| 1:-0.38540238 2:-0.029400405 3:-0.011971226 4:-0.46540889 5:-0.014149606 6:-0.061438378 7:-0.64122146 8:0.0075905132 9:0.17704339 10:0.59466285 11:-0.15140823 12:-0.85643876 13:-0.11542233 14:0.19611438 15:-1.1484331 16:-0.5874536 17:-0.36097178 18:-0.0859688 19:-0.069137 20:-0.47890177 21:-0.23110723 22:-1.7506665 23:0.98535472 24:-0.02434249 25:-0.65138614 26:0.09895923 27:-0.30374384 28:-0.28374431 29:-0.38876918 30:0.87318093 31:-0.032878403 32:-0.62267059 33:0.74707758 34:0.74080104 35:-0.65818441 36:-0.60471076 37:-0.78161919 38:0.47585368 39:-0.29289764 40:-0.58492202 41:-0.16998658 42:-0.059208658 43:0.17626646 44:-0.17418414 45:0.2940405 46:0.074455582 47:-0.33273157 48:-0.25629267 49:0.24928108 50:-0.11851276 51:0.02406328 52:-0.084605463 53:0.20529212 54:-0.10385428 55:-0.021631127 56:-0.51458961 57:0.2339794 58:-0.041426707 59:-0.022182839 60:0.064581431  |EV| 
1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (NP (JJ (Intraoperative))(NN (reversal)))(PP (IN (of))(NP (NP (JJ (shallow))(JJ (rocuronium-induced))(NN (block)))(PP (IN (with))(NP (DT (either))(NN (sugammadex))(CC (or))(NN (neostigmine)))))))(VP (VBZ (is))(NP (DT (an))(JJ (efficient))(NN (method)))))(. (.)))) |ET|  |BV| 1:-0.73282301 2:-0.62496716 3:-0.55196631 4:-0.59960639 5:0.041034617 6:-0.34943715 7:0.12115459 8:0.74872983 9:0.71173537 10:-0.54305732 11:0.92430598 12:-0.20378846 13:0.71527505 14:-0.89005417 15:-1.0758097 16:1.0591766 17:-0.083953075 18:0.84651631 19:-0.49481836 20:-0.20741776 21:-0.28035849 22:-0.66492361 23:-1.4868039 24:-1.2775159 25:-0.9833383 26:-0.078630149 27:-0.38102743 28:0.35317224 29:0.38730726 30:1.2455752 31:-1.1416824 32:1.3641849 33:-0.38747263 34:-0.81455058 35:1.2371266 36:0.32304311 37:-0.10055397 38:0.55439442 39:-0.33715427 40:0.62531954 41:-0.1911501 42:-0.064142168 43:0.080318287 44:0.12172906 45:-0.0679444 46:-0.38642785 47:-0.075485706 48:-0.39173815 49:0.082309857 50:0.20881766 51:-0.16660972 52:0.054589316 53:-0.11797197 54:-0.20701867 55:-0.43976885 56:-0.010314 57:0.05650153 58:-0.13493067 59:-0.6235109 60:0.018977882  |EV| 
1  |BT| (ROOT (S (PP (IN (In))(NP (NN (contrast))))(, (,))(NP (NP (JJR (higher))(JJ (systemic))(NN (progestin))(NNS (levels)))(VP (VBN (associated))(PP (IN (with))(NP (NP (DT (the))(NN (use)))(PP (IN (of))(NP (NN (depot))))))))(VP (VBP (medroxyprogesterone))(S (NP (NN (acetate))(CC (and))(NN (combination))(JJ (oral))(NNS (contraceptives)))(VP (VP (VB (suppress))(NP (JJ (ovarian))(JJ (estradiol))(NN (production))))(CC (and))(VP (VB (reduce))(NP (NP (NN (acquisition)))(PP (IN (of))(NP (NNP (BMD)))))(PP (IN (in))(NP (NP (NNS (teenagers)))(CC (and))(NP (NP (JJ (young))(NN (adult))(NNS (women)))(SBAR (WHNP (WP (who)))(S (VP (VBP (use))(NP (JJ (injectable))(CC (and))(JJ (oral))(NNS (contraceptives)))))))))))))(. (.)))) |ET|  |BV| 1:0.0075069615 2:-0.76159483 3:0.0072029829 4:0.21510205 5:1.5778799 6:0.032157119 7:-0.08121945 8:-0.9997527 9:-0.40311038 10:0.012075305 11:0.51479554 12:0.48672074 13:-0.51028436 14:-0.29528299 15:0.15372056 16:1.025586 17:-0.77464366 18:-0.38708535 19:1.0757443 20:0.63239014 21:-0.85465068 22:-0.1223867 23:0.039865397 24:-0.019043626 25:0.45820934 26:-0.23349798 27:-0.055019416 28:-0.62751144 29:0.28472161 30:0.22962189 31:0.65343541 32:0.033011775 33:0.56688863 34:0.29359838 35:0.41499624 36:0.37236989 37:-0.36746573 38:0.17696653 39:0.45934385 40:0.74600995 41:-0.26126534 42:-0.16405618 43:-0.31750327 44:0.041268915 45:0.25356588 46:0.11393085 47:-0.43540379 48:-0.15843214 49:-0.095958613 50:0.12409505 51:-0.24023718 52:0.19074287 53:-0.2754091 54:-0.45372441 55:0.24797782 56:0.4879556 57:0.66895187 58:-0.083837099 59:0.076331407 60:-0.60232747  |EV| 
1  |BT| (ROOT (NP (NP (NNP (CONCLUSIONS))(CC (AND))(NNP (CLINICAL))(NNP (RELEVANCE)))(: (:))(S (NP (NNS (Results)))(VP (VBD (indicated))(SBAR (S (NP (NNP (GFR)))(VP (VBD (decreased))(PP (IN (after))(NP (NP (CD (8))(NNS (days)))(PP (IN (of))(NP (NP (NP (JJ (concurrent))(NN (administration)))(PP (IN (of))(NP (NN (furosemide))(CC (and))(NN (carprofen)))))(CC (or))(ADJP (JJ (furosemide))(CC (and))(JJ (etodolac)))))))(PP (TO (to))(NP (NNS (dogs)))))))))(. (.)))) |ET|  |BV| 1:-0.35126665 2:-0.35966042 3:-1.2996027 4:0.3386966 5:0.57237959 6:-0.4551442 7:0.61909175 8:-0.39228794 9:-0.39884531 10:0.13205177 11:0.36984587 12:-0.12144778 13:0.32529017 14:-1.1934534 15:-0.072098196 16:-0.35082138 17:-0.55683655 18:-0.31578785 19:0.44719502 20:-0.57014626 21:-0.48421079 22:-1.12875 23:-2.0836501 24:0.35519877 25:0.39339939 26:0.15301745 27:0.23268715 28:-1.1000104 29:0.20585585 30:-0.054519765 31:0.70638853 32:-0.60043603 33:-0.184725 34:-1.0133271 35:-0.40158907 36:-0.65332186 37:0.25478646 38:-0.44143197 39:-0.0095129134 40:-0.51650977 41:-0.13787584 42:0.22905584 43:0.11288229 44:0.26910439 45:-0.012605 46:-0.13184425 47:-0.19608331 48:-0.19864675 49:-0.34608155 50:0.47461173 51:0.15770796 52:-0.27253968 53:0.18563646 54:0.085415475 55:0.048456632 56:-0.093080647 57:-0.24917749 58:0.16052054 59:-0.79285282 60:-0.082639083  |EV| 
-1  |BT| (ROOT (S (ADVP (RB (Thus)))(, (,))(NP (NP (DT (the))(NN (administration)))(PP (IN (of))(NP (NP (NN (tenofovir-emtricitabine)))(PP (IN (for))(NP (NP (QP (IN (at))(JJS (least))(CD (3)))(NNS (weeks)))(PP (IN (after))(NP (NN (delivery)))))))))(VP (MD (should))(VP (VB (be))(VP (VBN (considered))(S (VP (TO (to))(VP (VB (prevent))(NP (NP (DT (the))(NN (emergence)))(PP (IN (of))(NP (ADJP (JJ (resistant)))(NNS (viruses)))))))))))(. (.)))) |ET|  |BV| 21:0.1779982 22:-0.27787179 23:0.30854255 24:0.62476873 25:-0.30178851 26:-0.72277117 27:-0.20537347 28:-0.059938192 29:0.11513255 30:0.025801292 31:-1.0807257 32:0.31774664 33:-0.16543099 34:1.414973 35:-0.72933728 36:-0.079194382 37:-0.81688738 38:-0.25846809 39:0.31218413 40:-0.18701985 41:-0.037113633 42:-0.089855231 43:-0.31068224 44:0.0015581683 45:0.06181572 46:-0.47191155 47:-0.28859434 48:-0.64450157 49:-0.11683331 50:0.43316478 51:0.27864674 52:0.59716046 53:-0.028225392 54:-0.15025483 55:0.30855858 56:0.059578165 57:0.51985157 58:0.015887072 59:-0.10807843 60:-0.32809609  |EV| 
-1  |BT| (ROOT (FRAG (NP (NNP (TAKE))(NNP (HOME))(NNP (MESSAGE)))(: (:))(S (NP (NP (DT (The))(JJ (triple))(NN (combination))(NN (therapy)))(PP (IN (of))(NP (NN (simvastatin/ER))(NN (niacin/laropiprant)))))(VP (MD (may))(VP (VP (VB (reduce))(NP (JJ (flushing))(NN (side))(NNS (effects))))(CC (and))(VP (VB (facilitate))(NP (NP (DT (a))(ADJP (RBR (more))(JJ (comprehensive)))(NN (treatment)))(PP (IN (for))(NP (NNS (patients)))))(PP (IN (with))(NP (VBN (mixed))(NN (dyslipidemia))))))))(. (.)))) |ET|  |BV| 1:1.1755447 2:-1.6775537 3:-1.1906594 4:0.61045361 5:0.70769036 6:-0.031282343 7:0.94075429 8:-0.33137652 9:0.78358227 10:0.53738695 11:-0.15538402 12:1.1314317 13:0.17060195 14:-0.69844198 15:-0.82150435 16:1.1374702 17:-0.57808673 18:-0.068459444 19:1.4661564 20:0.54127604 21:-0.12533671 22:-0.15019466 23:-0.21028246 24:0.47810677 25:0.60104865 26:-0.29292217 27:-0.027071103 28:-0.054589707 29:-0.12048685 30:0.70986199 31:-0.53128153 32:-0.012126103 33:0.036642201 34:-0.15276179 35:-0.65743715 36:0.53913814 37:-0.41278499 38:0.16837849 39:0.86304891 40:0.013139965 41:0.055222802 42:-0.36201236 43:-0.080147125 44:-0.1283403 45:0.6775806 46:0.30834919 47:-0.22131686 48:0.19909947 49:0.22284813 50:0.62098342 51:-0.20983891 52:-0.015792197 53:-0.18879044 54:0.21441358 55:-0.17812967 56:-0.43472257 57:0.37388122 58:0.020790638 59:0.62976539 60:-0.29366228  |EV| 
-0.88637375334383528002746288620983  |BT| (ROOT (FRAG (NP (NNP (CONCLUSIONS)))(: (:))(S (PP (IN (Among))(NP (NP (NNS (children)))(PP (NP (QP (CD (6))(TO (to))(CD (23)))(NNS (months)))(IN (of))(NP (NN (age))))(PP (IN (with))(NP (JJ (acute))(NNS (otitis))(NNS (media))))))(, (,))(NP (NP (NN (treatment)))(PP (IN (with))(NP (NP (NN (amoxicillin-clavulanate)))(PP (IN (for))(NP (CD (10))(NNS (days)))))))(VP (VP (VBD (tended))(S (VP (TO (to))(VP (VB (reduce))(NP (DT (the))(NN (time)))(PP (TO (to))(NP (NP (NN (resolution)))(PP (IN (of))(NP (NNS (symptoms))))))))))(CC (and))(VP (VBD (reduced))(NP (NP (DT (the))(JJ (overall))(NN (symptom))(NN (burden)))(CC (and))(NP (NP (DT (the))(NN (rate)))(PP (IN (of))(NP (NP (JJ (persistent))(NNS (signs)))(PP (IN (of))(NP (JJ (acute))(NN (infection))))))))(PP (IN (on))(NP (JJ (otoscopic))(NN (examination)))))))(. (.)))) |ET|  |BV| 1:0.35244706 2:-0.53398049 3:0.61924434 4:-0.04641439 5:0.014703782 6:-0.15338266 7:-0.11245583 8:0.21922614 9:1.1140474 10:0.22506315 11:-0.13748759 12:-0.50418454 13:0.055349298 14:-0.46502516 15:-0.59570587 16:-0.52668715 17:0.8910346 18:-0.040526476 19:0.8127467 20:-0.76265353 41:0.085949436 42:0.23730715 43:0.11128265 44:0.24194649 45:0.24496929 46:-0.16206677 47:-0.014506514 48:-0.032957513 49:-0.10342194 50:0.0016394954 51:0.0071134437 52:0.01312697 53:-0.13648118 54:-3.0848543e-05 55:0.45185885 56:-0.26350069 57:0.23227164 58:0.19531415 59:-0.007273118 60:0.051537462  |EV| 
1  |BT| (ROOT (S (NP (NP (NP (JJ (20-O-ß-d-glucopyranosyl-20)))(PRN (-LRB- (-LRB-))(NP (NNP (S)))(-RRB- (-RRB-))))(: (-))(NP (NP (NN (protopanaxadiol)))(, (,))(NP (NP (DT (a))(NN (metabolite)))(PP (IN (of))(NP (NN (ginseng))))))(, (,)))(VP (VBZ (inhibits))(NP (NN (colon))(NN (cancer))(NN (growth)))(PP (IN (by))(S (VP (VBG (targeting))(NP (CD (TRPC))(JJ (channel-mediated))(NN (calcium))(NN (influx)))))))(. (.)))) |ET|  |BV| 1:-0.76733154 2:0.2460794 3:-0.36372909 4:-0.26238525 5:-0.33067521 6:-0.33500141 7:-0.089534409 8:0.13414255 9:0.37700409 10:0.26008978 11:-0.075949982 12:-0.24670501 13:0.17961161 14:-0.15187471 15:-1.0580264 16:-0.25400683 17:-0.31937048 18:0.033552781 19:0.48308486 20:-0.69982004 21:-0.6087867 22:-0.011024807 23:0.14656921 24:0.36022162 25:0.2953164 26:-0.57830232 27:0.28156734 28:0.47401625 29:0.8644281 30:0.083395809 31:0.12959622 32:0.41102698 33:0.25162068 34:0.06466005 35:-0.10712874 36:-0.28840005 37:-0.44536808 38:-0.029718379 39:0.62244087 40:-0.046636596 41:-0.021951012 42:-0.086069316 43:0.30741966 44:-0.1036191 45:0.0033883832 46:0.071943223 47:-0.38905534 48:0.22787996 49:0.25433129 50:0.32759985 51:0.30417359 52:-0.085765317 53:0.22378229 54:-0.10968653 55:-0.060962465 56:0.31327388 57:-0.21888827 58:0.31850329 59:0.024710931 60:0.033135325  |EV| 
1  |BT| (ROOT (S (ADVP (RB (Finally)))(, (,))(NP (NP (DT (the))(NN (noradrenalin))(NN (transporter)))(PP (ADVP (RB (together)))(IN (with))(NP (JJ (dopamine))(NN (transporter))(NN (blocker))(NN (bupropion)))))(VP (VBD (was))(ADJP (RBR (more))(JJ (effective))(PP (IN (in))(S (VP (VBG (decreasing))(NP (NP (DT (the))(NN (stress)))(PP (IN (of))(NP (NP (DT (an))(NN (injection)))(PP (IN (in))(NP (JJ (SERT))(PRN (-LRB- (-LRB-))(FRAG (ADJP (RB (-))(JJ (/)))(: (-)))(-RRB- (-RRB-)))(NNS (rats)))))))(PP (IN (than))(PP (IN (in))(NP (JJ (SERT))(PRN (-LRB- (-LRB-))(NP (NNP (+))(NNP (/))(NNP (+)))(-RRB- (-RRB-)))(NNS (rats))))))))))(. (.)))) |ET|  |BV| 1:-0.43928695 2:-0.056595359 3:0.080920085 4:-0.55128294 5:-0.23415083 6:-0.65561533 7:0.89014655 8:1.0537024 9:1.1572906 10:0.81946075 11:0.24070236 12:-0.68536693 13:0.80484867 14:0.47524852 15:-0.47601759 16:0.36912289 17:-0.87052554 18:0.28288737 19:0.39863423 20:-0.07936205 21:0.43385875 22:-0.70879608 23:-0.15121306 24:-0.4984982 25:0.25945014 26:-0.21913771 27:-0.77050805 28:-0.65597773 29:0.77728212 30:0.75117898 31:0.26791933 32:0.098864079 33:0.040396873 34:0.34282583 35:-0.63833892 36:0.37242758 37:-0.52486193 38:-0.39260066 39:0.14577915 40:0.077141792 41:-0.30710801 42:-0.11094452 43:0.46930155 44:0.14255986 45:0.19020131 46:-0.64546072 47:-0.18757522 48:0.043041289 49:-0.098300159 50:-0.067231648 51:0.56252474 52:0.035957605 53:0.60373741 54:-0.19733548 55:-0.17642644 56:-0.070108272 57:-0.038676135 58:-0.1489349 59:0.06508337 60:-0.017799556  |EV| 
0.77040533528012944408658313477645  |BT| (ROOT (S (NP (PRP (It)))(VP (VBD (was))(ADVP (RB (recently)))(VP (VBN (shown))(SBAR (IN (that))(S (NP (NP (DT (the))(JJ (benzoxaborole))(JJ (antifungal))(NN (compound))(NN (AN2690)))(PRN (-LRB- (-LRB-))(NP (NN (5-fluoro-1))(CD (,3)))(: (-))(NP (NP (JJ (dihydro-1-hydroxy-1))(CD (,2)))(: (-))(NP (NN (benzoxaborole))))(-RRB- (-RRB-))))(VP (VBZ (inhibits))(NP (NNS (LeuRS)))(PP (IN (by))(S (VP (VBG (forming))(NP (NP (DT (a))(JJ (covalent))(NN (adduct)))(PP (IN (with))(NP (DT (the))(CD (3))('' ('))(NN (adenosine))))(PP (IN (of))(NP (NP (NN (tRNA)))(PRN (-LRB- (-LRB-))(NP (NN (leu)))(-RRB- (-RRB-))))))(PP (IN (at))(NP (DT (the))(NN (editing))(NN (site))))(, (,))(S (ADVP (RB (thus)))(VP (VBG (locking))(NP (DT (the))(NN (enzyme)))(PP (IN (in))(NP (DT (an))(JJ (inactive))(NN (conformation))))))))))))))(. (.)))) |ET|  |BV| 1:-1.4009563 2:-1.5814769 3:0.49416432 4:0.52210379 5:-0.019844569 6:-1.0101516 7:0.88953322 8:0.38296342 9:0.64190757 10:-0.87704146 11:0.28260985 12:0.91117328 13:0.1239359 14:-0.088209145 15:0.32299581 16:-0.10356185 17:-0.22162217 18:-0.51198089 19:0.6591621 20:-1.2448485 21:-1.4069481 22:-1.075496 23:0.73630089 24:0.14236891 25:-0.059509687 26:-0.69115633 27:0.24420214 28:0.1404658 29:-0.34585404 30:-0.90413207 31:-0.30341196 32:0.6098696 33:1.0032715 34:0.10490897 35:0.60823131 36:-0.85505229 37:-0.50288063 38:-0.46083355 39:2.1474571 40:-1.3225567 41:-0.35740626 42:-0.64486313 43:-0.24115458 44:-0.18268776 45:0.12594779 46:-0.30661178 47:-0.2484213 48:0.033529665 49:0.16844782 50:0.41002226 51:0.19995184 52:-0.034642503 53:-0.11106802 54:-0.16693349 55:0.19326207 56:0.031277787 57:0.059685953 58:0.31206495 59:-0.020300008 60:-0.073638663  |EV| 
-0.93855539426960188365001158672385  |BT| (ROOT (S (NP (NP (DT (A))(NN (guanine)))(PRN (-LRB- (-LRB-))(NP (NNP (G)))(-RRB- (-RRB-))))(VP (VBZ (/))(NP (NP (NN (adenine)))(PRN (-LRB- (-LRB-))(NP (NNP (A)))(-RRB- (-RRB-)))(SBAR (S (NP (NP (JJ (common))(JJ (single))(NN (nucleotide))(NN (polymorphism)))(PP (IN (at))(NP (NP (JJ (first))(NN (position)))(PP (IN (of))(NP (NP (NN (codon))(CD (589)))(PP (IN (in))(NP (NNP (Exo))(CD (1))(NN (gene)))))))))(VP (VBZ (determines))(NP (DT (a))(JJ (glutamic))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NNP (Glu)))(, (,))(NP (NNP (E)))(-RRB- (-RRB-)))(PP (TO (to))(NP (NP (NP (NN (lysine)))(PRN (-LRB- (-LRB-))(NP (NNP (Lys)))(, (,))(NP (NNP (K)))(-RRB- (-RRB-))))(PRN (-LRB- (-LRB-))(NP (NNP (K589E)))(-RRB- (-RRB-)))))))))(NP (NP (JJ (aminoacidic))(NN (substitution)))(SBAR (WHNP (WDT (which)))(S (VP (MD (may))(VP (VB (alter))(NP (NN (cancer))(NN (risk)))(PP (IN (by))(S (VP (VBG (influencing))(NP (NP (DT (the))(NN (activity)))(PP (IN (of))(NP (NNP (Exo))(CD (1))(NN (protein))))))))))))))(. (.)))) |ET|  |BV| 1:-0.89806104 2:-0.88740349 3:0.6684531 4:-0.72632658 5:-1.6517493 6:-0.36108562 7:0.26906854 8:1.6386491 9:0.22852036 10:0.079020485 11:0.19047874 12:0.77491361 13:0.37403876 14:0.77928269 15:-0.82996875 16:0.47676581 17:-0.69418496 18:0.11014714 19:-0.58469981 20:-0.93877232 21:-0.98417938 22:0.41805446 23:0.35911784 24:-0.89342439 25:-0.28451303 26:-0.78242135 27:-0.58465123 28:0.97099948 29:0.19545634 30:-1.8243748 31:-0.0024916052 32:0.65486383 33:0.1811683 34:1.1890516 35:-0.096406184 36:-0.96060628 37:-0.53619105 38:-0.27410814 39:-0.029814117 40:-1.4676652 41:-0.051239736 42:-0.28658754 43:0.34319121 44:0.14093253 45:-0.21908839 46:-0.098751724 47:0.078506082 48:-0.060891476 49:0.20008431 50:-0.14257202 51:0.7868917 52:0.071409814 53:-0.1009173 54:0.14273414 55:-0.12032348 56:0.10546955 57:-0.25631997 58:0.26697889 59:0.14741941 60:-0.049186252  |EV| 
-1  |BT| (ROOT (S (NP (DT (The))(NP (NNP (Nicotrol))(NNP (®))(PRN (-LRB- (-LRB-))(NP (NNP (Pfizer)))(, (,))(NP (NNP (USA)))(-RRB- (-RRB-)))(NNP (nicotine)))(NN (inhaler)))(VP (VBZ (reduces))(NP (NN (craving)))(PP (IN (by))(S (VP (VP (VBG (mimicking))(NP (NP (DT (the))(JJ (behavioural))(NN (component)))(PP (IN (of))(NP (NNS (cigarettes))))))(CC (and))(VP (VBG (delivering))(NP (NP (JJ (controlled))(NNS (doses)))(PP (IN (of))(NP (NP (NN (nicotine)))(, (,))(SBAR (WHNP (WDT (which)))(S (VP (VBZ (binds))(PP (TO (to))(NP (NP (DT (the))(JJ (beta-2))(JJ (subunit-containing))(JJ (nicotinic))(NN (acetylcholine))(NNS (receptors)))(PRN (-LRB- (-LRB-))(NP (NP (JJ (ß2))(NNS (*)))(: (-))(NP (NNS (nAChRs))))(-RRB- (-RRB-))))))))))))))))(. (.)))) |ET|  |BV| 1:-0.31161079 2:-0.36281344 3:0.18907669 4:0.085704744 5:-0.025418209 6:-0.14755964 7:0.024619143 8:-0.21351071 9:1.1228068 10:0.1944949 11:0.71831656 12:-0.64764792 13:-0.3232435 14:-0.11913425 15:-0.39324352 16:1.1804386 17:0.10067534 18:0.44076952 19:-0.1683571 20:0.32567781 21:-0.6964218 22:0.36328217 23:0.839136 24:-0.91466933 25:-0.27204117 26:-0.37875962 27:0.44033417 28:0.29511434 29:0.8904736 30:-0.26710111 31:0.88625318 32:-0.29589823 33:0.97394598 34:-0.12877832 35:-0.10586167 36:0.56494546 37:0.2942304 38:0.2748687 39:0.5583688 40:-0.16265568 41:-0.13013077 42:-0.25981644 43:0.093551666 44:-0.32276356 45:0.052727435 46:0.046370339 47:-0.5112021 48:-0.42461124 49:-0.21455133 50:0.35746774 51:0.67682666 52:0.1710259 53:-0.10439385 54:0.0082091782 55:-0.1243705 56:0.39434627 57:0.20973958 58:0.18682955 59:-0.062972702 60:-0.22990212  |EV| 
-1  |BT| (ROOT (S (NP (NP (NP (NNP (Tolvaptan)))(PRN (-LRB- (-LRB-))(NP (NP (NNP (TOL)))(: (;))(NP (JJ (selective))(NN (V2))(NN (antagonist))))(-RRB- (-RRB-))))(CC (and))(NP (NP (NNP (Conivaptan)))(PRN (-LRB- (-LRB-))(NP (NP (NNP (CON)))(: (;))(NP (JJ (dual))(JJ (V1a/V2))(NN (antagonist))))(-RRB- (-RRB-)))))(VP (VBP (are))(NP (NP (CD (two))(NNP (AVP))(NNS (antagonists)))(SBAR (WHNP (WDT (that)))(S (VP (VB (counteract))(NP (NP (DT (the))(NN (action)))(PP (IN (of))(NP (NNP (AVP)))))(PP (IN (with))(NP (JJ (distinct))(NNS (profiles)))))))))(. (.)))) |ET|  |BV| 1:-0.099199012 2:-0.59156978 3:1.3558156 4:-1.1025531 5:0.37526837 6:-0.27797398 7:0.70420802 8:1.389861 9:0.94101846 10:-0.49985513 11:0.72899067 12:0.42401269 13:-0.083025023 14:0.33309704 15:-0.41587144 16:0.44663921 17:1.021216 18:-1.3189735 19:-0.14416024 20:-0.66059715 21:0.47521439 22:-0.46435663 23:1.2071205 24:-1.2103273 25:0.12324187 26:-0.33217537 27:0.83428329 28:0.99301606 29:0.28150648 30:-0.17493747 31:0.71685445 32:0.19261353 33:-0.25161031 34:-0.12366971 35:-0.39026871 36:0.56242198 37:0.36128464 38:-0.91560704 39:-0.22868571 40:-0.40150341 41:-0.15018162 42:-0.51398051 43:0.18935935 44:0.041888025 45:0.15456265 46:-0.25415865 47:0.30340156 48:-0.045860093 49:-0.61562616 50:-0.072516426 51:0.67239285 52:0.047182575 53:-0.057147928 54:-0.2689198 55:-0.052209131 56:0.83301347 57:-0.018257987 58:-0.036308259 59:-0.30328986 60:0.059476748  |EV| 
1  |BT| (ROOT (S (ADVP (RB (Thus)))(, (,))(NP (NP (DT (the))(ADJP (JJ (vasodilative))(, (,))(JJ (antianginal))(CC (and))(JJ (antiarrhythmic)))(NNS (actions)))(PP (IN (of))(NP (NN (amiodarone)))))(VP (MD (may))(VP (VB (be))(VP (RBR (further))(VBN (enhanced))(PP (IN (by))(NP (NP (DT (the))(JJ (simultaneous))(NN (supplementation)))(PP (IN (of))(NP (NP (NN (calcium))(NN (channel))(NNS (blockers)))(PP (IN (via))(NP (JJ (synergistic))(NNS (mechanisms))))))(, (,))(VP (VBG (supporting))(NP (NP (DT (the))(JJ (clinical))(NN (use)))(PP (IN (of))(NP (JJ (such))(NN (drug))(NNS (combinations)))))))))))(. (.)))) |ET|  |BV| 1:-0.40201533 2:0.26041409 3:-0.33256418 4:-0.47749305 5:-0.57279712 6:0.030752117 7:-0.033705521 8:0.3530972 9:0.86477917 10:0.27282262 11:-0.11382813 12:-0.56814915 13:0.24151221 14:-0.036625974 15:-1.4665904 16:-0.45977589 17:-0.25449222 18:-0.13983984 19:0.50851893 20:-0.67701018 21:-0.16469966 22:0.022516429 23:-0.73193413 24:0.045193154 25:0.4222194 26:0.036796849 27:0.2352435 28:-0.27031907 29:0.41419598 30:0.20313478 31:-0.29296407 32:-0.33279586 33:0.23716505 34:-0.20832293 35:-0.14375141 36:-0.043305229 37:-0.10976048 38:-0.43185729 39:0.685583 40:0.18347895 41:-0.60841829 42:-0.20048393 43:0.62815654 44:0.092391551 45:0.36841097 46:-0.00071928446 47:-0.32054833 48:-0.1099953 49:0.19344208 50:0.56079072 51:0.19191693 52:0.2797282 53:0.15170592 54:-0.10124607 55:0.054922797 56:0.086886637 57:0.49230745 58:0.078592889 59:-0.2667661 60:-0.56223077  |EV| 
1  |BT| (ROOT (S (NP (NP (DT (This))(NN (phase))(NN (I))(NN (trial)))(PP (IN (in))(NP (JJ (healthy))(NNS (subjects)))))(VP (VBD (investigated))(NP (NP (NP (DT (the))(NN (bronchodilator))(NN (activity)))(PP (IN (of))(NP (NN (aclidinium)))))(CC (and))(NP (PRP$ (its))(NN (ability))(S (VP (TO (to))(VP (VB (reduce))(NP (JJ (methacholine-induced))(NN (bronchoconstriction)))))))))(. (.)))) |ET|  |BV| 1:-0.56929779 2:0.11275183 3:-0.12096316 4:-0.33661121 5:0.015454964 6:-0.54766327 7:-0.41220659 8:-0.22145909 9:0.88924897 10:0.479875 11:-0.46322623 12:0.2768335 13:1.436738 14:-0.36349216 15:0.020116759 16:-0.098351911 17:-0.18360977 18:0.025702953 19:-0.42553788 20:-0.72200239 41:-0.158465 42:0.034803238 43:0.16103907 44:-0.31827056 45:0.20409922 46:0.11032236 47:-0.0079452591 48:-0.42260876 49:0.13054189 50:0.071465231 51:0.4752413 52:0.17953965 53:0.11966962 54:0.045247983 55:0.11527257 56:0.0070465468 57:0.19392149 58:-0.47613615 59:0.13856952 60:0.2462654  |EV| 
1  |BT| (ROOT (NP (NP (NNP (Antagonism)))(PP (IN (of))(NP (NP (DT (the))(ADJP (JJ (antithrombotic))(CC (and))(JJ (anti-atherosclerotic)))(NNS (actions)))(PP (IN (of))(NP (NN (aspirin))))))(PP (IN (by))(NP (NN (rofecoxib))))(PP (IN (in))(NP (DT (the))(JJ (cholesterol-fed))(NN (rabbit))))(. (.)))) |ET|  |BV| 1:0.18413414 2:-1.2404205 3:-0.24337347 4:0.4783988 5:-0.54357165 6:0.25719765 7:-0.66916507 8:-0.43968144 9:1.0442492 10:-0.45525748 11:-0.078946494 12:1.317522 13:1.1431879 14:-2.6085827 15:-0.17483136 16:1.2728422 17:-0.59851855 18:-0.71260118 19:-0.057639375 20:-0.84565258 21:-0.45031631 22:0.15654109 23:-0.14055742 24:0.57517284 25:0.1998097 26:-0.003260914 27:-0.33045915 28:-0.79845482 29:0.2162341 30:-0.19117653 31:-0.26789901 32:0.13184972 33:0.5689823 34:-0.53675497 35:-0.25804719 36:0.65332514 37:-0.48971584 38:-0.86091042 39:0.14939134 40:-0.01000188 41:-0.049917482 42:-0.24687789 43:0.20389214 44:-0.19835202 45:0.1175063 46:-0.043385059 47:-0.20002733 48:-0.35882074 49:-0.019832287 50:0.28691065 51:-0.14373778 52:0.50583249 53:0.036804058 54:-0.29259381 55:-0.34638202 56:0.41542119 57:0.50908768 58:0.084679425 59:-0.11858629 60:-0.27503875  |EV| 
-1  |BT| (ROOT (S (NP (JJ (Toxicological))(NN (examination)))(VP (VBD (confirmed))(NP (NP (DT (a))(JJ (recent))(NN (intake)))(PP (IN (of))(NP (NN (mefloquine)))))(PP (ADVP (RB (together)))(IN (with))(NP (NP (NN (chloroquine)))(, (,))(NP (DT (another))(JJ (antimalarial))(NN (drug))))))(. (.)))) |ET|  |BV| 1:-0.44465402 2:-0.32230401 3:-0.045599494 4:0.39940435 5:0.65570676 6:-0.75953043 7:-0.077495389 8:0.46600577 9:0.02426268 10:0.39012048 11:-1.4777908 12:0.13325724 13:0.47489363 14:0.99156183 15:-1.030862 16:0.12335151 17:-0.30270708 18:-0.059895068 19:-0.040842503 20:-0.3289873 21:-0.56343693 22:-0.35159785 23:-0.14530689 24:0.41392627 25:0.43864274 26:-0.62473142 27:-0.74550021 28:0.10656618 29:0.38636047 30:1.0745468 31:-0.93271834 32:0.50037241 33:-0.11474589 34:-0.72066718 35:-0.34713095 36:1.3505288 37:-0.14346741 38:-0.084357351 39:-0.13472518 40:-0.72076881 41:-0.094799429 42:0.028020205 43:0.069429196 44:0.061938088 45:0.26012227 46:0.051171158 47:0.41731721 48:-0.39252681 49:0.28055552 50:0.052727427 51:0.22744687 52:-0.095782071 53:-0.20767178 54:-0.068187743 55:0.334362 56:0.2492743 57:-0.27498114 58:0.28063262 59:0.14184166 60:0.44808555  |EV| 
-1  |BT| (ROOT (S (NP (ADJP (RB (Minimally))(JJ (invasive)))(NN (aspiration)))(VP (VBD (was))(VP (VBN (applied))(PP (IN (within))(NP (NP (CD (72))(NN (h)))(PP (IN (after))(NP (NN (onset))))))(, (,))(S (ADVP (IN (along))(PP (IN (with))(NP (NN (mannitol))(CC (or))(NN (furosemide)))))(VP (TO (to))(VP (VB (lower))(NP (NP (DT (the))(JJ (intracranial))(NN (pressure)))(CC (and))(NP (JJ (symptomatic))(NN (treatment)))))))))(. (.)))) |ET|  |BV| 1:-0.62696892 2:-0.36565167 3:-0.1138407 4:0.44427595 5:0.45800436 6:-0.26020354 7:-0.19542311 8:-0.9882676 9:-0.10918805 10:0.59983301 11:-0.27702549 12:-0.65473092 13:0.58738786 14:-0.20297447 15:-0.1769674 16:0.99944466 17:0.34191957 18:0.22632022 19:-0.61622745 20:-1.169777 21:-0.35126665 22:-0.35966042 23:-1.2996027 24:0.3386966 25:0.57237959 26:-0.4551442 27:0.61909175 28:-0.39228794 29:-0.39884531 30:0.13205177 31:0.36984587 32:-0.12144778 33:0.32529017 34:-1.1934534 35:-0.072098196 36:-0.35082138 37:-0.55683655 38:-0.31578785 39:0.44719502 40:-0.57014626 41:0.0033704631 42:-0.22132783 43:-0.36639515 44:0.12309282 45:0.52829379 46:-0.14449844 47:-0.16318546 48:0.14585845 49:-0.060612865 50:0.52935928 51:0.15475383 52:-0.16273543 53:-0.28403702 54:-0.096480556 55:0.31771207 56:-0.15114406 57:0.22274947 58:-0.027484309 59:-0.39348614 60:-0.049821202  |EV| 
-1  |BT| (ROOT (NP (NP (NNS (RESULTS)))(: (:))(S (NP (PRP (It)))(VP (VBD (was))(VP (VBN (found))(SBAR (IN (that))(S (NP (NP (DT (the))(NNS (levels)))(PP (IN (of))(NP (NP (JJ (acylated))(, (,))(JJ (desacylated))(NN (ghrelin)))(, (,))(NP (JJ (paraoxonase))(NN (arylesterase)))(, (,))(NP (JJ (total))(NN (cholesterol)))(CC (and))(NP (NN (triglyceride))))))(VP (VBD (were))(ADJP (ADJP (JJR (lower)))(PP (IN (in))(NP (JJ (depressive))(NNS (patients)))))(PP (IN (before))(NP (NN (citalopram))(NN (treatment))))(PP (IN (than))(PP (IN (in))(NP (DT (the))(NN (control))(NN (group)))))))))))(. (.)))) |ET|  |BV| 1:-0.40574127 2:0.058164272 3:-0.55703866 4:-0.45595855 5:0.55642027 6:-0.69570565 7:-0.81506693 8:-0.36349747 9:-0.10663576 10:0.16767016 11:0.47130343 12:-0.055568293 13:-0.14277528 14:0.29299292 15:-0.92808807 16:-0.24978071 17:0.050095562 18:-0.21021543 19:1.06243 20:-0.29777443 21:-0.72881132 22:0.5290817 23:0.59164304 24:-0.024455303 25:-0.52654779 26:-0.36971462 27:0.13414875 28:-0.08233285 29:-0.12963098 30:0.58822078 31:-0.046490178 32:0.53263962 33:0.26568893 34:-0.39370897 35:-0.34961393 36:0.028063374 37:-0.14020984 38:0.32197952 39:0.76699817 40:0.29744563 41:-0.39295569 42:0.1886147 43:-0.25878462 44:0.39115742 45:-0.0040546465 46:0.66834962 47:-0.1418177 48:0.0049863365 49:0.1131925 50:-0.024216022 51:0.44701204 52:-0.14832591 53:-0.055177383 54:-0.20652506 55:-0.11224238 56:0.12763985 57:0.29367417 58:-0.045456134 59:0.064795427 60:0.0031734896  |EV| 
1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (NNP (Caudal)))(VP (VBP (clonidine))(PP (IN (at))(NP (NP (DT (a))(JJR (lower))(NN (dose)))(-LRB- (-LRB-))(NP (CD (1))(NN (µg)))(ADVP (RB (kg)))))))(. (?)))) |ET|  |BV| 1:-0.34696582 2:-0.0097431345 3:-0.23105963 4:-0.50302809 5:-0.020926366 6:0.2870712 7:-0.036876835 8:-0.00093980529 9:0.57171631 10:-0.061133616 11:0.5594151 12:-0.38323382 13:0.034318916 14:-0.24120934 15:-0.67039001 16:0.42504683 17:0.50754982 18:0.30065629 19:-0.016009297 20:-0.086647823 21:-0.51583421 22:-0.15732002 23:-0.67301118 24:-0.94175428 25:0.24679913 26:-0.6743508 27:-0.21775585 28:0.045891993 29:-0.18093675 30:0.41452351 31:-0.35863405 32:0.2783553 33:0.19278878 34:-1.1857703 35:0.0078831157 36:0.32769522 37:0.64750874 38:0.40576273 39:-0.44038063 40:-0.45647451 41:-0.10761163 42:-0.054392014 43:-0.15049385 44:0.070999056 45:0.14322309 46:-0.05423969 47:-0.65809071 48:-0.40447691 49:0.058322854 50:0.066104859 51:-0.31503156 52:0.095424451 53:-0.13669065 54:0.41309538 55:-0.45929831 56:0.10554063 57:0.60425711 58:0.19599248 59:0.054755546 60:-0.069189131  |EV| 
1  |BT| (ROOT (S (NP (JJ (Ethanol))(NN (abuse)))(VP (VBD (was))(VP (VBN (associated))(PP (IN (with))(NP (NP (CD (>))(ADJP (NP (CD (50))(NN (%)))(JJR (lower)))(JJ (cumulative))(NN (dose)))(PP (IN (of))(NP (NP (JJ (morphine))(NNS (equivalents)))(PRN (-LRB- (-LRB-))(NP (NP (NN (ratio))(CD (0.47)))(: (;))(NP (NP (ADJP (CD (95))(NN (%)))(NNP (CI)))(NP (CD (0.25-0))(CD (.87)))))(-RRB- (-RRB-)))))))))(. (.)))) |ET|  |BV| 1:-0.45263946 2:-0.44811127 3:-0.4024395 4:-0.35953194 5:0.29140186 6:-0.31026688 7:-0.16002285 8:0.027013453 9:0.46951276 10:0.70688903 11:0.51139504 12:-0.31645745 13:0.28384194 14:-0.14880067 15:-0.087615728 16:-0.37213057 17:0.33573028 18:0.14914471 19:-0.2827695 20:0.36941594 21:-0.18262425 22:-0.27455565 23:-0.63187039 24:-0.20303082 25:-0.49805775 26:-0.36358526 27:-0.67585135 28:-0.18507487 29:0.57143605 30:-0.13132448 31:0.033105545 32:0.39477274 33:0.01403023 34:-0.085290499 35:0.069696143 36:0.078646556 37:-0.2542069 38:-0.099925838 39:0.45036244 40:0.57571846 41:0.20964836 42:0.21594174 43:0.14140192 44:0.047380116 45:0.10607688 46:-0.07651335 47:0.005253105 48:-0.25008866 49:-0.47941738 50:-0.24737062 51:-0.050675459 52:0.29840505 53:0.044068847 54:-0.10152492 55:0.1286649 56:0.44614688 57:0.4337557 58:-0.39313215 59:-0.091315329 60:0.18066423  |EV| 
1  |BT| (ROOT (SINV (VP (VBG (Using))(NP (DT (the))(ADJP (ADJP (JJ (intranigral))(JJ (lipopolysaccharide)))(PRN (-LRB- (-LRB-))(NP (NNP (LPS)))(-RRB- (-RRB-))))(NN (rat))(NN (model))))(PRN (, (,))(S (NP (PRP (we)))(VP (VBP (show))(SBAR (IN (that))(S (NP (NP (NN (meloxicam)))(, (,))(NP (DT (a))(JJ (preferential))(NN (COX-2))(NN (inhibitor)))(, (,)))(VP (VP (VBZ (diminishes))(NP (NP (DT (the))(NN (activation)))(PP (IN (of))(NP (NNP (OX-42-immunoreactive))(PRN (-LRB- (-LRB-))(NP (NN (ir)))(-RRB- (-RRB-)))(NN (microglia))))))(CC (and))(VP (VBZ (reduces))(NP (NP (DT (the))(NN (loss)))(PP (IN (of))(NP (NP (JJ (tyrosine))(NN (hydroxylase)))(PRN (-LRB- (-LRB-))(NP (NNP (TH)))(-RRB- (-RRB-))))))))))))(, (-)))(VP (VBP (ir))(NP (JJ (dopamine))(PRN (-LRB- (-LRB-))(NP (NNP (DA)))(-RRB- (-RRB-)))(NNS (neurons)))(PP (IN (in))(NP (DT (the))(NN (substantia))(NN (nigra)))))(NP (NP (JJ (pars))(NN (compacta)))(PRN (-LRB- (-LRB-))(NP (NNP (SNpc)))(-RRB- (-RRB-)))(SBAR (WHNP (WDT (that)))(S (VP (VBZ (is))(ADVP (RB (normally)))(VP (VBN (induced))(PP (IN (by))(NP (NN (exposure))))(PP (TO (to))(NP (NNP (LPS)))))))))(. (.)))) |ET|  |BV| 1:-0.68889815 2:-0.29203573 3:-0.091921061 4:-0.85583287 5:0.19028556 6:-0.97280931 7:-0.1351376 8:0.43235838 9:0.49013329 10:0.22208227 11:0.58568132 12:-0.40404236 13:0.4984071 14:0.21775264 15:0.46412289 16:-0.10357713 17:-0.17316554 18:-0.52833509 19:-0.10205206 20:0.16675249 21:0.2228602 22:-0.36231247 23:-0.039630387 24:-0.27459741 25:-0.51627016 26:-0.25163805 27:-0.69397962 28:0.017182717 29:0.62085277 30:0.4650622 31:-1.2651849 32:-0.93857032 33:-0.61381608 34:0.33596033 35:-0.24084118 36:-0.22675507 37:0.21916914 38:-0.69940108 39:0.60645193 40:0.2717264 41:-0.18622424 42:-0.81706423 43:0.084611282 44:0.081445038 45:0.0030053484 46:-0.19037405 47:0.43096572 48:-0.13220996 49:-0.02393645 50:0.39518321 51:0.68101358 52:0.13603069 53:0.23453447 54:-0.40553513 55:-0.25994229 56:0.53839463 57:0.46485466 58:0.11911035 59:-0.087702088 60:-0.27450597  |EV| 
-1  |BT| (ROOT (S (ADVP (RB (However)))(, (,))(PP (IN (at))(NP (JJ (0.63))(NN (mg/kg))))(, (,))(NP (NP (NNP (F15063)))(VP (VBN (induced))(NP (NP (DT (a))(JJR (lower))(NN (degree)))(PP (IN (of))(NP (JJ (striatal))(NNP (IEG))(NNP (mRNA))(NN (expression)))))(PP (IN (than))(NP (NN (haloperidol))(CC (and))(NN (pretreatment))))(PP (IN (with))(NP (NP (NP (NP (NP (DT (the))(ADJP (JJ (serotonin))(NP-TMP (CD (5-HT))))(PRN (-LRB- (-LRB-))(NP (CD (1A)))(-RRB- (-RRB-)))(NN (receptor)))(NP (NNP (antagonist))(NNP (N))))(: (-))(NP (NP (NP (QP (CD (-LSB-))(CD (2))))(PRN (: (-))(NP (QP (CD (-LSB-))(CD (4))))(: (-))))(PRN (-LRB- (-LRB-))(ADJP (JJ (2-methoxyphenyl)))(-RRB- (-RRB-)))(NP-TMP (CD (-1))))(: (-))(NP (NP (JJ (piperazinyl))(NNS (-RSB-)))(NP (NN (ethyl-N))))(: (-))(NP (NP (PRN (-LRB- (-LRB-))(ADJP (JJ (2-pyridinyl)))(-RRB- (-RRB-)))(JJ (cyclohexane))(NN (carboxamide)))(NP (NN (trihydrochloride)))))(PRN (-LRB- (-LRB-))(NP (NNP (WAY100635)))(-RRB- (-RRB-))))(PRN (-LRB- (-LRB-))(NP (QP (CD (0.63))(CD (mg/kg))))(-RRB- (-RRB-)))))))(VP (VBD (increased))(NP (NP (DT (the))(NN (level)))(PP (IN (of))(NP (NNP (IEG))(NN (mRNA))(NN (induction)))))(PP (IN (by))(NP (NNP (F15063)))))(. (.)))) |ET|  |BV| 1:-0.53704453 2:-0.12204219 3:0.84530586 4:-0.62675083 5:-0.92522335 6:0.035758637 7:0.87108439 8:0.58559096 9:-1.1690227 10:-1.857342 11:0.25633058 12:0.35471615 13:-0.65178722 14:0.58234233 15:0.36624381 16:-0.4592455 17:0.57339162 18:-1.0607195 19:1.3023652 20:-0.84165275 21:-0.028838174 22:-0.1999528 23:-0.23261218 24:-0.71930772 25:0.47374251 26:-0.10928841 27:0.10452057 28:0.0037722627 29:0.53051585 30:0.38822696 31:0.94099838 32:0.33176014 33:0.12136629 34:0.3136653 35:-0.79584587 36:-0.020856442 37:0.28518173 38:-0.066591188 39:0.31751966 40:0.35279626 41:-0.38618639 42:-0.93829429 43:0.38555783 44:-0.77534562 45:0.35856313 46:-0.21710774 47:-0.11740205 48:-0.39984682 49:-0.36120972 50:-0.14159638 51:0.032128744 52:-0.010269973 53:0.079882212 54:-0.19202092 55:-0.15700236 56:-0.069073133 57:0.46875384 58:-0.011727256 59:0.40354019 60:0.34818971  |EV| 
-1  |BT| (ROOT (S (NP (DT (The))(NNS (results)))(VP (VBP (indicate))(SBAR (IN (that))(S (S (PP (IN (under))(NP (NP (DT (the))(JJ (same))(NN (dose))(NN (level)))(PP (IN (of))(NP (NN (mefloquine))))))(, (,))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (JJ (single))(NN (dose)))))(VP (VBZ (is))(ADJP (JJ (superior))(PP (TO (to))(NP (NP (DT (that)))(PP (IN (of))(NP (JJ (multiple))(JJ (daily))(NNS (doses)))))))))(: (;))(S (NP (NP (NN (mefloquine)))(VP (VBN (combined))(PP (IN (with))(NP (NN (artesunate))(CC (or))(NN (artemether))))(PP (IN (at))(NP (DT (an))(ADJP (JJ (invalid))(CC (or))(JJ (moderate)))(JJ (effective))(NN (dose))))))(VP (MD (may))(VP (VB (show))(NP (NP (JJ (synergistic))(NN (effect)))(, (,))(RB (especially))(NP (NP (DT (the))(NN (effect)))(PP (IN (against))(NP (JJ (female))(NNS (worms)))))))))(: (;))(S (NP (DT (no))(JJ (prominent))(JJ (synergistic))(NN (effect)))(VP (VBZ (is))(ADJP (JJ (observed)))(, (,))(SBAR (WHADVP (WRB (when)))(FRAG (NP (NP (DT (the))(JJ (similar))(NN (dose))(NN (level)))(PP (IN (of))(NP (NN (mefloquine))))(PP (IN (in))(NP (NN (combination)))))))(PP (IN (with))(NP (NN (praziquantel)))))))))(. (.)))) |ET|  |BV| 1:-0.56343693 2:-0.35159785 3:-0.14530689 4:0.41392627 5:0.43864274 6:-0.62473142 7:-0.74550021 8:0.10656618 9:0.38636047 10:1.0745468 11:-0.93271834 12:0.50037241 13:-0.11474589 14:-0.72066718 15:-0.34713095 16:1.3505288 17:-0.14346741 18:-0.084357351 19:-0.13472518 20:-0.72076881 21:-0.93005985 22:-0.30919522 23:0.31470484 24:0.076104596 25:0.72613853 26:1.0984204 27:0.33448243 28:-1.0921667 29:-0.3077887 30:2.266288 31:0.17608443 32:0.30545121 33:-1.0081551 34:-0.26120168 35:0.12075878 36:0.30791527 37:-0.13103454 38:-0.74474752 39:0.014664152 40:-0.36352623 41:-0.69996119 42:-0.16134493 43:0.13931625 44:0.086392276 45:0.35147309 46:0.12523282 47:0.58646411 48:-0.37716371 49:-0.0075372397 50:0.51305377 51:0.42101899 52:0.14617337 53:-0.062068481 54:0.43490702 55:0.13152415 56:-0.69503963 57:0.33024818 58:0.089715101 59:0.23025621 60:0.54238826  |EV| 
-0.9209371361784935983152422522835  |BT| (ROOT (S (PP (VBN (Compared))(PP (TO (to))(NP (NNP (IDC)))))(, (,))(NP (NNP (ILC)))(VP (VBD (showed))(SBAR (S (NP (NP (DT (a))(JJR (larger))(NN (tumor))(NN (size)))(PRN (-LRB- (-LRB-))(NP (NP (NNP (=))(NNP (T2)))(, (,))(NP (NP (CD (59.8))(NN (%)))(PP (IN (vs.))(NP (NP (CD (38.8))(NN (%)))(, (,))(NP (NP (NNP (P)))(SBAR (S (VP (SYM (=))(NP (CD (0.001)))))))))))(-RRB- (-RRB-)))(, (,))(NP (NP (DT (a))(ADJP (JJR (lower))(JJ (histologic)))(NN (grade)))(PRN (-LRB- (-LRB-))(NP (NP (NNP (HG))(CD (1/2)))(, (,))(NP (NP (CD (90.4))(NN (%)))(PP (IN (vs.))(NP (CD (64.4))(NN (%)))))(, (,))(NP (NNP (P))(NNP (<))(NNP (0.001))))(-RRB- (-RRB-))))(, (,))(NP (NP (JJR (more))(JJ (frequent))(NN (estrogen))(NN (receptor)))(ADJP (ADJP (JJ (positive)))(PRN (-LRB- (-LRB-))(NP (NP (CD (90.4))(NN (%)))(PP (IN (vs.))(NP (NP (CD (64.4))(NN (%)))(, (,))(NP (NNP (P))(NNP (<))(NNP (0.001))))))(-RRB- (-RRB-)))))(, (,)))(VP (VBP (progesterone))(S (VP (VP (VBG (receptor))(NP (NP (ADJP (ADJP (ADJP (JJ (positive)))(PRN (-LRB- (-LRB-))(NP (NP (CD (71.1))(NN (%)))(PP (IN (vs.))(NP (NP (CD (50.1))(NN (%)))(, (,))(NP (NNP (P))(NNP (<))(NNP (0.001))))))(-RRB- (-RRB-))))(CC (and))(ADJP (ADJP (RB (HER2))(JJ (negative)))(PRN (-LRB- (-LRB-))(NP (NP (CD (97.5))(NN (%)))(PP (IN (vs.))(NP (NP (CD (74.6))(NN (%)))(, (,))(NP (NNP (P))(NNP (<))(NNP (0.001))))))(-RRB- (-RRB-)))))(NN (status)))(, (,))(CC (and))(NP (NP (JJR (lower))(NN (Ki-67))(NN (expression)))(PRN (-LRB- (-LRB-))(NP (NP (CD (10.3))(NN (%)))(NP (NP (QP (CD (±))(CD (10.6)))(NN (%)))(PP (IN (vs.))(NP (NP (NP (CD (20.6))(NN (%)))(NP (QP (CD (±))(CD (19.8)))(NN (%))))(, (,))(NP (NP (NNP (P))(NNP (<)))(NP (CD (0.001))))))))(-RRB- (-RRB-))))))(, (,))(CONJP (RB (as))(RB (well))(IN (as)))(VP (VBG (being))(ADJP (RBR (more))(JJ (likely))(S (VP (TO (to))(VP (VB (be))(PP (IN (of))(NP (DT (the))(NN (luminal)))))))))(NP (NP (DT (A))(NN (subtype)))(PRN (-LRB- (-LRB-))(NP (NP (CD (91.4))(NN (%)))(PP (IN (vs.))(NP (NP (CD (51.2))(NN (%)))(, (,))(NP (NNP (P))(NNP (<))(NNP (0.001))))))(-RRB- (-RRB-))))))))))(. (.)))) |ET|  |BV| 1:-1.0670902 2:0.23203368 3:0.7180962 4:0.84020025 5:-0.31951991 6:0.4139142 7:0.47330904 8:0.026332116 9:0.39720982 10:-0.51868224 11:0.00086135836 12:-0.2706458 13:0.27077052 14:0.11533815 15:-0.078596331 16:0.25425336 17:-0.81162268 18:1.3172449 19:0.24948108 20:-0.41995546 21:-0.70291984 22:0.10596521 23:0.40353924 24:-0.0082024643 25:0.51516557 26:-0.4248296 27:0.15003122 28:0.1239915 29:0.20275137 30:0.48732561 31:0.47781709 32:-0.14894189 33:0.51152009 34:0.33163288 35:-0.5908134 36:0.57499492 37:0.029747412 38:0.11391607 39:0.40241897 40:0.6374259 41:0.72959906 42:0.31645319 43:0.33957493 44:0.064995825 45:-0.087116443 46:-0.079077385 47:-0.43598956 48:0.006599939 49:0.11535599 50:-0.35353127 51:0.64523482 52:0.50717562 53:0.10426375 54:-0.30898896 55:0.35681897 56:0.80943263 57:0.85897726 58:0.77472395 59:-0.10712278 60:0.39021918  |EV| 
1  |BT| (ROOT (S (NP (NNP (Clomipramine)))(VP (VBZ (is))(NP (NP (DT (a))(JJ (tricyclic))(NN (antidepressant)))(SBAR (WHNP (WDT (that)))(S (VP (VBZ (inhibits))(NP (NP (DT (the))(NN (reuptake)))(PP (IN (of))(NP (NN (serotonin))(CC (and))(NN (norepinephrine)))))(PP (IN (by))(NP (NP (JJ (indirect))(NNS (actions)))(PP (IN (on))(NP (NP (DT (the))(JJ (dopaminergic))(NN (system)))(CC (and))(NP (NNP (LHPA))(NNS (axis))))))))))))(. (.)))) |ET|  |BV| 1:-0.38979417 2:-0.50012702 3:-0.3015736 4:0.064433955 5:0.049931284 6:-1.1039975 7:-0.64272398 8:-0.016858406 9:-0.19306575 10:0.84069532 11:-0.14306119 12:-0.36533102 13:-0.17613606 14:-0.32045415 15:0.047505978 16:0.092567921 17:-0.67962086 18:-0.08659891 19:0.5127154 20:0.77329773 21:-1.0374453 22:0.85880065 23:-0.24367349 24:-1.0123558 25:0.14853026 26:0.064390242 27:0.82503897 28:0.057420235 29:0.23259422 30:0.22073723 31:0.8552382 32:-0.631019 33:0.38975126 34:-0.6101191 35:0.14520936 36:0.39410061 37:-0.23449533 38:0.13932607 39:0.37582126 40:-0.08262825 41:-0.077239081 42:-0.19914758 43:0.020278506 44:-0.12281031 45:0.43579081 46:-0.42261043 47:-0.0685606 48:-0.18911836 49:0.047354031 50:0.16439024 51:-0.1859255 52:0.10577066 53:-0.21476671 54:-0.29499033 55:-0.16324435 56:0.30024967 57:0.28345016 58:0.33873776 59:0.10391232 60:-0.20117396  |EV| 
1  |BT| (ROOT (S (S (S (VP (VBN (Considered))(ADVP (RB (together)))))(, (,))(NP (NP (DT (this))(NN (pattern)))(PP (IN (of))(NP (NNS (findings)))))(VP (VBZ (demonstrates))(SBAR (IN (that))(S (NP (NN (bupropion)))(VP (VBZ (decreases))(S (VP (VBG (responding))(PP (IN (for))(NP (NN (methamphetamine)))))))))))(, (,))(CC (but))(S (NP (DT (the))(NNS (effects)))(VP (VBP (are))(ADVP (RB (only)))(ADJP (RB (somewhat))(JJ (specific)))))(. (.)))) |ET|  |BV| 1:0.027203679 2:-0.44145474 3:0.1978243 4:-0.29811138 5:0.22199877 6:-0.42937174 7:-0.12837471 8:-0.42986649 9:0.51660991 10:0.45310685 11:0.30332148 12:0.0084803775 13:-0.29091501 14:0.30512857 15:0.1157142 16:0.4981862 17:-0.05296972 18:0.16757877 19:0.68114299 20:0.48334053 21:0.43385875 22:-0.70879608 23:-0.15121306 24:-0.4984982 25:0.25945014 26:-0.21913771 27:-0.77050805 28:-0.65597773 29:0.77728212 30:0.75117898 31:0.26791933 32:0.098864079 33:0.040396873 34:0.34282583 35:-0.63833892 36:0.37242758 37:-0.52486193 38:-0.39260066 39:0.14577915 40:0.077141792 41:-0.42586252 42:0.097476102 43:0.068828948 44:0.10124437 45:0.68796414 46:-0.27438805 47:0.11153818 48:0.078145474 49:0.046368867 50:0.14983895 51:0.29451695 52:0.024287337 53:-0.11595449 54:-0.39118788 55:0.083115488 56:0.60174638 57:0.03368073 58:-0.29728624 59:-0.072219074 60:-0.25036153  |EV| 
1  |BT| (ROOT (S (NP (NP (NP (NNP (Low))(NNS (doses)))(PP (IN (of))(NP (NN (oxybutynin)))))(, (,))(NP (NP (DT (an))(JJ (anticholinergic))(NN (medication)))(SBAR (WHNP (WDT (that)))(S (ADVP (RB (competitively)))(VP (VBZ (antagonizes))(NP (DT (the))(JJ (muscarinic))(NN (acetylcholine))(NN (receptor)))))))(, (,)))(VP (MD (can))(VP (VB (be))(VP (VBN (used))(S (VP (TO (to))(VP (VB (treat))(NP (NN (palmar))(NNS (hyperhidrosis)))(PP (IN (with))(NP (JJR (fewer))(NN (side))(NNS (effects))))))))))(. (.)))) |ET|  |BV| 1:-0.51880121 2:0.17045456 3:0.85412109 4:-0.69963861 5:-0.29431659 6:-0.34126419 7:0.62195432 8:0.27494204 9:0.82437688 10:0.068378299 11:0.80219162 12:-0.45784676 13:1.1120889 14:0.20851707 15:-0.052710541 16:0.37089568 17:0.32535321 18:-0.068557709 19:0.57967973 20:-0.2269354 21:-1.5915744 22:0.28387871 23:0.7078169 24:-0.82616466 25:0.52297723 26:0.27328888 27:0.6187607 28:0.99428755 29:1.2780675 30:1.2075726 31:-0.96468574 32:0.52205604 33:-0.58593369 34:-0.49952519 35:-0.72520173 36:-0.030002572 37:0.50635254 38:-0.38588539 39:0.90383446 40:-1.0607158 41:-0.17759308 42:0.096929029 43:0.31493446 44:-0.035304289 45:0.26120454 46:0.21718191 47:0.0020539106 48:-0.48884836 49:-0.062609412 50:0.26391169 51:0.29302233 52:0.086325034 53:-0.45860323 54:-0.089275755 55:0.31635192 56:-0.32018757 57:-0.10573237 58:-0.14954974 59:-0.19930482 60:0.018251302  |EV| 
-1  |BT| (ROOT (S (NP (NP (NP (NNP (AUTHORS))(POS (')))(NNS (CONCLUSIONS)))(: (:))(NP (NP (NNP (Sublingual))(NNP (nitroglycerin)))(, (,))(VP (VBN (given))(SBAR (WHADVP (WRB (when)))(S (NP (NN (oxytocin)))(VP (VBZ (fails)))))))(, (,)))(VP (VBZ (seems))(S (VP (TO (to))(VP (VB (reduce))(NP (NP (PDT (both))(DT (the))(NN (need)))(PP (IN (for))(NP (NP (JJ (manual))(NN (removal)))(PP (IN (of))(NP (NN (placenta))(CC (and))(NN (blood))(NN (loss)))))))(PP (IN (during))(NP (NP (DT (the))(JJ (third))(NN (stage)))(PP (IN (of))(NP (NN (labour))))))(SBAR (WHADVP (WRB (when)))(S (VP (VBN (compared))(PP (TO (to))(NP (NN (placebo)))))))))))(. (.)))) |ET|  |BV| 1:-0.73396552 2:-0.03563815 3:-0.47762555 4:-1.1443393 5:-0.29404604 6:-1.2843784 7:0.24934539 8:-0.11478796 9:0.55850881 10:0.73228472 11:0.35990876 12:0.1829201 13:-0.37143382 14:-0.65031296 15:0.24407633 16:0.39379451 17:-0.66080558 18:0.79185009 19:1.0224576 20:-0.68803889 21:-0.75388217 22:0.026484989 23:-0.93423945 24:-0.80403888 25:0.15034288 26:-0.057772785 27:0.20338556 28:-0.69750762 29:0.11853725 30:-0.193911 31:0.63666028 32:-0.52382642 33:-0.066916093 34:-0.78162348 35:-0.4030385 36:-0.30153197 37:0.27281329 38:0.071324416 39:0.16258468 40:-0.37367284 41:-0.14025825 42:0.1799354 43:0.28692123 44:0.16866462 45:0.13340171 46:-0.17866249 47:-0.44523141 48:-0.65965497 49:-0.42149514 50:-0.57263017 51:0.50604087 52:0.08195658 53:-0.087305821 54:0.016588148 55:0.5200491 56:0.051870335 57:0.42822832 58:-0.16960782 59:-0.22868252 60:-0.1605612  |EV| 
-1  |BT| (ROOT (S (PP (IN (As))(S (NP (NP (DT (a))(NN (result)))(PP (IN (of))(NP (NP (ADJP (ADVP (RB (molecularly)))(JJ (targeted)))(JJ (anti-EGFR))(NNS (therapies)))(PRN (-LRB- (-LRB-))(ADJP (JJ (cetuximab))(CC (and))(JJ (panitumumab)))(-RRB- (-RRB-))))))(VP (VBG (complementing))(ADVP (RB (chemotherapy))))))(, (,))(NP (NN (liver))(NNS (metastases)))(VP (MD (can))(VP (VP (VB (reduce))(PP (IN (in))(NP (NN (size)))))(CC (and))(VP (VB (become))(NP (NP (JJ (operable)))(PP (IN (in))(NP (NP (JJ (certain))(NNS (patients)))(, (,))(SBAR (WHNP (WDT (which)))(S (VP (MD (can))(VP (VB (contribute))(PP (TO (to))(NP (NP (DT (the))(JJ (complete))(NN (recovery)))(PP (IN (of))(NP (DT (the))(NN (patient))))))))))))))))(. (.)))) |ET|  |BV| 1:0.60125124 2:-0.76545882 3:1.1888238 4:0.45946464 5:0.6342001 6:-0.044119511 7:0.73391873 8:0.13165164 9:0.66971922 10:0.8942911 11:-0.68757224 12:0.64582759 13:0.27450234 14:1.3237469 15:-0.39306837 16:0.21697031 17:-0.37259692 18:-0.66445273 19:0.44825962 20:-0.88031834 21:-0.28161815 22:-0.68261337 23:0.44740391 24:0.2930876 25:0.58377028 26:0.37423158 27:0.70943683 28:-0.085498527 29:0.86710089 30:0.58071637 31:0.063820101 32:-0.0067333668 33:0.26994082 34:0.39133662 35:-0.33628094 36:1.5841424 37:-0.76286179 38:-0.42525661 39:-0.71097696 40:-0.94073945 41:0.55339426 42:0.025339678 43:0.10392881 44:-0.47433037 45:-0.051277269 46:-0.22727767 47:0.091562092 48:-0.10708047 49:0.60904169 50:0.40502673 51:0.20647898 52:-0.024519995 53:-0.2447584 54:-0.10245352 55:0.40801552 56:-0.28440028 57:0.48008108 58:0.20567422 59:0.35727257 60:-0.070227638  |EV| 
-1  |BT| (ROOT (S (NP (NNP (Amycolatopsis))(NNP (balhimycina)))(VP (VP (VBZ (produces))(NP (DT (the))(JJ (vancomycin-like))(NN (glycopeptide))(NN (balhimycin))))(CC (and))(ADVP (RB (therefore)))(VP (VBZ (has))(S (VP (TO (to))(VP (VB (protect))(NP (PRP (itself)))(PP (IN (from))(NP (NP (DT (the))(NN (action)))(PP (IN (of))(NP (DT (the))(NN (glycopeptide)))))))))))(. (.)))) |ET|  |BV| 1:-0.13414563 2:0.18827158 3:-0.24861152 4:0.041680168 5:1.3678234 6:-1.745497 7:1.0956513 8:0.61100626 9:1.0161031 10:0.37403691 11:1.2081023 12:-0.68180752 13:-0.57862562 14:0.64649957 15:1.630529 16:0.24926952 17:-0.22660105 18:-0.52584243 19:1.0271124 20:-0.54040813 21:-0.29975867 22:-0.90835148 23:-0.35928813 24:-0.40498751 25:-0.070239365 26:-0.54183668 27:-0.41281372 28:0.56097722 29:-0.59817785 30:0.68011802 31:-1.0664285 32:-0.33847964 33:-0.050172817 34:1.0202811 35:-0.51219434 36:0.73061973 37:-0.31654057 38:-0.64519918 39:-0.52202326 40:0.20618306 41:0.070051014 42:0.16281335 43:0.17735888 44:0.038011342 45:0.19181298 46:-0.49094817 47:0.12295219 48:0.017939292 49:0.13433383 50:0.25992981 51:0.29989624 52:-0.28517362 53:0.17889977 54:-0.13441737 55:-0.0044565229 56:0.16566184 57:0.1166174 58:-0.37749651 59:0.11853175 60:0.41051045  |EV| 
0.88574331853579701956391545536462  |BT| (ROOT (S (NP (PRP (We)))(VP (VBD (co-administered))(NP (NN (carbidopa)))(PP (IN (with))(NP (NN (levodopa))))(S (VP (TO (to))(VP (VP (VB (prevent))(NP (NP (JJ (peripheral))(NN (synthesis)))(PP (IN (of))(NP (ADJP (ADJP (JJ (dopamine))(PP (IN (from))(NP (NN (levodopa)))))(, (,))(CC (and))(ADJP (JJ (observed))(JJ (tactile)))(, (,)))(NN (cold))))))(, (,))(CC (and))(VP (VB (heat))(NP (NP (NN (allodynia))(NN (pre-administration)))(, (,))(CC (and))(ADVP (IN (at))(NP (CD (15))))(, (,))(NP (CD (30)))(, (,))(NP (CD (60)))(, (,))(NP (CD (90)))(, (,))(NP (CD (120)))(, (,))(NP (CD (150)))(, (,))(NP (CD (180)))(, (,))(CC (and))(NP (CD (240))(NN (min))))(PP (IN (after))(NP (NN (drug))(NN (administration)))))))))(. (.)))) |ET|  |BV| 1:0.28785473 2:0.33784044 3:-0.077978127 4:-0.70704013 5:0.86684585 6:-0.37076586 7:-0.067946956 8:-0.20228431 9:0.32697809 10:0.719715 11:0.19001259 12:-0.033035219 13:-0.073462017 14:-0.11689436 15:-0.00086127908 16:0.72606879 17:-0.16583562 18:0.07556168 19:0.12820369 20:0.77919751 21:-0.64544392 22:-0.44983807 23:-0.34344029 24:-1.2095876 25:0.45658329 26:-0.69317514 27:-0.016772546 28:0.045951527 29:0.75048918 30:0.34895226 31:0.028257851 32:-0.40035602 33:0.83469516 34:-0.0950922 35:0.34242991 36:1.5515863 37:-0.044769358 38:0.76400512 39:0.17933919 40:0.63299578 41:0.091936685 42:-0.20212761 43:0.61215627 44:-0.57111537 45:0.53473794 46:-0.52292252 47:0.51268625 48:-0.21048023 49:-0.52308983 50:-0.10698354 51:0.22619526 52:0.80689484 53:-0.63964802 54:-0.4812541 55:0.12798703 56:0.15573078 57:-0.2056195 58:0.20286341 59:-0.11386026 60:0.37224671  |EV| 
0.92311357959112982918270517984638  |BT| (ROOT (S (NP (NP (JJ (Many))(ADJP (RB (commonly))(JJ (used)))(NNS (drugs)))(, (,))(PP (JJ (such))(IN (as))(NP (NP (NN (bile))(NN (acid))(NNS (sequestrants)))(, (,))(NP (JJ (ferrous))(NN (sulphate)))(, (,))(NP (NN (sucralfate)))(, (,))(NP (NN (calcium))(NN (carbonate)))(, (,))(NP (JJ (aluminium-containing))(NNS (antacids)))(, (,))(NP (JJ (phosphate))(NNS (binders)))(, (,))(NP (NN (raloxifene)))(CC (and))(NP (JJ (proton-pump))(NNS (inhibitors)))))(, (,)))(VP (VBP (have))(ADVP (RB (also)))(VP (VBN (been))(VP (VBN (shown))(S (VP (TO (to))(VP (VB (interfere))(PP (IN (with))(NP (NP (DT (the))(NN (absorption)))(PP (IN (of))(NP (NN (levothyroxine))))))))))))(. (.)))) |ET|  |BV| 1:-0.29329422 2:-0.00032358587 3:-0.52397877 4:-0.14979698 5:0.18156201 6:-0.15531416 7:-0.94168329 8:-1.04003 9:-0.020318013 10:-0.00048563216 11:-0.29679406 12:0.17399098 13:-0.26366597 14:-0.16816862 15:-1.0546118 16:0.86308473 17:-0.27049592 18:-0.42290097 19:0.27473414 20:-0.41727701 21:-0.42913553 22:-1.4204276 23:-0.1845077 24:-0.17486823 25:-0.23320828 26:-0.70937651 27:0.4484399 28:0.076854005 29:-0.28111053 30:0.35369068 31:-0.21005453 32:0.49035081 33:0.23017047 34:-0.28456178 35:-1.3246332 36:0.68069863 37:-0.10216844 38:0.60250902 39:0.58728558 40:0.31180346 41:-0.22720583 42:-0.24226001 43:0.36310989 44:0.66716933 45:0.346138 46:-0.18039674 47:-0.31450996 48:0.1037826 49:0.18795817 50:0.089048557 51:0.70327199 52:0.1130985 53:-0.043622714 54:-0.44350961 55:0.30346686 56:0.45103353 57:-0.10387065 58:0.44122136 59:-0.51673943 60:0.16441642  |EV| 
0.84063032668112214196298737078905  |BT| (ROOT (NP (NP (JJ (Nicotine))(NN (treatment)))(NP (-LRB- (-LRB-))(JJ (0.4))(NN (mg))(NN (·))(NN (kg)))(. (?)))) |ET|  |BV| 1:-1.1741339 2:-0.80376834 3:0.736395 4:-1.3107953 5:-0.50124806 6:-0.71202838 7:0.037885159 8:0.024502341 9:-0.62534022 10:-1.0763079 11:0.46874541 12:0.821136 13:-0.54107004 14:0.027600111 15:-1.078476 16:0.68977898 17:0.37871653 18:0.36807838 19:0.72015947 20:0.38100523 21:-0.31161079 22:-0.36281344 23:0.18907669 24:0.085704744 25:-0.025418209 26:-0.14755964 27:0.024619143 28:-0.21351071 29:1.1228068 30:0.1944949 31:0.71831656 32:-0.64764792 33:-0.3232435 34:-0.11913425 35:-0.39324352 36:1.1804386 37:0.10067534 38:0.44076952 39:-0.1683571 40:0.32567781 41:-0.26463479 42:-0.55324954 43:0.27039886 44:-0.26796728 45:0.18832435 46:0.26036689 47:-0.47951382 48:-0.13806488 49:-0.56894797 50:0.37010613 51:0.48502937 52:0.11663242 53:0.49399641 54:0.028105782 55:-0.23181823 56:0.22351535 57:0.63156885 58:0.1119284 59:0.25994405 60:-0.43358517  |EV| 
-1  |BT| (ROOT (S (ADVP (RB (Here)))(, (,))(NP (PRP (we)))(VP (VBP (report))(SBAR (IN (that))(S (NP (NP (NP (NP (JJ (systemic))(CC (or))(JJ (local))(NN (administration)))(PP (IN (of))(NP (NN (SB-277011A)))))(, (,))(NP (DT (a))(ADJP (RB (highly))(JJ (selective)))(NNP (D3))(NN (R))(NN (antagonist)))(, (,))(PP (IN (into))(NP (NP (NP (DT (the))(NN (NAc)))(PRN (-LRB- (-LRB-))(NP (JJ (core))(CC (and))(JJ (shell)))(-RRB- (-RRB-))))(CC (or))(NP (DT (the))(NN (CeA))))))(, (,))(CONJP (CC (but))(RB (not)))(NP (DT (the))(JJ (dorsal))(NN (striatum))(CC (or))(NN (basolateral))(NN (amygdala)))(, (,)))(ADVP (RB (significantly)))(VP (VP (VBZ (inhibits))(NP (NP (NN (expression)))(PP (IN (of))(NP (NP (NN (incubation)))(PP (IN (of))(NP (NP (NN (cocaine))(NN (craving)))(PP (IN (in))(NP (NNS (rats)))))))))(PP (IN (after))(NP (NP (CD (2-30))(NNS (days)))(PP (IN (of))(NP (NP (NN (withdrawal)))(PP (IN (from))(NP (JJ (previous))(NN (cocaine))(NN (self-administration)))))))))(CC (but))(VP (VBD (had))(NP (NP (DT (no))(NN (effect)))(PP (IN (on))(NP (NP (JJ (sucrose-seeking))(NN (behavior)))(PP (IN (in))(NP (NNS (rats)))))))(PP (IN (after))(NP (NP (CD (10-30))(NNS (days)))(PP (IN (of))(NP (NN (withdrawal)))))))))))(. (.)))) |ET|  |BV| 1:0.04645972 2:-0.243412 3:-0.12847507 4:-0.020735495 5:0.046708986 6:-0.63118833 7:-0.37865597 8:-0.77093482 9:0.74587637 10:-0.46059707 11:0.0066282842 12:-0.22267382 13:-0.17692463 14:-0.36518228 15:-0.20190102 16:0.29322821 17:-0.080923498 18:-0.18870497 19:0.15922587 20:0.54918379 21:-0.93499321 22:-0.84000343 23:-0.41635552 24:-0.38887846 25:-0.25315806 26:-0.15392397 27:0.025107415 28:0.56973457 29:0.38532907 30:0.37857184 31:0.66472489 32:0.96014047 33:0.74786615 34:-0.18957825 35:-0.72223562 36:-0.079844475 37:-0.32539806 38:0.89657247 39:0.50971693 40:0.36139879 41:-0.33865368 42:-0.24848591 43:0.3995091 44:-0.41769773 45:0.68927538 46:-0.26330471 47:-0.62767434 48:0.32440564 49:-0.06086744 50:-0.0041808765 51:0.37946677 52:0.17346567 53:0.77269131 54:-0.38428909 55:-0.28520402 56:-0.25364316 57:-0.3077842 58:-0.50354427 59:0.028540878 60:-0.70094997  |EV| 
-1  |BT| (ROOT (S (ADVP (RB (However)))(, (,))(NP (DT (the))(NNS (authors)))(VP (VBD (were))(ADJP (JJ (unable))(S (VP (TO (to))(VP (VB (reduce))(S (NP (NNP (KAV)))(VP (VBG (using))(NP (JJ (adjunctive))(NN (atropine))(CC (or))(NN (metoclopramide))))))))))(. (.)))) |ET|  |BV| 1:-0.67935634 2:-0.76576102 3:-0.22106758 4:-0.57372367 5:0.28197569 6:0.20814733 7:0.15986425 8:-0.027409209 9:0.26356155 10:0.089581832 11:0.42520076 12:-0.090538852 13:0.23981953 14:-0.41005591 15:-0.60331243 16:0.26125708 17:0.019843308 18:-0.055050366 19:-0.095602602 20:-0.014820319 21:-0.18249138 22:-0.10426323 23:-0.17040956 24:-0.23240829 25:1.2175658 26:0.12161294 27:-0.0248219 28:-0.48099515 29:0.19091956 30:-0.18165459 31:0.62016201 32:-0.12164176 33:0.44775671 34:0.30970037 35:-0.55052608 36:0.18322083 37:-0.037191644 38:0.17589921 39:0.13660975 40:-0.067096911 41:-0.18703142 42:-0.11043822 43:0.049154583 44:0.10559073 45:0.32764149 46:-0.34180167 47:-0.089928105 48:-0.096381903 49:0.23679715 50:0.15417252 51:0.22425766 52:0.18542746 53:0.098555706 54:0.086516596 55:0.21475337 56:-0.22649337 57:0.36151773 58:-0.1460931 59:-0.26087633 60:-0.15423661  |EV| 
-1  |BT| (ROOT (S (NP (NP (DT (The))(NN (breast))(NN (cancer))(NN (cell))(NN (line))(NN (MCF7)))(CC (and))(NP (DT (the))(NN (lung))(NN (cancer))(NN (cell))(NN (line))(NN (H1299))))(VP (VBD (were))(VP (VBN (treated))(PP (IN (with))(NP (JJ (usnic))(NN (acid))(CD (29))(NN (microM))))(PP (IN (for))(NP (NP (NP (CD (24))(NNS (hours)))(CC (and))(NP (CD (two))(JJ (positive))(NNS (controls))))(: (:))(NP (NP (NN (vincristine)))(PRN (-LRB- (-LRB-))(SBAR (WHNP (WDT (which)))(S (VP (VBZ (prevents))(NP (NP (DT (the))(NN (formation)))(PP (IN (of))(NP (NNS (microtubules))))))))(-RRB- (-RRB-))))(CC (or))(NP (NP (NN (taxol)))(PRN (-LRB- (-LRB-))(SBAR (WHNP (WDT (which)))(S (VP (VBZ (stabilizes))(NP (NNS (microtubules))))))(-RRB- (-RRB-))))))))(. (.)))) |ET|  |BV| 1:-0.23953435 2:-0.57552445 3:-0.091918863 4:0.5484069 5:-0.17151169 6:-0.22737147 7:0.78435564 8:-0.81545115 9:-0.1806661 10:0.74495709 11:-0.34301224 12:-0.20670249 13:-0.2042933 14:-0.04339077 15:0.5533796 16:0.36979359 17:-0.11731836 18:-0.15539655 19:0.6986894 20:0.17335755 21:0.10806209 22:-0.73798895 23:1.6558137 24:0.51094294 25:0.81971055 26:-1.1616857 27:1.1428647 28:-0.11010087 29:-0.050751615 30:-0.44537079 31:1.1681331 32:0.33287895 33:-0.79483718 34:0.0312462 35:0.29051206 36:0.28662109 37:-0.33912843 38:-1.6960806 39:-0.73355275 40:-0.3957302 41:-0.068689667 42:-0.26722994 43:-0.62467772 44:0.80861115 45:-0.16673295 46:-0.5172134 47:-0.26220453 48:-0.089695491 49:0.13679996 50:-0.016236933 51:0.740749 52:0.0048364378 53:0.053002104 54:0.41280836 55:0.0089981183 56:0.2014052 57:0.10079674 58:0.01941967 59:0.68656081 60:0.35450247  |EV| 
1  |BT| (ROOT (S (NP (NNP (Tocilizumab))(NN (treatment)))(VP (VBD (increased))(NP (NP (DT (the))(NN (activity)))(PP (IN (of))(NP (NN (factor))(CD (VIII)))))(PP (IN (in))(NP (DT (a))(JJ (rapid))(CC (and))(JJ (sustained))(NN (manner))))(, (,))(S (VP (VBG (leading))(PP (TO (to))(NP (NP (DT (a))(NN (reduction)))(PP (IN (of))(NP (DT (the))(JJ (prednisolone))(NN (dose)))))))))(. (.)))) |ET|  |BV| 1:-0.86115587 2:0.28541219 3:0.19052702 4:0.29966226 5:0.23198517 6:-0.52643561 7:-0.044808477 8:-0.85596228 9:0.0143711 10:0.88446832 11:0.27386928 12:-0.20425533 13:0.76129603 14:-0.2296589 15:-0.19001731 16:0.42697901 17:-0.95155835 18:-0.71085143 19:0.25387961 20:0.33171183 21:-0.68103641 22:0.69052052 23:0.33124778 24:-0.32335159 25:0.34961897 26:-0.65285879 27:0.21090874 28:-0.45215768 29:-0.24057396 30:0.11513281 31:-0.32448405 32:-0.20304349 33:0.55820858 34:-0.11459028 35:0.62634766 36:0.13714281 37:-0.77483606 38:-0.47620785 39:0.49472842 40:0.55531633 41:-0.5260402 42:0.040202778 43:-0.16155222 44:0.077654392 45:0.1007771 46:-0.26393121 47:0.019789228 48:-0.18529819 49:-0.15939566 50:0.2901181 51:0.2908119 52:-0.35136083 53:-0.1588743 54:-0.10575747 55:-0.024212973 56:0.096512109 57:0.57491863 58:0.31312901 59:0.13119067 60:0.19278426  |EV| 
1  |BT| (ROOT (S (NP (NP (NNP (Quercetin)))(VP (VBN (administered))(PP (TO (to))(NP (JJ (pregnant))(JJ (diabetic))(NNS (rats))))))(VP (VP (VBD (controlled))(NP (NN (dyslipidemia))(CC (and))(JJ (improved))(NN (lipid))(NNS (profiles)))(PP (IN (in))(NP (NP (NN (diabetes))(NNS (mellitus)))(, (,))(VP (VBN (regulated))(NP (JJ (oxidative))(NN (stress)))(PP (IN (by))(S (VP (VBG (reducing))(NP (NP (DT (the))(NN (generation)))(PP (IN (of))(NP (NN (lipid))(NNS (hydroperoxides)))))))))(, (,)))))(CC (and))(VP (VBD (increased))(NP (NP (DT (the))(NN (activity)))(PP (IN (of))(NP (DT (the))(JJ (antioxidant))(JJ (enzyme))(NN (glutathione))(NN (peroxidase)))))))(. (.)))) |ET|  |BV| 1:-1.0285524 2:-2.3016484 3:0.730923 4:0.65657192 5:0.51125544 6:-0.16373804 7:-0.64307582 8:0.82430935 9:0.1517085 10:0.22306097 11:0.020307016 12:-1.1585945 13:1.1519955 14:0.041456573 15:-1.2895825 16:0.20305891 17:0.47542363 18:0.4105868 19:0.043337997 20:-0.73385173 21:-2.1319661 22:1.0506796 23:0.8612175 24:-0.52978295 25:-0.84027267 26:-0.48896053 27:-0.34385866 28:0.59534967 29:-0.29902795 30:0.96731508 31:0.075172231 32:0.12474465 33:1.6130536 34:0.37658465 35:-0.24996969 36:-1.5141646 37:-1.6431141 38:-0.34250835 39:0.28368518 40:-1.1796204 41:-0.45986328 42:-0.074190155 43:0.052184958 44:0.48105171 45:-0.096510798 46:0.22683632 47:-0.13920078 48:0.044212051 49:-0.21483889 50:0.30211842 51:0.56919539 52:-0.23745051 53:0.2306751 54:-0.17022194 55:-0.053008053 56:0.098537087 57:0.41827282 58:0.022013312 59:-0.19443515 60:-0.075295225  |EV| 
1  |BT| (ROOT (S (PP (IN (In))(NP (NN (conclusion))))(NP (PRP$ (our))(NNS (data)))(VP (VBP (indicate))(SBAR (IN (that))(S (NP (NP (JJ (concurrent))(NN (use)))(PP (IN (of))(NP (NP (NN (morphine)))(PP (IN (with))(NP (NN (buspirone)))))))(VP (MD (may))(VP (VB (produce))(NP (NP (JJ (good))(NN (cancer))(NN (pain))(NN (control))(CC (and))(NN (attenuate))(NN (development)))(PP (IN (of))(NP (NN (tolerance))))))))))(. (.)))) |ET|  |BV| 1:-0.49507847 2:-0.71530449 3:-0.77657247 4:-0.13436721 5:1.0161602 6:-1.4441125 7:-0.52347863 8:-1.4935842 9:0.88833487 10:0.65763009 11:0.1956035 12:0.40116826 13:0.06076365 14:-0.23411644 15:0.4729718 16:0.4168762 17:0.52853537 18:-0.12988424 19:0.21823958 20:-0.31002545 21:-0.45263946 22:-0.44811127 23:-0.4024395 24:-0.35953194 25:0.29140186 26:-0.31026688 27:-0.16002285 28:0.027013453 29:0.46951276 30:0.70688903 31:0.51139504 32:-0.31645745 33:0.28384194 34:-0.14880067 35:-0.087615728 36:-0.37213057 37:0.33573028 38:0.14914471 39:-0.2827695 40:0.36941594 41:0.091693901 42:0.32548028 43:0.43764916 44:0.51747513 45:0.19535899 46:0.027892163 47:-0.19995555 48:-0.36302069 49:-0.068299182 50:0.0079165641 51:-0.018338172 52:0.47815737 53:0.38058698 54:0.35721511 55:0.019564636 56:0.14336304 57:-0.13666575 58:-0.10139389 59:-0.71600759 60:0.21857794  |EV| 
-1  |BT| (ROOT (S (PP (IN (In))(NP (DT (this))(NN (report))))(, (,))(NP (PRP (we)))(VP (VBP (demonstrate))(SBAR (IN (that))(S (NP (NP (JJ (monomeric))(NN (rituximab)))(, (,))(PP (IN (at))(NP (NP (DT (the))(JJ (high))(NNS (concentrations)))(VP (VBN (found))(PP (IN (in))(NP (NP (NN (plasma))(VBG (following))(NN (infusion)))(PP (IN (of))(NP (JJ (therapeutic))(NNS (doses)))))))))(, (,)))(VP (VP (VBZ (induces))(NP (NP (JJ (prolonged))(JJ (low-amplitude))(NN (release)))(PP (IN (of))(NP (NN (calcium)))))(PP (IN (from))(NP (JJ (thapsigargin-sensitive))(NN (intracellular))(NNS (stores)))))(CC (and))(VP (VBZ (reduces))(NP (NP (DT (the))(NN (growth)))(PP (IN (of))(NP (NNP (Ramos))(NNP (B))(NNS (cells)))))(PP (IN (in))(NP (NN (culture)))))))))(. (.)))) |ET|  |BV| 1:-0.8092041 2:-0.19329149 3:-0.70447874 4:0.16662487 5:0.29772061 6:-0.64029855 7:-0.70728737 8:-0.16949117 9:-0.54650426 10:1.4144824 11:-0.060322113 12:0.17590384 13:-0.13637727 14:0.23657389 15:-0.57702953 16:1.4925574 17:0.57485455 18:-0.11306486 19:0.70975369 20:-1.2286081 21:-0.76733154 22:0.2460794 23:-0.36372909 24:-0.26238525 25:-0.33067521 26:-0.33500141 27:-0.089534409 28:0.13414255 29:0.37700409 30:0.26008978 31:-0.075949982 32:-0.24670501 33:0.17961161 34:-0.15187471 35:-1.0580264 36:-0.25400683 37:-0.31937048 38:0.033552781 39:0.48308486 40:-0.69982004 41:-0.27599439 42:-0.26065519 43:0.30075505 44:-0.04619623 45:-0.060590416 46:-0.18635866 47:0.24706767 48:-0.41342449 49:0.13261177 50:0.00053175585 51:0.11162081 52:-0.34493485 53:0.19853544 54:-0.53599483 55:0.1525014 56:-0.0047129244 57:0.37931886 58:-0.1014578 59:0.47082669 60:-0.037061524  |EV| 
-1  |BT| (ROOT (S (ADVP (RB (Importantly)))(, (,))(NP (PRP (we)))(VP (VBP (report))(SBAR (IN (that))(S (NP (NP (NN (inhibition)))(PP (IN (of))(NP (NP (NNP (AMPARs)))(PP (IN (in))(NP (DT (the))(NNP (DMS)))))))(VP (VBZ (attenuates))(NP (JJ (operant))(NN (self-administration)))(PP (PP (IN (of))(NP (NN (ethanol))))(, (,))(CC (but))(RB (not))(PP (IN (of))(NP (NN (sucrose)))))))))(. (.)))) |ET|  |BV| 1:-0.93499321 2:-0.84000343 3:-0.41635552 4:-0.38887846 5:-0.25315806 6:-0.15392397 7:0.025107415 8:0.56973457 9:0.38532907 10:0.37857184 11:0.66472489 12:0.96014047 13:0.74786615 14:-0.18957825 15:-0.72223562 16:-0.079844475 17:-0.32539806 18:0.89657247 19:0.50971693 20:0.36139879 21:-0.18262425 22:-0.27455565 23:-0.63187039 24:-0.20303082 25:-0.49805775 26:-0.36358526 27:-0.67585135 28:-0.18507487 29:0.57143605 30:-0.13132448 31:0.033105545 32:0.39477274 33:0.01403023 34:-0.085290499 35:0.069696143 36:0.078646556 37:-0.2542069 38:-0.099925838 39:0.45036244 40:0.57571846 41:0.043245044 42:-0.21047522 43:0.16295318 44:-0.06986735 45:0.37599695 46:-0.36789513 47:-0.13689072 48:-0.10459423 49:-0.2404068 50:-0.21403892 51:-0.10588984 52:-0.29037097 53:0.23817398 54:-0.42229828 55:-0.1009757 56:0.19665396 57:0.38879347 58:-0.087785542 59:-0.037347183 60:-0.067421697  |EV| 
-1  |BT| (ROOT (S (NP (DT (The))(NN (examination)))(VP (VBD (demonstrated))(SBAR (IN (that))(S (NP (NP (CD (1))(NN (%)))(VP (VBG (acetic))(NP (CD (acid/95))(NN (%)))(PP (ADVP (NP (CD (ethanol))(NN (fixative)))(RB (together)))(IN (with))(NP (NN (zinc))(NN (staining))))))(VP (VBD (provided))(NP (DT (a))(JJ (high))(NN (contrast)))(NP (JJ (micro-CT))(NN (image)))(, (,))(S (VP (VBG (enabling))(NP (NP (DT (the))(NN (segmentation)))(PP (IN (of))(NP (JJ (soft))(NNS (tissues)))))))))))(. (.)))) |ET|  |BV| 1:0.11782391 2:-0.11326382 3:-0.45559829 4:0.23644729 5:0.76049387 6:-0.59329844 7:0.54228014 8:0.41613418 9:0.040011354 10:-0.32132769 11:0.92303711 12:0.70906955 13:-0.073625803 14:0.061595749 15:0.56586367 16:0.75466645 17:-0.81484872 18:-0.17582589 19:0.64058375 20:-0.051477093 21:-0.18262425 22:-0.27455565 23:-0.63187039 24:-0.20303082 25:-0.49805775 26:-0.36358526 27:-0.67585135 28:-0.18507487 29:0.57143605 30:-0.13132448 31:0.033105545 32:0.39477274 33:0.01403023 34:-0.085290499 35:0.069696143 36:0.078646556 37:-0.2542069 38:-0.099925838 39:0.45036244 40:0.57571846 41:0.39236972 42:-0.00080840726 43:-0.49571657 44:0.21134223 45:0.42398912 46:-0.094265543 47:-0.46978244 48:-0.13828225 49:0.21080624 50:0.07591226 51:0.011811668 52:0.050475437 53:-0.12781434 54:-0.091617227 55:0.16044585 56:0.10710389 57:0.32368404 58:-0.008756551 59:-0.24492981 60:0.6281727  |EV| 
1  |BT| (ROOT (S (NP (DT (The))(NNS (results)))(VP (VBD (showed))(SBAR (IN (that))(S (NP (NP (JJ (bilateral)))(CONJP (CC (but))(RB (not)))(NP (NP (JJ (unilateral))(JJ (intra-VTA))(NN (administration)))(PP (IN (of))(NP (NN (lidocaine))))))(VP (ADVP (RB (significantly)))(VBZ (decreases))(NP (NP (DT (the))(NN (acquisition)))(PRN (-LRB- (-LRB-))(NP (NNP (P))(NNP (<))(NNP (0.01)))(-RRB- (-RRB-)))(CC (and))(NP (NP (NP (NN (expression)))(PRN (-LRB- (-LRB-))(NP (NNP (P))(NNP (<))(NNP (0.05)))(-RRB- (-RRB-))))(PP (IN (of))(NP (JJ (morphine-induced))(NNP (CPP))))))(PP (VBN (compared))(PP (TO (to))(NP (PRP$ (their))(JJ (respective))(JJ (saline-microinjected))(NNS (groups)))))))))(. (.)))) |ET|  |BV| 1:-0.45263946 2:-0.44811127 3:-0.4024395 4:-0.35953194 5:0.29140186 6:-0.31026688 7:-0.16002285 8:0.027013453 9:0.46951276 10:0.70688903 11:0.51139504 12:-0.31645745 13:0.28384194 14:-0.14880067 15:-0.087615728 16:-0.37213057 17:0.33573028 18:0.14914471 19:-0.2827695 20:0.36941594 21:-0.18326178 22:-0.6332702 23:-1.2221074 24:-0.7760886 25:0.18754745 26:-0.082618378 27:-0.14242551 28:0.073615573 29:-0.11079296 30:-0.01262922 31:0.16777821 32:0.12226185 33:-0.071352325 34:-0.55858153 35:-0.28625986 36:0.31376615 37:0.34146345 38:0.47314885 39:-0.37956539 40:-0.51146042 41:-0.42424983 42:0.10557403 43:-0.054078311 44:0.34094205 45:0.10015013 46:-0.010194913 47:0.23688002 48:0.086190775 49:-0.29944128 50:0.060071792 51:-0.13022438 52:0.3423616 53:0.15164569 54:-0.3305952 55:-0.49831271 56:0.19626048 57:0.31068483 58:0.100687 59:-0.44201908 60:0.010440249  |EV| 
1  |BT| (ROOT (S (PP (IN (In))(NP (NN (aggregate))))(, (,))(NP (DT (these))(NNS (data)))(VP (VBP (show))(NP (NP (DT (the))(NN (ability)))(PP (IN (of))(NP (NN (crizotinib)))))(S (VP (TO (to))(VP (VP (ADVP (RB (specifically)))(VB (target))(NP (NNP (CSC-like-subpopulations))))(, (,))(VP (VB (interfere))(PP (IN (with))(NP (NN (cell-proliferation)))))(, (,))(VP (VB (induce))(NP (NNS (apoptosis))))(, (,))(VP (VB (reduce))(NP (NN (migration))))(CC (and))(ADVP (RB (synergistically)))(VP (VB (interact))(PP (IN (with))(NP (NN (gemcitabine))))))))(, (,))(S (VP (VBG (supporting))(NP (JJ (further))(NNS (studies)))(PP (IN (on))(NP (NP (DT (this))(JJ (novel))(JJ (therapeutic))(NN (approach)))(PP (IN (for))(NP (NNP (PDAC)))))))))(. (.)))) |ET|  |BV| 1:-0.32645553 2:-0.51431543 3:-0.2220355 4:0.054847911 5:-0.52514684 6:0.39572904 7:0.60794675 8:0.013867657 9:1.4301472 10:0.94179541 11:-0.67312551 12:-0.0018658602 13:1.2140834 14:0.70735598 15:0.39855564 16:-0.33303973 17:-0.86975241 18:-0.0896345 19:-0.86895335 20:-0.76535708 21:-1.0761337 22:-0.72653055 23:-0.047030564 24:-0.095044218 25:0.87921143 26:0.14182645 27:0.56299537 28:0.30437505 29:0.050402731 30:0.29846507 31:-0.081354752 32:0.20232107 33:0.73375541 34:-0.26733202 35:-0.23603797 36:0.81133437 37:-0.32434905 38:-1.4542429 39:-0.4224728 40:-0.82956928 41:-0.02221271 42:-0.33393845 43:-0.080343783 44:-0.41405708 45:0.089188173 46:0.16960371 47:-0.12338004 48:-0.52255028 49:0.71358865 50:0.40976417 51:0.37765881 52:0.094765574 53:0.26585048 54:-0.12116871 55:0.067760147 56:0.17826179 57:0.24473719 58:0.00073120458 59:0.44768232 60:-0.028090073  |EV| 
1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (NNP (Ketamine)))(VP (MD (can))(ADVP (RB (remarkably)))(VP (VB (inhibit))(NP (NN (calcium))(NNS (currents)))(PP (IN (in))(NP (NP (DT (the))(JJ (central))(NNS (neurons)))(, (,))(SBAR (WHNP (WDT (which)))(S (VP (MD (may))(VP (VB (explain))(PP (ADVP (IN (at))(JJS (least)))(RB (partly))(NP (DT (the))(NN (action))))(PP (IN (of))(NP (NP (NN (ketamine)))(PP (IN (on))(NP (JJ (central))(JJ (nervous))(NN (system)))))))))))))))(. (.)))) |ET|  |BV| 1:-0.11668429 2:-0.74165034 3:-1.0241296 4:-0.74730933 5:0.10768051 6:-0.027183697 7:-0.3724331 8:0.063145764 9:0.61295736 10:0.35496283 11:0.77447647 12:-0.23379371 13:0.25274378 14:-0.1552559 15:-0.41261145 16:0.58029056 17:0.033387862 18:0.43734667 19:-0.18863106 20:-0.29837921 21:-0.76733154 22:0.2460794 23:-0.36372909 24:-0.26238525 25:-0.33067521 26:-0.33500141 27:-0.089534409 28:0.13414255 29:0.37700409 30:0.26008978 31:-0.075949982 32:-0.24670501 33:0.17961161 34:-0.15187471 35:-1.0580264 36:-0.25400683 37:-0.31937048 38:0.033552781 39:0.48308486 40:-0.69982004 41:-0.11363626 42:0.022131165 43:0.12533018 44:0.0041282559 45:0.37490556 46:-0.57854283 47:-0.050534822 48:-0.18694185 49:-0.033041459 50:0.2962434 51:-0.2781719 52:-0.0035328257 53:-0.079793364 54:-0.16357665 55:-0.18437088 56:0.096353397 57:0.050870422 58:-0.34409943 59:-0.23008823 60:0.43239722  |EV| 
-1  |BT| (ROOT (S (NP (NNP (Naphazoline/antazoline)))(VP (VBD (had))(NP (NP (JJR (lower))(NN (tolerability)))(PP (IN (than))(NP (DT (the))(JJ (other))(NN (study))(NNS (treatments))))))(. (.)))) |ET|  |BV| 1:-0.86237121 2:0.76710021 3:-0.38122648 4:-0.79891813 5:0.33592528 6:-0.83879489 7:1.3031261 8:0.50441796 9:0.92010999 10:0.12217025 11:1.3788344 12:-0.79902411 13:-0.51619488 14:0.32232094 15:-0.96453553 16:0.87845308 17:1.0339965 18:1.1403891 19:0.49555647 20:0.445714 41:0.095250353 42:0.11562728 43:0.42178336 44:0.16357337 45:0.36177072 46:0.27381998 47:-0.21962748 48:-0.29974627 49:-0.17445591 50:-0.067788847 51:0.1052556 52:-0.38929647 53:0.0018837682 54:0.3526127 55:0.0099860216 56:0.086867087 57:0.12770666 58:-0.26723984 59:-0.20702082 60:0.19667321  |EV| 
-1  |BT| (ROOT (S (NP (NNP (Carvedilol)))(VP (VBZ (seems))(ADJP (RBR (more))(JJ (potent))(PP (IN (in))(NP (DT (this))(NN (regard)))))(, (,))(SBAR (IN (whereas))(S (NP (NN (nebivolol)))(VP (VP (ADVP (RBR (more))(RB (effectively)))(VBZ (prevents))(NP (DT (the))(NN (shift)))(PP (TO (to))(NP (DT (a))(VBG (nondipping))(NNP (BP))(NN (profile)))))(CC (and))(VP (VBZ (is))(ADJP (RBR (better))(JJ (tolerated))))))))(. (.)))) |ET|  |BV| 1:-0.45039117 2:0.38605702 3:-0.42609346 4:-0.37955847 5:-0.22535276 6:-0.3483457 7:-1.0166146 8:-0.4630875 9:-0.036711063 10:0.82484084 11:0.29723334 12:-0.24628274 13:-0.047303818 14:0.7992658 15:-1.0971371 16:1.157854 17:-0.49170932 18:-0.54788107 19:-0.22961012 20:-0.9926061 21:-0.0042967023 22:0.034283325 23:-0.21294767 24:0.31639028 25:-0.40563652 26:-0.14845498 27:0.0062819254 28:0.38031819 29:0.50935042 30:0.38778004 31:0.1041638 32:-0.25147206 33:0.71918088 34:-0.36877102 35:-0.25780648 36:-0.32105729 37:-0.49079657 38:-1.0289202 39:0.19370994 40:0.16015957 41:-0.37132189 42:-0.03870187 43:-0.013332527 44:0.021456603 45:0.18104921 46:-0.25221601 47:-0.010084689 48:-0.2544716 49:0.19561294 50:0.091618694 51:0.50530028 52:-0.013907106 53:0.18033877 54:0.3722831 55:0.20084439 56:-0.096450329 57:0.056584619 58:0.17607246 59:-0.1357988 60:0.18655547  |EV| 
-0.99119561926572219423547949190834  |BT| (ROOT (S (S (NP (DT (Some))(ADJP (RB (clinically))(JJ (important)))(NNS (exceptions)))(, (,))(ADVP (RB (however)))(, (,))(VP (VBD (were))(ADJP (JJ (apparent)))))(: (:))(S (NP (NNS (women)))(VP (VBD (experienced))(NP (ADJP (RB (substantially))(JJR (lower)))(NN (response))(NNS (rates)))(PP (IN (with))(NP (NP (JJR (newer))(NNS (antiemetics)))(PP (IN (than))(NP (NP (NNS (men)))(PRN (-LRB- (-LRB-))(NP (NP (NP (NP (CD (45))(NN (%)))(PP (IN (vs.))(NP (CD (58))(NN (%)))))(: (;))(NP (NP (JJ (relative))(NN (risk))(NNS (1.49)))(, (,))(NP (ADJP (CD (95))(NN (%)))(NN (confidence))(NN (interval)))))(NP (CD (1.35-1))(CD (.64))))(-RRB- (-RRB-)))))))))(: (;))(S (NP (NNS (men)))(VP (VBD (had))(NP (NP (JJR (higher))(NNS (rates)))(PP (IN (of))(NP (JJ (sexual))(NN (dysfunction)))))(PP (IN (than))(NP (NP (NNS (women))(NN (while)))(PP (IN (on))(NP (NP (NN (paroxetine)))(PP (IN (for))(NP (JJ (major))(NN (depressive))(NN (disorder))))))))))(: (;))(S (NP (NNS (women)))(VP (VBN (discontinued))(NP (NN (lovastatin)))(PP (ADVP (RBR (more))(RB (frequently)))(IN (than))(NP (NP (NNS (men)))(PP (RB (because))(IN (of))(NP (JJ (adverse))(NNS (events))))))))(. (.)))) |ET|  |BV| 1:0.5095225 2:0.4465341 3:-0.42117476 4:-0.31547651 5:0.94188535 6:-0.87366015 7:0.0058062556 8:0.31431654 9:0.2806915 10:1.0075365 11:-0.33895001 12:-0.26962867 13:0.99218714 14:-0.40420467 15:-0.64567238 16:0.22010013 17:0.14331116 18:-1.06801 19:2.110348 20:-0.18157062 21:0.40516424 22:-0.34817231 23:-0.21981068 24:0.67711431 25:0.84233093 26:0.27862197 27:-0.19206375 28:-0.024393862 29:-0.023376223 30:0.99878728 31:-1.1819035 32:0.31121749 33:-0.043033008 34:-0.55655074 35:-1.3637564 36:0.078063138 37:0.20712908 38:0.049719755 39:1.4825402 40:-0.26617381 41:-0.031649016 42:0.22462671 43:-0.16766463 44:0.20247023 45:0.2385591 46:0.37477896 47:-0.49243805 48:-0.67391932 49:0.16632746 50:-0.10955181 51:0.047606394 52:0.41431329 53:-0.84957355 54:-0.091051146 55:0.31255504 56:0.52172166 57:0.47119716 58:0.30716452 59:0.4766213 60:0.012856621  |EV| 
1  |BT| (ROOT (NP (NP (NNP (CONCLUSION)))(: (:))(NP (NP (JJ (RSVL))(NN (treatment)))(VP (VBN (increased))(NP (NP (DT (the))(JJ (cytotoxic))(NN (activity)))(PP (IN (of))(NP (NNP (DOX)))))(PP (IN (against))(NP (NP (DT (the))(NN (growth)))(PP (IN (of))(NP (JJ (human))(NN (breast))(NN (cancer))(NNS (cells))))))(SBAR (WHADVP (WRB (when)))(S (VP (VBN (given))(S (UCP (DT (either))(ADVP (RB (simultaneously)))(CC (or))(NP (CD (24))(NN (h)))))(PP (IN (before))(NP (NNP (DOX)))))))))(. (.)))) |ET|  |BV| 1:-0.43929073 2:-0.67373717 3:-0.53861225 4:-0.046874858 5:-0.53273952 6:-0.30216259 7:-0.14578676 8:-0.73413217 9:0.44355381 10:-0.043656945 11:-0.57645649 12:0.35209975 13:-0.044508263 14:0.41163665 15:-0.45349112 16:-1.0206017 17:-0.23767275 18:-0.839935 19:-0.47550419 20:0.92739779 21:-1.2889895 22:-0.063427232 23:-0.84276575 24:1.3173349 25:-0.72840911 26:0.017096534 27:-0.20289576 28:-1.1163548 29:-0.27790627 30:1.1979542 31:0.22071043 32:-0.31944266 33:0.37083739 34:0.46889552 35:0.14528438 36:0.93364543 37:-0.12006246 38:-1.0134157 39:0.036733259 40:0.40486678 41:-0.14015959 42:-0.25202194 43:-0.25003257 44:0.47291315 45:-0.23475029 46:-0.41609609 47:0.0520331 48:0.30007082 49:-0.13595416 50:0.21810681 51:0.18289909 52:0.28365561 53:0.54377806 54:0.11507036 55:0.23024531 56:0.038623646 57:0.17944461 58:-0.091930874 59:-0.29189217 60:0.20200916  |EV| 
0.88533852004673996294314974875306  |BT| (ROOT (S (NP (PRP$ (Our))(NN (analysis)))(VP (VBZ (suggests))(SBAR (IN (that))(S (NP (NP (NNS (prophylaxis)))(PP (IN (with))(NP (NN (peg-filgrastim)))))(VP (MD (may))(ADVP (RB (considerably)))(VP (VB (reduce))(NP (NP (DT (the))(NN (incidence)))(PP (IN (of))(NP (NN (grade)))))(NP (NP (QP (CD (3))(CC (or))(JJR (more)))(NN (neutropenia)))(CC (and))(, (,))(ADVP (RB (possibly)))(, (,))(PP (IN (of))(NP (JJ (febrile))(NN (neutropenia)))))(PP (IN (in))(NP (NP (JJ (mCRPC))(NNS (patients)))(VP (VBN (treated))(PP (IN (with))(NP (NN (cabazitaxel))))))))))))(. (.)))) |ET|  |BV| 1:-0.17127512 2:-0.081878498 3:0.39199337 4:0.72913873 5:1.4089456 6:0.47026303 7:0.54464996 8:-0.87871236 9:-0.73467505 10:-0.12670057 11:-0.79316813 12:-0.47285756 13:-0.3618243 14:0.87553316 15:-1.0385197 16:-0.12822555 17:-0.088221565 18:-0.61373365 19:-0.30714664 20:-0.77258039 21:-0.66210604 22:0.3838352 23:-0.4943583 24:-0.036724292 25:0.72278142 26:-0.081386149 27:-0.38601914 28:-0.47692117 29:0.25727651 30:1.0441566 31:-1.3555667 32:1.0722915 33:0.25008437 34:0.20421921 35:0.88996851 36:0.92478824 37:0.56790215 38:0.95575649 39:-0.65361971 40:-0.48245412 41:0.13127542 42:0.10783552 43:-0.29009476 44:0.31877181 45:0.23046258 46:0.24212383 47:-0.25039005 48:0.31367588 49:-0.026833531 50:0.38692692 51:0.37597352 52:0.19827481 53:0.10000693 54:-0.026924517 55:0.65761656 56:-0.19525468 57:0.36977288 58:-0.1233435 59:0.32315329 60:0.21149889  |EV| 
0.97559894606227082203275813299115  |BT| (ROOT (S (NP (PRP (We)))(VP (VBP (find))(SBAR (IN (that))(S (NP (NP (JJ (microtubule))(NN (depolymerization)))(PP (IN (in))(NP (NP (DT (the))(NNP (SCN)))(VP (VBG (using))(ADJP (DT (either))(JJ (Colcemid))(CC (or))(JJ (nocodazole)))))))(VP (VBZ (enhances))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (CD (10))(JJ (pm))(NN (melatonin))(S (VP (TO (to))(VP (VB (phase-shift))(NP (NP (DT (the))(NN (activity))(NNS (rhythms)))(PP (IN (of))(NP (DT (the))(NNP (Long))(NNP (Evans))(NN (rat)))))))))))))))(. (.)))) |ET|  |BV| 1:-0.4176586 2:-0.68634278 3:-0.59409255 4:0.42226446 5:0.1000756 6:-0.37648991 7:-0.22770603 8:0.20558573 9:0.65462661 10:0.64355832 11:0.83729345 12:-0.063424356 13:0.33500063 14:0.31329021 15:0.52702087 16:-0.65230078 17:-0.26013902 18:0.57008058 19:-0.13120672 20:0.10561328 21:0.14181808 22:-2.4269383 23:-0.84405088 24:-0.53943479 25:-0.42466804 26:-0.82872939 27:-0.44055548 28:0.022210281 29:1.0151966 30:0.39334691 31:0.9663198 32:-0.25544932 33:0.15719511 34:0.36114249 35:-0.48273674 36:0.1939843 37:-1.0067675 38:0.58725923 39:-1.1392194 40:-0.81571043 41:-0.49851003 42:0.017982302 43:0.20432484 44:0.37905493 45:-0.06482134 46:-0.14704335 47:0.41416767 48:-0.079732224 49:-0.077219173 50:0.23643932 51:0.76747173 52:0.017314436 53:0.38471863 54:-0.11618458 55:-0.11766621 56:0.22682501 57:-0.2027905 58:0.0084129274 59:-0.34750932 60:-0.25483564  |EV| 
-0.78479630132534228259544306638418  |BT| (ROOT (NP (NP (NNP (PURPOSE)))(: (:))(S (VP (TO (To))(VP (VB (evaluate))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (NP (NN (treatment)))(PP (IN (of))(NP (NP (JJ (diffuse))(JJ (diabetic))(NN (macular))(NN (oedema)))(PRN (-LRB- (-LRB-))(NP (NNP (DME)))(-RRB- (-RRB-))))))))(PP (IN (with))(NP (NP (NP (JJ (difluprednate))(JJ (ophthalmic))(NN (emulsion)))(ADVP (CD (0.05))(NN (%))))(PRN (-LRB- (-LRB-))(NP (NNP (Durezol))(. (?)))(-RRB- (-RRB-)))))))))) |ET|  |BV| 1:0.0074482057 2:0.2949973 3:1.4387265 4:-1.1476662 5:-0.64328653 6:0.43120196 7:-0.076076508 8:-0.018693238 9:-0.3028034 10:0.37171096 11:0.56226039 12:0.31723472 13:-0.91562837 14:0.44643798 15:0.23893417 16:-0.64331084 17:0.48012441 18:-0.20058265 19:-0.52912825 20:-1.3126281 21:-0.14188018 22:-0.94352543 23:0.81149566 24:-0.44199204 25:1.0645791 26:1.3857076 27:0.2539399 28:1.0044879 29:0.3539218 30:-0.3645077 31:0.47678646 32:0.023343705 33:-1.2897381 34:0.64845151 35:0.35698289 36:0.040471822 37:-1.486171 38:-0.95685506 39:-0.028377658 40:-0.90302408 41:0.21191996 42:-0.18754245 43:0.10140096 44:0.23462889 45:0.34704784 46:-0.14721571 47:0.20495027 48:0.40999645 49:-0.26365712 50:0.38600507 51:-0.020621007 52:0.037403658 53:-0.25752446 54:0.37224379 55:0.023043158 56:0.67274588 57:0.57435364 58:-0.26281261 59:-0.22206716 60:0.18009809  |EV| 
-1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (DT (These))(NNS (data)))(VP (VBP (do))(RB (not))(VP (VB (support))(NP (NP (DT (the))(NN (use)))(PP (IN (of))(NP (NNP (NMDA))(NN (receptor))(NNS (antagonists))(, (,))(NN (ketamine))(CC (and))(NN (magnesium))(NNS (sulfate)))))(S (VP (TO (to))(VP (VB (prevent))(NP (NP (DT (the))(NN (development)))(PP (IN (of))(NP (JJ (remifentanil-induced))(NN (postoperative))(NN (hyperalgesia))(CC (and))(NN (tolerance)))))))))))(. (.)))) |ET|  |BV| 1:-1.0434687 2:-0.48374432 3:-2.1462996 4:-0.59154266 5:1.345314 6:0.0023006133 7:-0.0087117944 8:0.089628853 9:-0.58979571 10:0.58092844 11:-0.06251359 12:-0.19914944 13:-0.1330969 14:-0.49067828 15:0.58802539 16:1.4150664 17:-0.09405186 18:0.91224408 19:-0.72598648 20:-0.45793393 21:-0.69870472 22:-0.24796677 23:-0.81360668 24:-0.010563116 25:0.23021409 26:-0.49103528 27:-0.12774047 28:0.32772008 29:-0.10109277 30:0.37758282 31:-0.10246789 32:-0.17838542 33:-0.41387382 34:-0.30004424 35:-0.10441614 36:0.11705339 37:-0.5140717 38:0.68735868 39:0.66774976 40:-0.36981764 41:0.12311483 42:-0.17266284 43:0.54261172 44:0.073040731 45:0.34987366 46:-0.15822597 47:0.16371936 48:-0.34874821 49:-0.13257727 50:0.055886976 51:-0.079014599 52:0.47449544 53:0.019402876 54:0.096627094 55:0.12965058 56:0.089846835 57:0.29744983 58:-0.37044382 59:-0.3985568 60:-0.064133599  |EV| 
-0.99584682116743161728322775161359  |BT| (ROOT (S (NP (NP (CD (24))(NN (ml)))(PP (IN (of))(NP (NP (NNP (Bupivacaine)))(ADJP (CD (0.5))(NN (%)))(PP (IN (with))(NP (NN (injection))(NNP (Dexamethasone))(CD (4)))))))(ADVP (RB (mg)))(VP (VBD (was))(VP (VBN (used))(S (VP (TO (to))(VP (VB (block))(NP (NP (DT (the))(JJ (individual))(CD (four))(NNS (nerves)))(PP (IN (with))(NP (NP (CD (6))(NN (ml)))(PP (IN (of))(NP (NP (DT (the))(JJ (local))(JJ (anaesthetic))(NN (solution)))(PP (IN (per))(NP (NN (nerve))))(ADVP (RB (namely)))(NP (NN (ulnar))(, (,))(NN (radial))(, (,))(NN (median))(CC (and))(NNS (musculocutaneous)))))))))))))(. (.)))) |ET|  |BV| 1:-0.8905074 2:-0.068780981 3:-0.47116345 4:-0.32579431 5:-0.21974571 6:-0.086479373 7:0.31466416 8:-0.11319269 9:0.079392374 10:0.18790373 11:0.23570172 12:-0.12637585 13:0.10259232 14:-0.49600062 15:-0.2559278 16:0.32329068 17:0.42616135 18:0.28018206 19:-0.7610113 20:0.10418049 21:-0.37860355 22:-0.77694696 23:0.15381135 24:-0.30914474 25:0.1739258 26:-0.038748726 27:-0.1213993 28:-0.30365685 29:-0.37887204 30:0.97536069 31:-0.10927109 32:-0.26525721 33:0.15702246 34:-0.080765247 35:0.04058389 36:0.47821069 37:-0.2975603 38:-0.32002869 39:-0.079881735 40:0.0094199497 41:-0.1219848 42:0.090587869 43:-0.2645717 44:0.303177 45:0.30610082 46:0.062370043 47:0.20278507 48:-0.11053276 49:-0.4231897 50:-0.27317315 51:-0.090461411 52:-0.020297233 53:-0.026960362 54:-0.12974785 55:-0.15520893 56:-0.32401338 57:0.017402904 58:0.41060919 59:-0.51318979 60:-0.08102008  |EV| 
1  |BT| (ROOT (S (NP (NNP (Cyproheptadine)))(VP (VBZ (blocks))(NP (NP (DT (all))(NNS (transformations)))(PP (IN (with))(NP (NN (progesterone))(CC (or))(NN (HO-progesterone)))))(PP (IN (as))(S (VP (VBG (starting))(NP (NN (point)))))))(. (.)))) |ET|  |BV| 1:-0.27791855 2:-1.9419111 3:0.49334106 4:0.30221549 5:0.77765125 6:-0.11540045 7:0.92698359 8:1.2718743 9:-0.46127716 10:1.2597574 11:-0.2625255 12:0.0078048287 13:1.4247032 14:-0.20076533 15:-1.2998761 16:-0.067311682 17:1.4078094 18:0.29920349 19:1.2955601 20:-0.031746265 21:-0.70291984 22:0.10596521 23:0.40353924 24:-0.0082024643 25:0.51516557 26:-0.4248296 27:0.15003122 28:0.1239915 29:0.20275137 30:0.48732561 31:0.47781709 32:-0.14894189 33:0.51152009 34:0.33163288 35:-0.5908134 36:0.57499492 37:0.029747412 38:0.11391607 39:0.40241897 40:0.6374259 41:-0.35305032 42:-0.4524101 43:-0.08457648 44:-0.22547582 45:0.48539174 46:-0.23283583 47:-0.029635534 48:0.19868575 49:0.18919443 50:-0.020114535 51:0.44707873 52:-0.20469512 53:-0.19786438 54:0.026881995 55:0.13744402 56:-0.18406853 57:0.49954224 58:0.080206595 59:-0.5275498 60:-0.05908864  |EV| 
0.97472119852935745765165620468906  |BT| (ROOT (S (NP (NP (NNP (Adenosine))(NNP (A2A))(NN (receptor))(NN (activation)))(CC (and))(NP (NN (hyaluronan))(NN (fragment))(NN (inhibition))))(VP (VBP (reduce))(NP (NN (inflammation)))(PP (IN (in))(NP (NP (NN (mouse))(NN (articular))(NNS (chondrocytes)))(VP (VBN (stimulated))(PP (IN (with))(ADJP (JJ (interleukin-1ß))))))))(. (.)))) |ET|  |BV| 1:-0.70083106 2:-0.48336688 3:1.5551089 4:-0.66309351 5:-0.2768268 6:0.29311046 7:0.97332656 8:0.26250023 9:0.66947347 10:0.11007383 11:0.12701353 12:0.18884884 13:2.0751088 14:0.70770031 15:0.70161557 16:1.250882 17:1.0054638 18:0.26610258 19:0.17825437 20:-0.33795878 41:-0.055080209 42:0.17051971 43:0.24311967 44:-0.23639181 45:-0.057900582 46:-0.2191066 47:-0.28970817 48:-0.33767453 49:-0.02021179 50:0.38227299 51:0.31343594 52:0.055278443 53:0.19324942 54:-0.34066781 55:0.082516164 56:0.36719826 57:0.3030279 58:0.28605852 59:-0.31925508 60:-0.11240701  |EV| 
0.98853166391849445204798030317761  |BT| (ROOT (S (NP (PRP$ (Our))(NNS (results)))(VP (VBP (indicate))(SBAR (IN (that))(S (NP (NN (modafinil)))(VP (MD (can))(VP (VP (VB (interfere))(PP (IN (with))(NP (JJ (methamphetamine))(NNS (actions)))))(CC (and))(VP (VB (provide))(NP (NN (protection)))(PP (IN (against))(NP (NP (JJ (dopamine))(NN (toxicity)))(, (,))(NP (NN (cell))(NN (death)))(, (,))(CC (and))(NP (NP (NN (neuroinflammation)))(PP (IN (in))(NP (DT (the))(NN (mouse))(NN (striatum)))))))))))))(. (.)))) |ET|  |BV| 1:0.027203679 2:-0.44145474 3:0.1978243 4:-0.29811138 5:0.22199877 6:-0.42937174 7:-0.12837471 8:-0.42986649 9:0.51660991 10:0.45310685 11:0.30332148 12:0.0084803775 13:-0.29091501 14:0.30512857 15:0.1157142 16:0.4981862 17:-0.05296972 18:0.16757877 19:0.68114299 20:0.48334053 21:-0.11594255 22:-0.51243991 23:-0.22024177 24:-0.41140586 25:-0.064051807 26:-0.74794525 27:-1.6191601 28:-1.0811833 29:0.50388539 30:0.16303076 31:-0.042243145 32:0.11824001 33:-0.59603453 34:0.60282111 35:-1.1580086 36:1.3130836 37:-0.59139764 38:1.0908021 39:-0.36715442 40:0.88050574 41:0.0011498228 42:-0.33488002 43:0.025831804 44:-0.20449509 45:0.3785471 46:-0.32272053 47:-0.15697743 48:0.11565983 49:0.12671818 50:0.38314155 51:0.14023679 52:0.79046482 53:0.37624115 54:-0.11012566 55:0.10984369 56:0.19161691 57:0.057213083 58:-0.082648337 59:-0.04898759 60:0.051528007  |EV| 
-0.92824872332766605875775667300331  |BT| (ROOT (S (SBAR (IN (As))(S (NP (NP (PDT (both))(DT (the))(NN (response)))(SBAR (S (VP (TO (to))(VP (VB (prednisolone))(PP (IN (in))(NP (NP (ADJP (NN (vitro))(CC (and))(JJ (prednisone))))(PP (IN (in))(NP (NN (vivo)))))))))))(VP (VBP (are))(VP (VBG (predictive))(PP (IN (for))(NP (JJ (clinical))(NN (outcome))))))))(, (,))(S (VP (VBG (understanding))(CC (and))(VBG (overcoming))(NP (JJ (glucocorticoid))(NN (resistance)))))(VP (VBZ (remains))(NP (DT (an))(JJ (essential))(NN (step)))(PP (IN (towards))(S (VP (VBG (improving))(NP (NN (prognosis)))))))(. (.)))) |ET|  |BV| 1:-0.25088975 2:-0.22417608 3:-0.23734774 4:0.15524609 5:-0.19554201 6:-0.68985355 7:-0.11541075 8:-0.0034374148 9:-0.091236964 10:0.71780586 11:-0.60373032 12:-0.48826259 13:-0.32568598 14:0.51839215 15:-0.49920413 16:0.075583301 17:-0.023438318 18:0.37608865 19:0.045492861 20:0.3178238 21:-0.21683902 22:-0.58271813 23:-0.3773798 24:0.31495053 25:-0.075841524 26:-0.13666572 27:-0.077723585 28:-0.39503255 29:0.06788633 30:0.4634937 31:-0.58181411 32:0.057384633 33:0.24518061 34:0.18402077 35:-0.60698193 36:-0.26682448 37:0.12457526 38:-0.7255078 39:0.078947604 40:-0.59980386 41:-0.058952384 42:-0.34687319 43:-0.10381656 44:0.079854757 45:0.18420377 46:-0.20589992 47:-0.13227901 48:-0.028267972 49:0.44925666 50:-0.093968749 51:0.25786161 52:0.091424741 53:-0.39672804 54:-0.16570562 55:0.24398781 56:0.50884503 57:0.010939389 58:0.34082115 59:-0.10389297 60:0.051601786  |EV| 
-1  |BT| (ROOT (S (NP (DT (The))(JJ (optimal))(NN (ritonavir))(NN (dose))(S (VP (TO (to))(VP (VB (be))(VP (VBN (given))(ADVP (RB (together)))(PP (IN (with))(NP (NN (fosamprenavir)))))))))(VP (VBZ (is))(ADVP (RB (still)))(S (VP (TO (to))(VP (VB (be))(VP (VBN (defined))))))(, (,))(SBAR (IN (though))(S (NP (JJ (available))(NNS (results)))(VP (VBP (indicate))(SBAR (IN (that))(S (NP (NP (DT (a))(NN (dose)))(PP (IN (of))(NP (CD (100))(NN (mg)))))(VP (MD (may))(VP (VB (be))(ADJP (JJ (adequate))(SBAR (S (VP (VBD (provided))(SBAR (IN (that))(S (NP (DT (no))(JJ (protease))(NN (inhibitor))(NN (resistance)))(VP (VBZ (is))(ADJP (JJ (present))))))))))))))))))(. (.)))) |ET|  |BV| 1:-1.444625 2:-0.4934392 3:0.30289012 4:0.098139897 5:-0.084036902 6:-0.60067528 7:-0.045485895 8:-0.20654243 9:-0.25986937 10:0.44161755 11:-0.53373361 12:-0.044802453 13:0.69945645 14:0.23874845 15:-0.098392785 16:0.19838865 17:-0.83548248 18:0.0063304347 19:0.92346603 20:-0.050698824 21:-0.43200842 22:-1.1393423 23:-1.2164291 24:0.24824609 25:0.32690027 26:-0.54055738 27:-0.32841584 28:-0.014385451 29:0.37410015 30:0.74537265 31:-1.8347021 32:0.63277042 33:0.71766102 34:-0.62978011 35:-0.20860316 36:-0.11949666 37:-0.51998025 38:0.3343159 39:-0.38128576 40:-0.62202567 41:-0.077343866 42:-0.024539631 43:0.093327776 44:-0.11456116 45:0.29569077 46:0.054075863 47:0.059512634 48:-0.54479396 49:0.2519896 50:0.043473069 51:0.10861761 52:0.4089101 53:-0.045286305 54:0.23647296 55:-0.17434925 56:-0.19584173 57:0.5338136 58:0.16138247 59:0.062433433 60:0.47094709  |EV| 
-1  |BT| (ROOT (S (NP (PRP (It)))(ADVP (RB (further)))(VP (VBD (showed))(NP (DT (that))(NN (melatonin)))(ADVP (RB (together)))(PP (IN (with))(NP (NP (NN (insulin)))(VP (ADVP (RB (synergistically)))(VBN (enhanced))(NP (DT (the))(NN (leptin))(NN (synthesis)))(PP (IN (by))(NP (JJ (adipose))(NN (tissue))))(PP (IN (through))(NP (NP (NN (phosphorylation)))(PP (IN (of))(NP (NP (JJ (mitogen-activated))(NN (protein))(NN (kinase)))(PP (IN (in))(NP (NNP (C.))(NN (sphinx))))))))))))(. (.)))) |ET|  |BV| 1:-0.4176586 2:-0.68634278 3:-0.59409255 4:0.42226446 5:0.1000756 6:-0.37648991 7:-0.22770603 8:0.20558573 9:0.65462661 10:0.64355832 11:0.83729345 12:-0.063424356 13:0.33500063 14:0.31329021 15:0.52702087 16:-0.65230078 17:-0.26013902 18:0.57008058 19:-0.13120672 20:0.10561328 21:-1.1923358 22:0.36651093 23:0.14956017 24:-0.25442144 25:-0.74738133 26:0.29904133 27:0.63527578 28:0.27886191 29:0.45418373 30:0.062229525 31:0.63828611 32:-0.17143264 33:0.40124375 34:0.10097073 35:0.77508128 36:-0.08437378 37:-1.0932121 38:0.10228246 39:1.0465006 40:-0.54566127 41:0.10501792 42:-0.41132966 43:0.16034517 44:0.064595185 45:0.032805074 46:0.27733612 47:0.13718084 48:-0.052063465 49:-0.12556699 50:0.45286706 51:0.30769271 52:-0.47150424 53:-0.037359003 54:-0.69581383 55:0.18580177 56:0.004578359 57:0.62929893 58:-0.018739227 59:-0.025088396 60:0.24558863  |EV| 
1  |BT| (ROOT (S (S (NP (NP (DT (These))(NNS (effects)))(PP (IN (of))(NP (NN (guanfacine)))))(VP (VBD (were))(VP (VBN (blocked))(PP (IN (by))(NP (NP (JJ (co-administered))(NN (yohimbine)))(, (,))(NP (NP (DT (a))(JJ (non-selective))(DT (a)))(PRN (-LRB- (-LRB-))(NP (CD (2)))(-RRB- (-RRB-)))))))))(: (-))(S (NP (NNP (AR)))(VP (VBP (antagonist))))(. (.)))) |ET|  |BV| 1:-0.82425267 2:-0.8887285 3:0.32665569 4:-1.1507614 5:0.63887143 6:0.21949336 7:-0.11004896 8:0.4045319 9:1.5391494 10:-0.078226939 11:0.34095329 12:0.16447394 13:0.62266612 14:-0.10437249 15:-0.50367969 16:0.76363891 17:0.55498886 18:0.8659538 19:0.86516798 20:-0.053705126 21:-0.89714491 22:-1.1104369 23:0.80272061 24:-1.9180505 25:0.92880183 26:0.17917651 27:-0.23519698 28:0.66925979 29:0.97777557 30:-0.61555344 31:0.64202237 32:-0.15306135 33:0.4715361 34:0.43802297 35:-1.9512649 36:0.25710699 37:0.77113324 38:-0.60681844 39:1.1966633 40:-0.12156482 41:-0.18629229 42:-0.12930734 43:0.1015211 44:-0.46571738 45:0.33528453 46:-0.12253592 47:0.12576793 48:0.51849157 49:-0.28153476 50:0.5437296 51:0.57153225 52:-0.12852766 53:-0.19165665 54:-0.25152349 55:-0.007489006 56:0.14497557 57:-0.18790273 58:-0.48442668 59:0.27011037 60:-0.095364563  |EV| 
1  |BT| (ROOT (NP (NP (NNP (DISCUSSION)))(: (:))(NP (NP (NNP (Addition)))(PP (IN (of))(NP (NP (NN (magnesium))(NN (lidocaine)))(PP (IN (in))(NP (NP (NNS (patients)))(VP (VBG (undergoing))(NP (NP (JJ (upper))(JJ (extremity))(JJ (orthopedic))(NNS (operations)))(VP (VBG (using))(S (S (NP (NNP (IVRA)))(VP (VBZ (decreases))(ADVP (RB (significantly)))(NP (NP (NP (DT (the))(NN (time))(NN (gap)))(PP (IN (between))(NP (NN (drug))(NN (administration)))))(CC (and))(NP (NP (DT (the))(NN (start)))(PP (IN (of))(NP (DT (the))(NN (block))))))))(: (;))(S (ADVP (RB (also)))(, (,))(NP (DT (this))(NN (drug))(NN (combination)))(VP (VBZ (increases))(NP (DT (the))(NNP (IVRA))(NN (block))(NN (length)))(, (,))(SBAR (IN (while))(S (NP (NNP (paracetamol)))(VP (VBZ (does))(RB (not))(VP (VB (have))(NP (PDT (such))(DT (a))(JJ (significant))(NN (effect))))))))))))))))))(. (.)))) |ET|  |BV| 1:-0.69870472 2:-0.24796677 3:-0.81360668 4:-0.010563116 5:0.23021409 6:-0.49103528 7:-0.12774047 8:0.32772008 9:-0.10109277 10:0.37758282 11:-0.10246789 12:-0.17838542 13:-0.41387382 14:-0.30004424 15:-0.10441614 16:0.11705339 17:-0.5140717 18:0.68735868 19:0.66774976 20:-0.36981764 21:-0.18326178 22:-0.6332702 23:-1.2221074 24:-0.7760886 25:0.18754745 26:-0.082618378 27:-0.14242551 28:0.073615573 29:-0.11079296 30:-0.01262922 31:0.16777821 32:0.12226185 33:-0.071352325 34:-0.55858153 35:-0.28625986 36:0.31376615 37:0.34146345 38:0.47314885 39:-0.37956539 40:-0.51146042 41:-0.14086781 42:0.30037495 43:-0.097284853 44:0.1301499 45:0.42104021 46:-0.30829734 47:-0.041039914 48:-0.34421268 49:0.020515801 50:-0.25443634 51:-0.26521 52:0.020620639 53:0.20517096 54:-0.1703351 55:0.13005041 56:-0.066182412 57:0.26216039 58:0.31447414 59:0.11923023 60:-0.080269575  |EV| 
0.99915835730660584879103680577828  |BT| (ROOT (S (NP (PRP (We)))(VP (VBD (demonstrated))(SBAR (IN (that))(S (NP (NP (ADJP (JJ (low))(, (,))(JJ (ineffective)))(NNS (doses)))(PP (IN (of))(NP (NP (NP (NNP (NMDA))(NNP (antagonists)))(-LRB- (-LRB-))(NP (NP (NP (DT (the))(JJ (competitive))(NNP (NMDA))(NN (antagonist)))(ADJP (NP (NNP (CGP))(CD (37849))(, (,))(CD (0.3)))(JJ (mg/kg))))(: (;))(NP (NP (DT (an))(NN (antagonist)))(PP (IN (of))(NP (DT (the))(ADJP (JJ (glycineB))(NP-TMP (NP (NNS (sites)))(, (,))(NP (NNP (L-701))(CD (,324))(, (,))(CD (1)))))(NN (mg/kg)))))(: (;))(NP (NP (DT (a))(JJ (partial))(NN (agonist)))(PP (IN (of))(NP (NP (NP (DT (the))(JJ (glycineB))(NNS (sites)))(, (,))(NP (NNP (D-cycloserine)))(, (,)))(ADJP (CD (2.5))(JJ (mg/kg))))))(: (;))(CC (and))(NP (NP (DT (the))(JJ (non-competitive))(NNP (NMDA))(NN (antagonist))(NN (MK-801)))(, (,))(NP (CD (0.05))(NN (mg/kg)))))(-RRB- (-RRB-)))(VP (VBN (administered))(ADVP (RB (together)))(PP (IN (with))(NP (NP (DT (an))(JJ (ineffective))(NN (dose)))(PP (IN (of))(NP (NP (NN (magnesium)))(PRN (-LRB- (-LRB-))(NP (CD (10))(NN (mg/kg)))(-RRB- (-RRB-)))))))))))(VP (VBD (evoked))(NP (DT (a))(JJ (significant))(NN (increase)))(PP (IN (in))(NP (NP (DT (the))(NN (percentage)))(PP (IN (of))(NP (NP (NN (time)))(VP (VBN (spent))(PP (IN (in))(NP (NP (DT (the))(JJ (open))(NN (arm)))(PP (IN (of))(NP (NP (DT (the))(NN (maze)))(PRN (-LRB- (-LRB-))(NP (NP (DT (an))(NN (index)))(PP (IN (of))(NP (NN (anxiety)))))(-RRB- (-RRB-))))))))))))))))(. (.)))) |ET|  |BV| 21:-0.69870472 22:-0.24796677 23:-0.81360668 24:-0.010563116 25:0.23021409 26:-0.49103528 27:-0.12774047 28:0.32772008 29:-0.10109277 30:0.37758282 31:-0.10246789 32:-0.17838542 33:-0.41387382 34:-0.30004424 35:-0.10441614 36:0.11705339 37:-0.5140717 38:0.68735868 39:0.66774976 40:-0.36981764 41:-0.17929016 42:-0.48915225 43:0.40144381 44:-0.21350884 45:0.66443074 46:-0.099982217 47:-0.44317305 48:-0.63355392 49:0.049792826 50:-0.24860612 51:0.4650588 52:0.26322609 53:0.21710432 54:-0.35157239 55:0.045225006 56:-0.2926738 57:-0.097702369 58:-0.15896466 59:-0.24270134 60:0.22951385  |EV| 
-1  |BT| (ROOT (S (NP (NP (NNP (Gefitinib)))(PRN (-LRB- (-LRB-))(NP (NNP (Iressa)))(, (,))(NP (NNP (ZD1839)))(-RRB- (-RRB-)))(, (,))(NP (NP (DT (a))(JJ (selective))(JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor)))(NP (JJ (tyrosine))(NN (kinase))(NN (inhibitor))))(, (,)))(VP (VBZ (inhibits))(NP (NP (NN (growth))(, (,))(NN (invasion))(CC (and))(NN (colony))(NN (formation)))(PP (IN (of))(NP (JJ (various))(NN (cancer))(NNS (cells))))))(. (.)))) |ET|  |BV| 1:0.10216856 2:-0.81429821 3:1.1611762 4:-0.40571943 5:-0.4586145 6:-0.34065512 7:-0.39178714 8:2.1131852 9:-0.11075847 10:-1.6941171 11:-0.048676334 12:0.47019652 13:0.37841219 14:-0.057027876 15:-0.33348978 16:-0.28858173 17:-0.27989534 18:-0.32981867 19:0.20724149 20:-0.91898322 21:0.065595999 22:-1.0159993 23:1.604534 24:-0.35524637 25:0.076724894 26:-0.35726005 27:-0.40416232 28:2.2256074 29:-0.80645549 30:-1.0412927 31:0.1146354 32:0.1874216 33:0.6872865 34:-0.35357696 35:-0.31467438 36:-0.64426547 37:-1.1745644 38:-0.24322222 39:0.81377113 40:-1.0585378 41:-0.26250494 42:-0.12209284 43:0.17311475 44:-0.32206807 45:-0.052710257 46:-0.11155495 47:0.1030077 48:0.16907573 49:0.16935766 50:0.24108896 51:0.92404282 52:0.08721929 53:0.17738707 54:-0.082045339 55:0.32149088 56:0.10629202 57:0.25221282 58:-0.30146322 59:0.03583755 60:-0.34616727  |EV| 
-1  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(NP (NP (NNP (Pegfilgrastim)))(VP (VBN (prescribed))(PP (IN (as))(NP (NP (NNS (prophylaxis)))(VP (VBN (resulted))(PP (IN (in))(NP (NP (JJR (lower))(NN (risk)))(PP (IN (of))(NP (JJ (neutropenia-related))(CC (and))(JJ (all-cause))(NNS (hospitalizations))))))(PP (VBN (compared))(PP (TO (to))(NP (NN (filgrastim))(NNS (prophylaxis))))))))))(. (.)))) |ET|  |BV| 1:-0.59783238 2:-0.21577467 3:-1.3032204 4:0.11277531 5:0.15912826 6:-0.55854386 7:-0.62208253 8:-0.31364322 9:-0.7487855 10:1.5309749 11:0.17169061 12:0.36441717 13:0.020225095 14:0.087127075 15:-0.041777067 16:0.98396909 17:0.29103649 18:-0.33411053 19:0.15795299 20:0.19866879 21:-0.84683192 22:-0.1294937 23:-0.33711621 24:0.90230113 25:0.4417955 26:0.52285892 27:-0.66048056 28:-0.82847643 29:0.01847434 30:1.2685339 31:-0.3169775 32:0.76004559 33:-0.8526029 34:0.46231094 35:-1.3743161 36:1.1914694 37:0.22807598 38:0.37001562 39:0.033245873 40:0.38829821 41:0.1475179 42:0.20781209 43:0.20133418 44:0.22575296 45:0.24077056 46:-0.1127293 47:-0.071849011 48:-0.22113422 49:0.042046204 50:-0.14211532 51:0.21430181 52:-0.25657484 53:-0.16298628 54:0.12978213 55:0.40566981 56:-0.076135136 57:0.32060182 58:-0.10927128 59:0.28213686 60:-0.22288972  |EV| 
-1  |BT| (ROOT (S (NP (NP (DT (The))(NN (influence)))(PP (IN (of))(NP (NN (angiostatin))(NN (K1-4))(CD (.5))))(PRN (: (--))(NP (NP (NP (DT (a))(NN (fragment)))(PP (IN (of))(NP (NP (DT (the))(JJ (heavy))(NN (chain)))(PP (IN (of))(NP (NN (plasmin)))))))(CC (and))(NP (NP (DT (a))(JJ (powerful))(NN (inhibitor)))(PP (IN (of))(NP (NNS (angiogenesis))))))(: (--)))(PP (IN (on))(NP (NP (NP (JJ (kinetic))(NNS (parameters)))(-LRB- (-LRB-))(NP (NP (NP (NN (k)))(PRN (-LRB- (-LRB-))(NP (NNP (Pg)))(-RRB- (-RRB-))))(CC (and))(NP (NP (NNP (K)))(PRN (-LRB- (-LRB-))(NP (NNP (Pg)))(-RRB- (-RRB-)))))(-RRB- (-RRB-)))(PP (IN (of))(S (NP (NP (JJ (human))(JJ (Glu-plasminogen))(NN (activation)))(PP (IN (under))(NP (NP (DT (the))(NN (action)))(PP (IN (of))(NP (NP (NN (urokinase)))(PRN (-LRB- (-LRB-))(NP (NN (uPA)))(-RRB- (-RRB-))))))))(RB (not))(VP (VBG (having))(NP (NN (affinity)))(PP (IN (for))(NP (NP (NN (fibrin)))(CC (and))(NP (JJ (fibrin-specific))(NN (tissue))(NN (plasminogen))(NN (activator))))))))(PRN (-LRB- (-LRB-))(NP (NN (tPA)))(-RRB- (-RRB-))))))(VP (VBD (was))(VP (VBN (investigated))))(. (.)))) |ET|  |BV| 1:-1.077231 2:-0.78749651 3:0.38568541 4:-1.0273858 5:-0.73517734 6:0.43055442 7:1.2307174 8:0.88914734 9:-0.012340114 10:0.39130142 11:0.00087484991 12:-0.34907985 13:0.97235614 14:1.1826136 15:0.96312881 16:-0.28996763 17:0.24392389 18:0.29467541 19:1.5927049 20:0.79999655 21:-0.26211697 22:-0.34698561 23:1.5166832 24:-0.8888787 25:-0.70370287 26:-0.96953869 27:1.0129305 28:0.60676825 29:1.348979 30:0.4176057 31:-0.69289726 32:1.3752183 33:-0.15909033 34:1.2053063 35:1.1177714 36:1.2419295 37:-1.2661891 38:-0.27901465 39:0.45664224 40:-0.80369884 41:-0.14090754 42:-0.45156783 43:0.13023336 44:-0.39831227 45:-0.44364297 46:-0.011735933 47:0.086790763 48:0.052822135 49:-0.088478528 50:0.1298715 51:0.66978848 52:-0.12746248 53:0.38101974 54:-0.18704313 55:-0.37873897 56:0.90354192 57:-0.22769904 58:0.22745048 59:0.37078217 60:0.41648433  |EV| 
1  |BT| (ROOT (S (S (VP (VBN (Randomized))))(, (,))(NP (JJ (double-blind))(NNS (studies)))(VP (VBD (demonstrated))(NP (NP (DT (the))(NN (effectiveness)))(PP (IN (of))(NP (NP (NN (neostigmine)))(, (,))(SBAR (WHNP (WDT (which)))(S (VP (VBZ (increases))(NP (JJ (cholinergic))(NN (tone)))))))))(, (,))(PP (VBN (combined))(PP (IN (with))(NP (NP (NN (glycopyrrolate)))(, (,))(NP (NP (DT (an))(JJ (anticholinergic))(NN (agent)))(PP (IN (with))(NP (NP (JJ (minimal))(NN (activity)))(PP (IN (in))(NP (NP (DT (the))(NN (colon)))(SBAR (WHNP (WDT (that)))(S (VP (VBZ (reduces))(NP (JJ (extracolonic))(NNS (side-effects)))))))))))))))(. (.)))) |ET|  |BV| 1:-0.73282301 2:-0.62496716 3:-0.55196631 4:-0.59960639 5:0.041034617 6:-0.34943715 7:0.12115459 8:0.74872983 9:0.71173537 10:-0.54305732 11:0.92430598 12:-0.20378846 13:0.71527505 14:-0.89005417 15:-1.0758097 16:1.0591766 17:-0.083953075 18:0.84651631 19:-0.49481836 20:-0.20741776 21:-0.59328508 22:-0.55294812 23:-0.5759756 24:-1.122306 25:0.67643136 26:0.43415868 27:0.16251482 28:-0.11341551 29:0.31060079 30:0.75220132 31:-0.15621032 32:0.58801216 33:-0.26563931 34:-0.96827412 35:0.25380415 36:-0.24970885 37:0.34735751 38:-0.5671438 39:-0.077489242 40:-0.71131533 41:-0.49468029 42:0.51294333 43:0.37286428 44:0.11083341 45:-0.022975842 46:0.073579207 47:-0.13125758 48:-0.83527756 49:0.0052624461 50:0.27846742 51:0.63454539 52:0.16527042 53:-0.27842113 54:-0.026566118 55:-0.41302904 56:-0.19662595 57:0.04714008 58:-0.20998394 59:0.25194424 60:0.039853305  |EV| 
1  |BT| (ROOT (S (PP (IN (In))(NP (NN (rat))(NNS (synaptosomes))))(, (,))(NP (NN (nomifensine)))(VP (VBD (reduced))(NP (NP (DT (the))(NN (potency)))(PP (IN (of))(NP (NN (amphetamine)))))(S (VP (TO (to))(VP (VB (induce))(S (NP (NNP (DA)))(VP (VB (release))(ADJP (RB (approximately))(JJ (270-fold))))))))(, (,))(S (ADVP (RB (potentially)))(VP (VBG (explaining))(NP (PRP$ (its))(NN (action)))(PP (IN (in))(S (VP (VBG (ameliorating))(NP (JJ (amphetamine-induced))(NN (RHS)))))))))(. (.)))) |ET|  |BV| 1:-1.4352882 2:0.23550102 3:0.28739452 4:-1.6928145 5:-0.10965688 6:-0.60174739 7:0.74265701 8:-0.91238713 9:0.85570979 10:0.393821 11:0.48118779 12:-0.74184155 13:1.2862357 14:-0.52537066 15:0.68416065 16:0.93611735 17:0.4934338 18:0.52505773 19:-0.21933049 20:1.0926528 21:-0.51009583 22:-0.56838346 23:0.018959643 24:-0.80733913 25:-0.028113127 26:-0.51623201 27:0.14834246 28:-0.50347131 29:0.91042084 30:0.16682194 31:0.37457371 32:-0.095307551 33:0.23110786 34:-0.50809145 35:-0.5548557 36:-0.40123346 37:0.65094382 38:-0.02916215 39:0.42906675 40:1.1775618 41:-0.21981847 42:0.34176943 43:0.55518115 44:-0.068571247 45:-0.021594889 46:-0.54393959 47:0.28206936 48:-0.19955233 49:-0.44449496 50:0.40461808 51:0.42225054 52:-0.26546428 53:0.12369771 54:-0.34355894 55:-0.34539044 56:-0.1203175 57:0.19918683 58:0.15975019 59:-0.31186643 60:0.10940905  |EV| 
1  |BT| (ROOT (S (SBAR (IN (As))(RB (even))(S (NP (NP (DT (the))(JJR (lower))(NNP (OTC))(NN (dose)))(PP (IN (of))(NP (NP (NN (ibuprofen)))(PRN (-LRB- (-LRB-))(NP (QP (CD (150))(CD (mg))))(-RRB- (-RRB-))))))(VP (VBD (was))(ADJP (JJ (enough))(S (VP (TO (to))(VP (VB (affect))(NP (NP (DT (the))(JJ (antiplatelet))(NN (effect)))(PP (IN (of))(NP (NN (aspirin))))))))))))(, (,))(NP (NN (health))(NNS (professionals)))(VP (MD (should))(VP (VB (take))(PP (IN (into))(NP (NN (account))(NNS (patients)))))))) |ET|  |BV| 1:-0.45031631 2:0.15654109 3:-0.14055742 4:0.57517284 5:0.1998097 6:-0.003260914 7:-0.33045915 8:-0.79845482 9:0.2162341 10:-0.19117653 11:-0.26789901 12:0.13184972 13:0.5689823 14:-0.53675497 15:-0.25804719 16:0.65332514 17:-0.48971584 18:-0.86091042 19:0.14939134 20:-0.01000188 21:0.24906121 22:-0.99049872 23:-0.41239464 24:-0.044612978 25:0.39299873 26:0.28446469 27:0.38468862 28:-0.28248656 29:0.67045301 30:0.52617681 31:-0.2217478 32:0.2344217 33:-0.71098858 34:-0.73123658 35:-0.32787028 36:0.053887159 37:0.38661277 38:0.071346872 39:0.66734159 40:0.38040379 41:-0.0093137976 42:0.018462202 43:0.015216661 44:-0.024045145 45:0.0070015639 46:0.010395795 47:0.019300697 48:-0.017343938 49:-0.010206613 50:0.012936257 51:-0.02208625 52:-0.0040375357 53:-0.01831731 54:-0.016737947 55:0.016575975 56:0.016731003 57:0.0043863808 58:-0.010104505 59:0.0094967494 60:-0.0042639249  |EV| 
-0.80128837804812513834207265972509  |BT| (ROOT (S (NP (NP (JJ (Faecal))(NNS (concentrations)))(PP (IN (of))(ADJP (JJ (butyrate))(, (,))(JJ (histamine))(, (,))(JJ (agmatine))(CC (and))(JJ (spermine)))))(VP (VBD (were))(ADJP (ADJP (JJR (lower)))(PRN (-LRB- (-LRB-))(S (VP (VB (P))(S (VP (SYM (=))(NP (CD (0.05)))))))(-RRB- (-RRB-)))(CC (and))(ADJP (JJ (faecal))(SBAR (S (NP (NN (pH)))(VP (VBD (was))(ADJP (JJR (higher)))))))(PRN (-LRB- (-LRB-))(S (VP (VB (P))(S (VP (SYM (=))(NP (CD (0.03)))))))(-RRB- (-RRB-))))(PP (IN (in))(NP (NP (JJR (older))(NNS (dogs)))(PP (IN (than))(PP (IN (in))(NP (JJ (mature))(NN (adult))(NNS (dogs)))))))(, (,))(S (VP (VBG (suggesting))(NP (DT (an))(NN (alteration)))(PP (PP (IN (in))(NP (JJ (bacterial))(JJ (metabolic))(NN (activity))))(, (,))(CC (or))(PP (IN (in))(NP (NP (DT (the))(NN (rate)))(PP (IN (of))(NP (NP (JJ (intestinal))(NN (absorption)))(PP (IN (of))(NP (DT (these))(NNS (compounds))))))))))))(. (.)))) |ET|  |BV| 1:-0.90909708 2:-0.43790835 3:1.3501079 4:-1.3608216 5:0.081174321 6:-0.21249093 7:-1.0717819 8:0.80661726 9:-0.76155025 10:0.22594225 11:1.2293903 12:0.55379337 13:-0.024003908 14:-0.59998882 15:-0.59560305 16:0.64742386 17:0.17508699 18:0.90198845 19:0.77773488 20:-1.8298787 21:-0.84031266 22:0.22099513 23:0.51324707 24:-0.33907509 25:-0.41379723 26:0.3911576 27:-1.084309 28:0.81841558 29:-0.599778 30:0.32891619 31:1.2701405 32:0.37494269 33:-0.013257502 34:-0.74156749 35:-0.50359577 36:0.39174271 37:-0.2314163 38:0.95422351 39:0.57688093 40:-1.48632 41:-0.50033259 42:-0.066424809 43:0.15158926 44:-0.13875812 45:0.13058163 46:0.012020104 47:-0.28837678 48:-0.32502675 49:-0.21197565 50:-0.21649404 51:-0.1153959 52:-0.19725558 53:0.12191854 54:-0.16530961 55:0.22591056 56:0.073661432 57:-0.23677075 58:0.10379894 59:-0.17816325 60:0.31161132  |EV| 
-1  |BT| (ROOT (S (NP (NP (NP (JJ (Relative))(NNS (increases)))(PP (IN (in))(NP (NP (DT (the))(NNS (levels)))(PP (IN (of))(NP (NN (lactate))(, (,))(NN (alanine))(, (,))(NN (low-density))(JJ (lipoprotein-very))(NN (low-density))(NN (lipoprotein)))))))(, (,))(CC (and))(NP (JJ (unsaturated))(NN (fatty))(NNS (acids)))(, (,))(CC (and))(NP (NP (NNS (decreases)))(PP (IN (in))(NP (NP (NN (choline)))(, (,))(NP (NN (phosphocholine)))(, (,))(CC (and))(NP (NN (glucose)))))))(VP (VBD (were))(VP (VBN (observed))(PP (IN (after))(NP (NN (swimming))))))(. (.)))) |ET|  |BV| 1:-0.72771055 2:0.70699549 3:0.43232453 4:0.33550581 5:-0.89898372 6:0.18198441 7:0.0091723008 8:0.18770394 9:1.3347713 10:0.6433441 11:0.30550799 12:0.54952681 13:0.89580816 14:-0.30918324 15:-0.11821036 16:0.26000285 17:-0.30350745 18:0.23642004 19:0.88033038 20:0.11831602 21:-1.0504352 22:1.2657102 23:0.20934516 24:0.38566321 25:-0.35332853 26:-0.27085355 27:-0.4657771 28:0.20200646 29:0.86259693 30:0.38503662 31:0.1210068 32:0.51461405 33:1.2604244 34:-0.57617891 35:-1.0637106 36:0.41204536 37:-0.96071708 38:0.57232869 39:0.5187338 40:0.24707116 41:-0.31770325 42:0.0140311 43:0.083081953 44:0.021874022 45:0.029208083 46:0.081701852 47:0.024770077 48:-0.20869172 49:0.076163255 50:0.33787704 51:0.52550435 52:0.25710011 53:0.14520063 54:-0.75008464 55:0.10759242 56:0.30930993 57:0.62188518 58:0.39399984 59:-0.068045534 60:0.36697903  |EV| 
-1  |BT| (ROOT (NP (NP (NNP (CONCLUSION)))(: (:))(S (PP (IN (As))(PP (VBN (compared))(PP (TO (to))(NP (JJ (norepinephrine-induced))(NN (hypertension))))))(, (,))(NP (JJ (dobutamine-induced))(JJ (high))(NN (CI)))(VP (VBD (did))(RB (not))(VP (VB (reduce))(NP (NP (DT (the))(NN (rate)))(PP (IN (of))(NP (NN (vasospasm)))))(PP (IN (in))(NP (NNP (SAH))(NNS (patients)))))))(. (.)))) |ET|  |BV| 1:-1.0374453 2:0.85880065 3:-0.24367349 4:-1.0123558 5:0.14853026 6:0.064390242 7:0.82503897 8:0.057420235 9:0.23259422 10:0.22073723 11:0.8552382 12:-0.631019 13:0.38975126 14:-0.6101191 15:0.14520936 16:0.39410061 17:-0.23449533 18:0.13932607 19:0.37582126 20:-0.08262825 21:0.60882604 22:-0.23329782 23:-1.6974742 24:-0.35691172 25:-0.29879364 26:-0.13806401 27:0.25545862 28:-0.36142683 29:0.17044505 30:-0.5944435 31:0.24077468 32:-0.20301823 33:0.18099 34:-0.18655179 35:0.019401098 36:0.23374529 37:-0.54920375 38:-0.50025564 39:-1.1375816 40:0.18487531 41:0.27587345 42:0.65306091 43:0.091484107 44:0.10153811 45:0.061800059 46:-0.014277156 47:-0.25318846 48:0.04884259 49:-0.054191679 50:-0.133063 51:0.053333018 52:-0.23034468 53:0.10888242 54:0.19153102 55:0.00062662078 56:0.20545039 57:0.23257196 58:-0.37533286 59:0.2309332 60:-0.020392369  |EV| 
1  |BT| (ROOT (S (NP (NNS (Results)))(VP (VBP (demonstrate))(SBAR (IN (that))(S (NP (NN (metformin)))(ADVP (RB (significantly)))(VP (VBZ (decreases))(NP (NP (DT (the))(JJ (forskolin/phorbol))(NN (ester)))(PRN (-LRB- (-LRB-))(NP (NNP (FSK/PMA)))(-RRB- (-RRB-)))(: (-))(NP (NP (JJ (induced))(NN (expression)))(PP (IN (of))(NP (ADJP (JJ (aromatase))(PP (IN (at))(NP (NP (NNS (concentrations)))(PP (IN (of))(NP (CD (10))(CC (and))(CD (50)))))))(NN (muM))))))))))(. (.)))) |ET|  |BV| 1:-0.98817074 2:-0.16603376 3:0.78174633 4:-0.90220064 5:0.49547943 6:-1.1498691 7:-0.40438485 8:1.2268531 9:0.10629954 10:0.69180793 11:0.10759706 12:0.38594195 13:0.46916869 14:-1.2533672 15:-0.59006315 16:-0.4775902 17:0.43856263 18:1.3870285 19:0.22676972 20:-0.9580304 21:-0.72917187 22:-0.43784007 23:0.11291414 24:-0.1686371 25:-0.028862542 26:-0.74388736 27:-0.63631111 28:-0.1496412 29:0.082612067 30:0.62254179 31:0.084620066 32:-0.22390963 33:0.23155889 34:0.69729364 35:-0.023859221 36:-0.039339174 37:-0.18612586 38:-0.67083597 39:0.021638148 40:-0.06030333 41:-0.62895966 42:-0.14026448 43:-0.11344119 44:-0.30993387 45:-0.13912851 46:0.26133624 47:0.15538946 48:-0.28124264 49:-0.93133098 50:0.41370296 51:0.44320068 52:0.11055624 53:0.25334534 54:-0.048394196 55:-0.017813999 56:0.17697428 57:0.0018483046 58:0.19902913 59:0.19674 60:0.32524005  |EV| 
1  |BT| (ROOT (FRAG (NP (NNS (METHODS))(CC (AND))(NNS (RESULTS)))(: (:))(S (NP (NP (JJ (Pravastatin))(PRN (-LRB- (-LRB-))(NP (CD (112))(NN (nmol/L)))(-RRB- (-RRB-)))(NN (pretreatment)))(PP (IN (for))(NP (CD (60))(NN (min)))))(VP (VBD (reduced))(NP (PDT (both))(DT (the))(NN (potency))(CC (and))(JJ (maximal))(NN (constrictor))(NNS (responses)))(PP (TO (to))(NP (NN (phenylephrine))))(, (,))(NP (NP (NN (thromboxane)))(PRN (-LRB- (-LRB-))(NP (NNP (U46619)))(-RRB- (-RRB-)))(CC (and))(NP (NP (NN (serotonin)))(PP (IN (in))(NP (JJ (small))(NNS (vessels))))))))(. (.)))) |ET|  |BV| 1:-0.29991701 2:-0.32896069 3:-0.69324625 4:-1.0911616 5:0.35399058 6:-0.10250002 7:0.39163858 8:-0.35641289 9:0.19815752 10:0.13153271 11:0.585962 12:-0.79918879 13:-0.1041747 14:-0.49502534 15:0.46688238 16:0.2814571 17:-0.51942658 18:-0.21242213 19:-0.45488372 20:-0.35163856 21:-0.085458741 22:-0.2685532 23:-0.95891404 24:0.34266898 25:-0.14177185 26:-1.6798562 27:-0.37157264 28:0.36406893 29:-0.41499808 30:-0.049521942 31:-0.14231883 32:0.50925773 33:0.38048643 34:-0.19903287 35:-0.6793493 36:1.0915194 37:0.41261297 38:-0.87610543 39:1.9340693 40:-1.4697438 41:-0.78685957 42:-0.025923936 43:0.040827677 44:-0.12168234 45:-0.38836396 46:-0.0030694625 47:0.22624081 48:0.15349112 49:-0.20691702 50:0.23347811 51:-0.0098274536 52:0.020269917 53:-0.0079178419 54:0.24336936 55:-0.468692 56:0.43465945 57:0.2024505 58:0.019488683 59:-0.64056653 60:-0.12111836  |EV| 
1  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(S (S (PP (IN (In))(NP (NP (DT (an))(NN (animal))(NN (model)))(PP (IN (of))(NP (JJ (PCP-induced))(NN (cognitive))(NN (impairment))))))(, (,))(NP (JJ (cariprazine))(NN (pretreatment)))(ADVP (RB (significantly)))(VP (VBD (diminished))(NP (JJ (PCP-triggered))(NN (cognitive))(NNS (deficits)))))(, (,))(CC (and))(S (NP (NP (NNS (studies)))(PP (IN (on))(NP (NN (knockout))(NNS (mice)))))(VP (VBP (show))(SBAR (IN (that))(S (NP (NP (NNP (dopamine))(NNP (D)))(PRN (-LRB- (-LRB-))(NP (CD (3)))(-RRB- (-RRB-)))(NNS (receptors)))(VP (VBP (contribute))(PP (TO (to))(NP (DT (this))(NN (effect))))))))))(. (.)))) |ET|  |BV| 1:0.15640557 2:-0.007430214 3:0.025819382 4:-0.9680776 5:1.9010214 6:-1.0429587 7:-1.9685529 8:0.59146118 9:0.89679003 10:0.12853971 11:0.54297715 12:-0.287135 13:0.56475461 14:0.053115763 15:-0.52928174 16:-0.37519956 17:-1.3576101 18:-0.51835185 19:-0.047495671 20:0.73703641 21:0.018219152 22:-0.016104124 23:-0.28840953 24:-0.8615182 25:1.1512752 26:0.63539976 27:-0.72126067 28:0.20782727 29:0.26834518 30:-0.37172693 31:0.3215901 32:-0.33738384 33:-0.062608078 34:1.410022 35:-0.93931729 36:-0.16542067 37:-0.77415127 38:-0.41038001 39:1.2455095 40:0.70139086 41:-0.33804488 42:-0.22307211 43:0.021574209 44:-0.39377779 45:0.37182522 46:0.39008608 47:0.29001707 48:-0.52709275 49:-0.17008969 50:0.30041569 51:0.13174185 52:0.22390319 53:0.45256802 54:-0.42137158 55:-0.2676135 56:0.11981118 57:0.0096147945 58:-0.29205677 59:0.11501373 60:-0.33139178  |EV| 
-0.85080728594603138859042701369617  |BT| (ROOT (S (S (NP (NP (NNS (Isoflavones)))(PP (JJ (such))(IN (as))(NP (NP (NP (NN (genistein)))(PRN (-LRB- (-LRB-))(NP (CD (10)))(-RRB- (-RRB-))))(, (,))(NP (NP (NN (biochanin))(NN (A)))(PRN (-LRB- (-LRB-))(NP (CD (11)))(-RRB- (-RRB-))))(, (,))(NP (NP (NN (tectorigenin)))(PRN (-LRB- (-LRB-))(NP (CD (12)))(-RRB- (-RRB-))))(, (,))(CC (and))(NP (NP (NP (CD (2))(POS (')))(JJ (-))(NN (methoxyformononetin)))(PRN (-LRB- (-LRB-))(NP (CD (13)))(-RRB- (-RRB-)))))))(VP (VBN (stimulated))(NP (NP (DT (the))(NN (proliferation)))(PP (IN (of))(NP (DT (both))(NNS (cells)))))))(, (,))(CC (and))(S (NP (NP (NNS (concentrations)))(PP (IN (of))(NP (NP (JJR (lower)))(PP (IN (than))(NP (NP (CD (1))(NN (muM)))(PP (IN (of))(NP (DT (these))(NNS (compounds)))))))))(VP (VBD (showed))(NP (NN (equivalent))(NN (activity)))(PP (TO (to))(NP (NP (CD (10))(NN (pM)))(PP (IN (of))(NP (NP (NN (estradiol)))(PRN (-LRB- (-LRB-))(NP (NNP (E2)))(-RRB- (-RRB-)))))))))(. (.)))) |ET|  |BV| 1:-0.85465068 2:-0.1223867 3:0.039865397 4:-0.019043626 5:0.45820934 6:-0.23349798 7:-0.055019416 8:-0.62751144 9:0.28472161 10:0.22962189 11:0.65343541 12:0.033011775 13:0.56688863 14:0.29359838 15:0.41499624 16:0.37236989 17:-0.36746573 18:0.17696653 19:0.45934385 20:0.74600995 21:-0.88100749 22:-0.82609057 23:-1.0307251 24:-0.55634868 25:-0.26797688 26:-0.3145192 27:0.50074118 28:0.95685005 29:-1.1553111 30:0.057921607 31:0.56989318 32:-0.15794641 33:1.2393218 34:0.034051262 35:0.38033518 36:1.0104743 37:0.24098912 38:-0.43851969 39:0.26584595 40:-0.64438432 41:-0.34721544 42:-0.28512558 43:-0.1205713 44:-0.066602863 45:-0.11335639 46:0.21175855 47:0.13927993 48:0.067316324 49:-0.52382398 50:-0.059564061 51:1.0340816 52:0.21518214 53:-0.22543478 54:-0.43967858 55:0.11394088 56:0.66286886 57:-0.072008222 58:0.054320592 59:-0.17068936 60:0.26421162  |EV| 
-1  |BT| (ROOT (S (PP (X (NP (NNS (CONCLUSIONS)))(: (:))(PP (IN (In))(NP (NNS (patients)))))(IN (with))(S (NP (NN (diabetes))(NNS (mellitus)))(VP (VBG (presenting))(PP (IN (with))(S (NP (NNP (STEMI)))(VP (VBG (undergoing))(NP (JJ (primary))(NN (PCI)))))))))(, (,))(NP (NP (JJ (anticoagulant))(NN (therapy)))(PP (IN (with))(NP (NP (NN (bivalirudin)))(PP (VBN (compared))(PP (IN (with))(NP (NNP (heparin))(CC (plus))(NNP (GPI))))))))(VP (VP (VBZ (is))(ADJP (JJ (safe))(CC (and))(JJ (effective))))(CC (and))(VP (MD (might))(VP (VB (reduce))(NP (JJ (cardiac))(NN (mortality)))(PP (IN (at))(NP (NP (CD (30))(NNS (days)))(CC (and))(NP (CD (1))(NN (year))))))))(. (.)))) |ET|  |BV| 1:-1.099122 2:-0.36827782 3:-0.22745463 4:0.79862171 5:1.1189055 6:-0.31402871 7:0.78748995 8:-1.436879 9:0.31192052 10:0.86474186 11:0.19004239 12:-0.21946681 13:-0.23166943 14:-0.094983436 15:-0.05241875 16:1.0033585 17:-0.59131497 18:-0.25575784 19:-0.77031678 20:-1.1225936 21:-0.41226777 22:-0.46324244 23:0.0736316 24:-0.10951338 25:0.16933341 26:-0.27944037 27:-0.18100022 28:-0.50181663 29:0.24505071 30:0.34632957 31:-0.46979761 32:0.0045941002 33:-0.65328467 34:-0.18240881 35:0.043888774 36:0.63524508 37:-0.069035769 38:0.38571858 39:0.22889823 40:-0.57725471 41:0.07721018 42:0.53104848 43:0.41290727 44:0.29133421 45:0.10447101 46:0.053088009 47:-0.21406367 48:-0.20055093 49:0.20370208 50:0.15551409 51:0.10436682 52:-0.10512314 53:-0.4236657 54:0.15486327 55:-0.18560886 56:0.0064896429 57:0.1893428 58:0.36462119 59:-0.28561786 60:0.069616042  |EV| 
-0.69776828301705429158374727194314  |BT| (ROOT (S (NP (DT (This)))(VP (VBD (was))(VP (VBN (concomitant))(PP (IN (with))(NP (NP (DT (a))(NN (decrease)))(PRN (-LRB- (-LRB-))(NP (NNP (P))(NNP (<))(NNP (0.05)))(-RRB- (-RRB-)))))(PP (IN (in))(NP (NP (DT (the))(NN (activity)))(PP (IN (of))(NP (NP (NNS (enzymes)))(VP (VBN (involved))(PP (IN (in))(NP (NP (NP (IN (de))(JJ (novo))(NN (fatty))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NNP (FA)))(-RRB- (-RRB-))))(NP (NP (NN (synthesis)))(PRN (-LRB- (-LRB-))(NP (NP (NNP (FA))(NNP (synthase)))(CC (and))(NP (JJ (glucose-6-phosphate))(NN (dehydrogenase))))(-RRB- (-RRB-))))(CC (and))(NP (NP (NNP (FA))(NNP (esterification)))(PRN (-LRB- (-LRB-))(NP (JJ (glycerol-3-phosphate))(NN (dehydrogenase)))(-RRB- (-RRB-)))(SBAR (WHADVP (WRB (when)))(S (S (VP (VBN (expressed))(PP (IN (per))(NP (CD (million))(NNS (adipocytes))))))(, (,))(CC (and))(S (VP (ADVP (IN (with))(DT (an)))(VB (increase))(-LRB- (-LRB-))(NP (NNP (P)))))))))))))))))(. (?)))) |ET|  |BV| 1:-1.1923358 2:0.36651093 3:0.14956017 4:-0.25442144 5:-0.74738133 6:0.29904133 7:0.63527578 8:0.27886191 9:0.45418373 10:0.062229525 11:0.63828611 12:-0.17143264 13:0.40124375 14:0.10097073 15:0.77508128 16:-0.08437378 17:-1.0932121 18:0.10228246 19:1.0465006 20:-0.54566127 21:-1.8900908 22:-0.95278627 23:-0.10516619 24:0.41801101 25:-0.82989311 26:-1.764289 27:0.72979474 28:0.93331784 29:0.77029908 30:0.27786386 31:0.93818867 32:0.17773449 33:0.43606043 34:-0.56340086 35:-0.88518381 36:-0.66564178 37:-0.10992546 38:0.58030707 39:0.83720535 40:-0.24087898 41:-0.23750593 42:0.0028952307 43:-0.01858812 44:-0.27196643 45:-0.18889652 46:-0.18162397 47:-0.077557489 48:0.40331829 49:0.020494709 50:0.091080956 51:0.85945529 52:0.33363289 53:0.041552924 54:-0.14560075 55:0.34892228 56:0.7493909 57:0.0088205449 58:0.41036832 59:0.11433691 60:0.50540876  |EV| 
1  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(NP (NP (PRP$ (Our))(NN (study)))(VP (VBN (demonstrated))(SBAR (IN (that))(S (NP (NP (DT (the))(NN (combination))(NN (treatment)))(PP (IN (of))(NP (CD (two))(JJ (different))(JJ (analgesic))(NNS (modalities))))(, (,))(ADJP (JJ (alfentanil))(CC (and))(JJ (lidocaine)))(, (,)))(VP (MD (could))(VP (VP (VB (prevent))(NP (NP (DT (the))(ADJP (JJ (moderate))(CC (and))(JJ (severe)))(NN (pain)))(PP (IN (on))(NP (JJ (propofol))(NN (injection))))))(, (,))(CC (and))(VP (VB (reduce))(NP (NP (DT (the))(NN (incidence)))(PP (IN (of))(NP (JJ (mild))(NN (pain)))))(PP (VBN (compared))(PP (IN (with))(NP (DT (each))(NN (drug)))(ADVP (RB (alone))))))))))))(. (.)))) |ET|  |BV| 1:-0.18326178 2:-0.6332702 3:-1.2221074 4:-0.7760886 5:0.18754745 6:-0.082618378 7:-0.14242551 8:0.073615573 9:-0.11079296 10:-0.01262922 11:0.16777821 12:0.12226185 13:-0.071352325 14:-0.55858153 15:-0.28625986 16:0.31376615 17:0.34146345 18:0.47314885 19:-0.37956539 20:-0.51146042 21:-1.0112695 22:-0.89826661 23:-0.63906997 24:-1.1833961 25:0.12017842 26:0.39283651 27:-0.20540407 28:-0.22584574 29:0.14834107 30:0.48220682 31:0.42650765 32:-0.26843318 33:-0.061430044 34:-0.50642443 35:-0.23243724 36:0.058564819 37:-0.37802315 38:0.82528675 39:-0.2525852 40:-0.2576302 41:-0.12717439 42:0.2864024 43:0.14180583 44:0.53970879 45:0.78179747 46:-0.18100482 47:-0.0058811735 48:-0.73840731 49:0.036690596 50:-0.62719065 51:-0.19391184 52:-0.13698447 53:-0.13529468 54:0.70689881 55:0.14281528 56:0.16665013 57:0.52882397 58:0.13799286 59:0.27933419 60:0.60259551  |EV| 
0.97862418351615976241930638934718  |BT| (ROOT (S (NP (DT (These))(NNS (results)))(VP (VBP (are))(PP (IN (in))(NP (NN (contrast))))(PP (TO (to))(NP (JJ (previous))(NNS (reports))))(SBAR (IN (that))(S (NP (DT (the))(JJ (sulfonamide-based))(NNP (ERA))(NN (bosentan)))(VP (MD (can))(VP (VB (cause))(NP (JJ (marked))(NNS (decreases)))(PP (IN (in))(NP (NP (DT (the))(NN (exposure)))(PP (IN (of))(NP (NN (tadalafil)))))))))))(. (.)))) |ET|  |BV| 1:-0.94872731 2:0.92150313 3:-1.3880236 4:0.062727883 5:-0.43740386 6:-0.72818339 7:-0.27547452 8:0.23511836 9:0.80953074 10:0.5146603 11:-0.50171864 12:0.33801734 13:1.3743784 14:0.23980531 15:0.004369101 16:0.088416725 17:1.2119985 18:0.71767831 19:0.20200036 20:0.080322586 21:-0.66392791 22:0.17296602 23:-1.954704 24:0.12645058 25:0.51305586 26:-0.52545053 27:-0.43873227 28:0.124403 29:0.66505593 30:0.60883856 31:-0.21927804 32:1.0090284 33:1.802382 34:1.228317 35:0.47323549 36:0.8639906 37:-0.54214644 38:0.044938117 39:-0.063308112 40:0.55163604 41:-0.059625588 42:0.13267758 43:-0.28590429 44:0.36782923 45:0.4363713 46:0.051295076 47:0.28762883 48:0.45142454 49:-0.72979832 50:0.60670763 51:-0.11368788 52:0.11871683 53:0.49273792 54:-0.026877282 55:0.22425406 56:0.24237001 57:0.30429631 58:0.22445272 59:-0.20453891 60:-0.15003856  |EV| 
0.92180289374889790021683211307391  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(S (NP (NP (JJ (Routine))(JJ (early))(NN (eptifibatide))(NN (use)))(, (,))(PP (VBN (compared))(PP (IN (with))(NP (JJ (delayed))(JJ (provisional))(NN (use)))))(, (,)))(VP (MD (may))(VP (VB (be))(VP (VBN (associated))(PP (IN (with))(NP (NP (JJR (lower))(JJ (30-day))(NN (ischemic))(NN (risk)))(PP (IN (in))(NP (NP (JJ (non-ST-elevation))(JJ (acute))(JJ (coronary))(NN (syndrome))(NNS (patients)))(VP (ADVP (RB (also)))(VBN (treated))(PP (IN (with))(NP (NN (clopidogrel))))(PP (IN (before))(NP (NN (angiography)))))))))))))(. (.)))) |ET|  |BV| 1:0.71652037 2:-0.40332907 3:-0.59834403 4:-0.0015883764 5:0.33634546 6:-0.38538182 7:-0.84922445 8:-1.5489 9:0.13503546 10:0.68433505 11:0.56421232 12:-0.42848802 13:-0.018336395 14:-0.19189461 15:0.010404168 16:0.41355923 17:-0.10771071 18:0.42704993 19:-0.22207615 20:-0.6142199 21:-0.15856889 22:0.3293196 23:-0.6357854 24:-0.037901204 25:0.4094055 26:0.16079946 27:-0.40807116 28:-0.96301061 29:0.22807567 30:0.12053797 31:-0.31293467 32:0.17092253 33:0.28423032 34:0.14488637 35:-0.22898345 36:1.0369015 37:-0.058853254 38:-0.22417794 39:0.88311076 40:0.051908705 41:-0.059676599 42:0.36429003 43:0.032328703 44:0.21317334 45:-0.32553592 46:0.22599727 47:-0.037548166 48:-0.13953444 49:0.21354544 50:-0.20223476 51:-0.093331568 52:0.16577838 53:-0.15364084 54:-0.11939657 55:0.44321066 56:0.18817712 57:0.66241956 58:-0.10786889 59:0.29866746 60:-0.589894  |EV| 
-0.94609546819325518463017488102196  |BT| (ROOT (S (NP (DT (These))(NNS (results)))(VP (VP (VBP (indicate))(NP (NP (DT (a))(JJ (major))(NN (role)))(PP (IN (of))(NP (NP (NN (acetylcholine)))(PP (IN (in))(NP (JJ (airway))(NN (inflammation))(CC (and))(NN (remodelling))))))(PP (IN (in))(NP (DT (a))(NNP (GORD))(NN (model))))))(, (,))(CC (and))(VP (VBP (demonstrate))(SBAR (IN (that))(S (NP (NN (tiotropium))(CC (and))(NN (atropine)))(VP (MD (can))(VP (VB (prevent))(NP (NN (lung))(NN (inflammation)))(PP (IN (with))(NP (NP (DT (an))(NN (effectiveness)))(ADJP (JJ (similar))(PP (TO (to))(NP (JJ (intraperitoneal))(NN (dexamethasone)))))))(, (,))(S (VP (VBG (providing))(NP (JJ (additional))(NN (evidence)))(SBAR (IN (that))(S (NP (NNS (anticholinergics)))(VP (MD (might))(VP (VB (contribute))(PP (TO (to))(NP (NP (DT (the))(NN (control)))(PP (IN (of))(NP (NP (JJ (inflammatory))(NNS (processes)))(PP (IN (in))(NP (JJ (airway))(NNS (diseases))))))))))))))))))))(. (.)))) |ET|  |BV| 1:-0.67935634 2:-0.76576102 3:-0.22106758 4:-0.57372367 5:0.28197569 6:0.20814733 7:0.15986425 8:-0.027409209 9:0.26356155 10:0.089581832 11:0.42520076 12:-0.090538852 13:0.23981953 14:-0.41005591 15:-0.60331243 16:0.26125708 17:0.019843308 18:-0.055050366 19:-0.095602602 20:-0.014820319 21:-0.37860355 22:-0.77694696 23:0.15381135 24:-0.30914474 25:0.1739258 26:-0.038748726 27:-0.1213993 28:-0.30365685 29:-0.37887204 30:0.97536069 31:-0.10927109 32:-0.26525721 33:0.15702246 34:-0.080765247 35:0.04058389 36:0.47821069 37:-0.2975603 38:-0.32002869 39:-0.079881735 40:0.0094199497 41:-0.25554961 42:-0.066803969 43:-0.041934393 44:-0.024751531 45:0.63210422 46:-0.54006594 47:-0.031161059 48:-0.71179026 49:0.11188504 50:0.12862749 51:0.33247223 52:-0.27847508 53:0.21757856 54:0.28733116 55:0.24617992 56:0.20327522 57:0.26331401 58:-0.05941309 59:-0.069137335 60:0.070984431  |EV| 
-1  |BT| (ROOT (S (PP (IN (On))(NP (DT (the))(JJ (other))(NN (hand))))(, (,))(S (NP (NP (JJ (dihydropyridine))(NN (calcium))(NN (channel))(NNS (blockers)))(, (,))(PP (JJ (such))(IN (as))(NP (NN (amlodipine))))(, (,)))(VP (VBP (have))(VP (VBN (been))(VP (VBN (proven))(S (VP (TO (to))(VP (VB (lower))(NP (NP (DT (the))(NN (incidence)))(PP (IN (of))(NP (NN (stroke))))))))))))(CC (but))(S (NP (PRP$ (their))(NN (use)))(VP (VBZ (seems))(S (VP (TO (to))(VP (VB (be))(ADJP (JJ (effective))(PP (IN (in))(S (VP (VP (VBG (relieving))(NP (NP (NNS (symptoms)))(PP (IN (of))(NP (JJ (coronary))(NN (artery))(NN (disease))))))(CC (and))(VP (VBG (reducing))(NP (NP (DT (the))(NN (rate)))(PP (IN (of))(NP (NN (revascularisation))(NNS (procedures)))))))))))))))(. (.)))) |ET|  |BV| 1:0.025097216 2:0.68531781 3:-0.80269665 4:0.0019880878 5:0.91691411 6:0.021895761 7:-0.2228858 8:0.3849802 9:0.99198967 10:0.45172033 11:-0.71133584 12:-0.37961367 13:0.20876648 14:0.18517704 15:-0.78236562 16:0.67130274 17:0.0048903967 18:0.15368357 19:0.60696161 20:-0.013395467 21:-0.76733154 22:0.2460794 23:-0.36372909 24:-0.26238525 25:-0.33067521 26:-0.33500141 27:-0.089534409 28:0.13414255 29:0.37700409 30:0.26008978 31:-0.075949982 32:-0.24670501 33:0.17961161 34:-0.15187471 35:-1.0580264 36:-0.25400683 37:-0.31937048 38:0.033552781 39:0.48308486 40:-0.69982004 41:-0.55360216 42:0.69416606 43:0.14143132 44:-0.012109168 45:0.060778696 46:0.042874884 47:-0.017658187 48:-0.1254151 49:0.015170814 50:-0.049119953 51:0.056066599 52:0.30813375 53:-0.48535234 54:0.17965734 55:0.10110472 56:-0.21423033 57:-0.37189919 58:-0.078309715 59:0.50929612 60:0.14844044  |EV| 
-1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (DT (The))(NNS (findings)))(VP (VBP (suggest))(SBAR (IN (that))(S (S (VP (VBG (lowering))(NP (NN (sodium))(NN (intake)))(PP (IN (while))(S (VP (VBG (maintaining))(NP (NP (JJ (high))(NNS (levels)))(PP (IN (of))(NP (JJ (dietary))(NN (calcium))(CC (and))(NN (magnesium))))))))))(VP (MD (may))(VP (VB (help))(VP (VB (prevent))(NP (JJ (ischemic))(NN (stroke)))(PP (IN (in))(NP (JJ (southern))(JJ (Chinese))(NNS (adults)))))))))))(. (.)))) |ET|  |BV| 1:-0.76733154 2:0.2460794 3:-0.36372909 4:-0.26238525 5:-0.33067521 6:-0.33500141 7:-0.089534409 8:0.13414255 9:0.37700409 10:0.26008978 11:-0.075949982 12:-0.24670501 13:0.17961161 14:-0.15187471 15:-1.0580264 16:-0.25400683 17:-0.31937048 18:0.033552781 19:0.48308486 20:-0.69982004 21:-0.69870472 22:-0.24796677 23:-0.81360668 24:-0.010563116 25:0.23021409 26:-0.49103528 27:-0.12774047 28:0.32772008 29:-0.10109277 30:0.37758282 31:-0.10246789 32:-0.17838542 33:-0.41387382 34:-0.30004424 35:-0.10441614 36:0.11705339 37:-0.5140717 38:0.68735868 39:0.66774976 40:-0.36981764 41:0.12490097 42:-0.24122033 43:0.364043 44:0.27269372 45:-0.020926356 46:0.099756584 47:-0.20888409 48:-0.52222663 49:0.25905439 50:0.23447201 51:-0.53805071 52:-0.010039113 53:-0.51783282 54:-0.27206084 55:-0.020578245 56:-0.09236417 57:0.2175418 58:0.24771287 59:-0.18901238 60:-0.20950763  |EV| 
1  |BT| (ROOT (S (NP (NP (DT (The))(JJ (morphine-induced))(NN (increase)))(PP (IN (in))(NP (NNP (OA-sensitive))(NNP (PP))(NN (activity)))))(VP (VP (VBD (was))(ADJP (JJ (dependent)))(PP (IN (on))(NP (DT (the))(NN (dose)))))(CC (and))(VP (VBD (attenuated))(PP (IN (by))(NP (NP (DT (the))(JJ (concurrent))(NN (administration)))(PP (IN (of))(NP (NP (NN (naloxone)))(PRN (-LRB- (-LRB-))(NP (CD (1))(NN (mg/kg)))(-RRB- (-RRB-)))))))))(. (.)))) |ET|  |BV| 1:-0.05787234 2:-0.78405076 3:-0.23945186 4:-0.92862201 5:0.1237028 6:-1.4632297 7:-0.18947482 8:0.65782112 9:0.862939 10:0.29095969 11:0.67317629 12:-0.56309271 13:0.58486265 14:-0.58568966 15:-0.41367728 16:-0.58864403 17:0.27380323 18:-0.69504911 19:0.2486784 20:0.60118753 21:-0.45263946 22:-0.44811127 23:-0.4024395 24:-0.35953194 25:0.29140186 26:-0.31026688 27:-0.16002285 28:0.027013453 29:0.46951276 30:0.70688903 31:0.51139504 32:-0.31645745 33:0.28384194 34:-0.14880067 35:-0.087615728 36:-0.37213057 37:0.33573028 38:0.14914471 39:-0.2827695 40:0.36941594 41:-0.61205178 42:0.12588213 43:0.30840448 44:0.1228061 45:0.22554168 46:-0.089570388 47:0.22344178 48:-0.12184786 49:-0.48486999 50:0.15206377 51:0.29158658 52:-0.010471693 53:0.258416 54:-0.089078896 55:-0.35090202 56:0.10321154 57:-0.068160035 58:-0.12700447 59:-0.13700327 60:0.52315933  |EV| 
0.89655049351846971550372700221487  |BT| (ROOT (S (S (NP (NNP (MEASUREMENTS))(CC (AND))(NNP (MAIN)))(VP (VBZ (RESULTS))))(: (:))(S (NP (PRP$ (Our))(NN (study)))(VP (VBZ (demonstrates))(SBAR (IN (that))(S (S (LST (LS (1))(-RRB- (-RRB-)))(NP (JJ (proteasomal))(JJ (glucocorticoid))(NN (receptor))(NNS (degradation)))(VP (VBZ (is))(VP (VBN (established))(PP (IN (in))(NP (NN (brain))(NN (endothelial))(NNS (cells))))(PP (IN (after))(NP (NP (JJ (traumatic))(NN (brain))(NN (injury)))(PP (IN (as))(NP (NP (DT (a))(NN (form)))(PP (IN (of))(NP (JJ (posttranslational))(JJ (glucocorticoid))(NN (receptor))(NN (modification)))))))))))(: (;))(S (NP (NP (LST (LS (2))(-RRB- (-RRB-)))(NP (NN (inhibition)))(PP (IN (of))(NP (NP (DT (the))(JJ (proteasomal))(NN (degradation))(NN (pathway)))(PP (IN (with))(NP (NN (bortezomib)))))))(PRN (-LRB- (-LRB-))(NP (CD (0.2))(NN (mg/kg)))(-RRB- (-RRB-)))(PP (IN (in))(NP (NP (NN (combination)))(PP (IN (with))(NP (NP (NP (DT (the))(JJ (glucocorticoid))(NN (dexamethasone)))(PRN (-LRB- (-LRB-))(NP (CD (10))(NN (mg/kg)))(-RRB- (-RRB-))))(PP (IN (by))(NP (JJ (subcutaneous))(NN (injection))))))(NP-TMP (CD (30))(NNS (minutes))))))(VP (VP (ADVP (RB (postinjury)))(VBZ (restores))(NP (NP (NNS (levels)))(PP (IN (of))(NP (NP (NN (barrier)))(VP (VBG (sealing))(NP (NP (JJ (glucocorticoid))(NN (receptor))(NN (target))(NN (occludin)))(PP (IN (in))(NP (NN (brain))(NN (endothelial))(NNS (cells))))))))))(, (,))(VP (VBZ (improves))(NP (JJ (blood-brain))(NN (barrier))(NN (integrity))))(, (,))(VP (VBZ (reduces))(NP (NN (edema))(NN (formation))))(, (,))(CC (and))(VP (VBZ (limits))(NP (JJ (neuronal))(NN (damage)))(PP (IN (after))(NP (NN (brain))(NN (trauma)))))))))))(. (.)))) |ET|  |BV| 1:-0.50815684 2:-0.81141806 3:0.69089633 4:0.50509024 5:0.87124819 6:-0.40051931 7:0.20089279 8:-0.3484312 9:-0.84581852 10:1.0982403 11:-0.055473689 12:0.25731325 13:0.77957821 14:0.46582648 15:0.6419639 16:0.82395142 17:0.15897982 18:-0.8258574 19:0.24042521 20:-0.81440455 21:-0.37860355 22:-0.77694696 23:0.15381135 24:-0.30914474 25:0.1739258 26:-0.038748726 27:-0.1213993 28:-0.30365685 29:-0.37887204 30:0.97536069 31:-0.10927109 32:-0.26525721 33:0.15702246 34:-0.080765247 35:0.04058389 36:0.47821069 37:-0.2975603 38:-0.32002869 39:-0.079881735 40:0.0094199497 41:-0.98713988 42:-0.7381556 43:-0.3788994 44:-0.68624175 45:-0.33139229 46:-0.16791049 47:0.070695803 48:-0.076030038 49:0.18732956 50:-0.04925666 51:0.28003922 52:-0.49605626 53:0.41498891 54:-0.11530301 55:0.13957149 56:0.39291275 57:0.22017333 58:-0.049427692 59:-0.29047385 60:0.054481585  |EV| 
0.91593770315996914099798686947906  |BT| (ROOT (S (NP (NP (DT (The))(NNP (MT-Mla)))(CC (and))(NP (DT (the))(NNP (M))(PRN (-LRB- (-LRB-))(NP (CD (1)))(-RRB- (-RRB-)))(NN (antagonist))(NN (pirenzepine))))(VP (VBD (caused))(NP (NP (DT (a))(JJ (dose-dependent))(NN (block)))(PP (IN (on))(NP (JJ (total))(NNS (-LSB-))))(PRN (-LRB- (-LRB-))(NP (CD (3)))(-RRB- (-RRB-)))(NP (NP (NNP (H))(NNP (-RSB-))(JJ (inositol))(NN (phosphate))(NN (accumulation)))(VP (VBN (induced))(PP (IN (by))(NP (NN (carbachol))))))))(. (.)))) |ET|  |BV| 1:-0.26564446 2:0.68711233 3:0.55531096 4:-0.70251048 5:0.95914066 6:0.12103315 7:1.1915694 8:0.85151488 9:0.68055475 10:-1.1901579 11:1.6873424 12:0.456395 13:1.5573533 14:-0.83339328 15:-0.9094485 16:-0.22246954 17:0.072595336 18:0.2450164 19:0.58629966 20:-0.17568555 21:-0.65054059 22:-0.21124956 23:0.17133197 24:-0.061776195 25:-0.37753147 26:-0.6811325 27:0.42972559 28:-0.13692035 29:0.10174469 30:-0.54913765 31:0.49487802 32:-0.135359 33:-0.27002528 34:-0.52904797 35:-0.31652325 36:0.14843516 37:0.20821591 38:0.50349724 39:0.40614331 40:0.028209951 41:-0.058400705 42:-0.71117145 43:-0.032866087 44:-0.25871566 45:0.47847918 46:-0.43941694 47:0.23059464 48:-0.15433836 49:-0.49508977 50:-0.19659707 51:0.14736114 52:-0.24759406 53:-0.17827643 54:-0.38701552 55:-0.35679951 56:0.39569595 57:0.56317908 58:0.19726054 59:0.22538692 60:0.33765104  |EV| 
-1  |BT| (ROOT (S (NP (PRP (It)))(VP (VBZ (is))(ADJP (JJ (unknown)))(SBAR (IN (whether))(S (NP (DT (the))(NN (glycosaminoglycan))(NN (drug))(NN (sulodexide)))(VP (VBZ (interferes))(PP (IN (with))(S (VP (VBG (transforming))(NP (NN (growth))(JJ (factor-beta1))))))(: (--))(NP (NP (NP (DT (a))(NN (member)))(PP (IN (of))(NP (JJ (heparin-binding))(NN (family)))))(CC (and))(NP (NP (DT (a))(JJ (potent))(NN (regulator)))(PP (IN (of))(NP (JJ (human))(NN (biology))(CC (and))(NNS (diseases))))))))))(. (.)))) |ET|  |BV| 1:-0.41226777 2:-0.46324244 3:0.0736316 4:-0.10951338 5:0.16933341 6:-0.27944037 7:-0.18100022 8:-0.50181663 9:0.24505071 10:0.34632957 11:-0.46979761 12:0.0045941002 13:-0.65328467 14:-0.18240881 15:0.043888774 16:0.63524508 17:-0.069035769 18:0.38571858 19:0.22889823 20:-0.57725471 21:-0.65510368 22:-0.52460599 23:0.11106169 24:0.67898494 25:0.13148628 26:-0.83193159 27:-0.15369746 28:0.52105713 29:1.2081888 30:-0.21189776 31:-1.027262 32:-0.70817798 33:0.71377504 34:-0.12052491 35:-0.096693188 36:0.41423789 37:-1.1564037 38:-0.47297087 39:1.5090388 40:0.57205814 41:0.31216297 42:0.0074428972 43:0.33363277 44:-0.16067104 45:-0.22803342 46:-0.26304579 47:0.37227073 48:-0.50172383 49:0.084706403 50:0.44456699 51:0.11748976 52:0.44630286 53:-0.093320549 54:-0.12813094 55:0.18731081 56:0.36073723 57:0.016233841 58:-0.036993947 59:-0.24337633 60:-0.17992486  |EV| 
-0.94093109961747278813248840378947  |BT| (ROOT (S (NP (NP (DT (The))(NN (purpose)))(PP (IN (of))(NP (DT (this))(NN (study)))))(VP (VBD (was))(S (VP (TO (to))(VP (VP (VB (evaluate))(NP (NP (DT (the))(NN (effect)))(PP (IN (of))(NP (JJ (atropine))(NN (dose))))))(, (,))(VP (VB (pyridostigmine))(S (NP (NP (NN (bromide)))(PRN (-LRB- (-LRB-))(NP (NNP (PB)))(-RRB- (-RRB-))))(ADJP (JJ (pretreatment)))))(, (,))(CC (and))(VP (VB (oxime))(NP (NN (selection)))(PP (IN (on))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (NNP (SCP))))))(PP (IN (as))(NP (DT (an))(JJ (adjunctive))(NN (treatment))))(S (VP (TO (to))(VP (VB (enhance))(NP (NP (NN (survival)))(PP (VBG (following))(NP (NP (JJ (lethal))(NN (nerve))(NN (agent))(NN (exposure)))(PP (IN (in))(NP (NN (guinea))(NNS (pigs)))))))))))))))(. (.)))) |ET|  |BV| 1:-0.67935634 2:-0.76576102 3:-0.22106758 4:-0.57372367 5:0.28197569 6:0.20814733 7:0.15986425 8:-0.027409209 9:0.26356155 10:0.089581832 11:0.42520076 12:-0.090538852 13:0.23981953 14:-0.41005591 15:-0.60331243 16:0.26125708 17:0.019843308 18:-0.055050366 19:-0.095602602 20:-0.014820319 21:-0.93410742 22:-0.65373468 23:-0.43406469 24:-0.62340039 25:-0.042419974 26:-0.59540313 27:0.0505023 28:0.71034038 29:0.87474036 30:0.61118281 31:1.0918378 32:-0.079266086 33:0.090141818 34:-0.43119365 35:0.71569562 36:0.51479262 37:-0.89098656 38:-0.34835291 39:1.2585413 40:-0.80709505 41:-0.26359537 42:-0.44234964 43:0.30599928 44:-0.017794991 45:0.18254153 46:0.23739402 47:0.19360054 48:-0.041642528 49:0.13987909 50:-0.024441687 51:0.039099436 52:-0.14512825 53:0.35809597 54:0.28925979 55:-0.30083889 56:0.12265188 57:-0.11060937 58:0.44460371 59:-0.38416731 60:-0.17028171  |EV| 
-1  |BT| (ROOT (SINV (S (S (NP (NNP (IFNT)))(ADVP (RB (also)))(VP (VBZ (suppresses))(NP (NP (NN (expression)))(PP (IN (of))(NP (JJ (classical))(JJ (IFN-stimulated))(NNS (genes)))))(PP (IN (by))(NP (NP (JJ (uterine))(JJ (lumenal))(NN (epithelium)))(PRN (-LRB- (-LRB-))(NP (NNP (LE)))(-RRB- (-RRB-)))))))(CC (and))(S (NP (NP (JJ (superficial))(NN (glandular)))(PRN (-LRB- (-LRB-))(NP (NN (sGE)))(-RRB- (-RRB-))))(VP (VBP (epithelium))(ADVP (CC (but)))(, (,))(S (VP (VBG (acting))(PP (IN (in))(NP (NN (concert))))(PP (IN (with))(NP (NN (progesterone)))))))))(, (,))(VP (VBZ (affects)))(NP (NP (NN (expression)))(PP (IN (of))(NP (NP (DT (a))(NN (multitude)))(PP (IN (of))(NP (NP (NNS (genes)))(ADJP (JJ (critical))(PP (TO (to))(NP (NP (NN (growth))(CC (and))(NN (development)))(PP (IN (of))(NP (DT (the))(NNS (conceptus))))))))))))(. (.)))) |ET|  |BV| 1:-0.70291984 2:0.10596521 3:0.40353924 4:-0.0082024643 5:0.51516557 6:-0.4248296 7:0.15003122 8:0.1239915 9:0.20275137 10:0.48732561 11:0.47781709 12:-0.14894189 13:0.51152009 14:0.33163288 15:-0.5908134 16:0.57499492 17:0.029747412 18:0.11391607 19:0.40241897 20:0.6374259 21:-0.096222363 22:0.94451559 23:0.38732514 24:0.33220047 25:0.6958468 26:0.46158853 27:0.089183718 28:0.71234727 29:0.23575859 30:-0.68371904 31:-0.48470005 32:0.017183764 33:0.82850325 34:0.46577826 35:0.49960998 36:-0.28507906 37:-1.0442582 38:0.681045 39:-0.16396788 40:-0.78167802 41:-0.3750062 42:-0.24547464 43:0.29125211 44:-0.058199205 45:-0.011699778 46:-0.16996717 47:-0.16920634 48:-0.06767752 49:0.16542676 50:0.42751682 51:0.45431086 52:0.10216087 53:0.27360913 54:-0.4327924 55:-0.043652076 56:0.54760718 57:0.22510488 58:0.11421139 59:-0.03462711 60:-0.06513574  |EV| 
1  |BT| (ROOT (S (NP (NNP (Selenium)))(VP (VBZ (attenuates))(NP (NP (JJ (adriamycin-induced))(JJ (cardiac))(NN (dysfunction)))(PP (IN (via))(S (VP (VBG (restoring))(NP (NP (NN (expression)))(PP (IN (of))(NP (JJ (ATP-sensitive))(NN (potassium))(NNS (channels)))))(PP (IN (in))(NP (NNS (rats)))))))))(. (.)))) |ET|  |BV| 1:-0.074493647 2:0.71976465 3:-0.21396433 4:-0.26380324 5:0.042501077 6:0.15227692 7:-0.046447642 8:-0.41188601 9:1.0815731 10:-0.58426511 11:-0.46673495 12:-0.78133094 13:0.31379315 14:0.83311576 15:0.56302768 16:-0.89255762 17:-0.16943435 18:-0.2020032 19:-0.2615982 20:0.71667403 21:-0.84095442 22:-0.26002046 23:0.35422635 24:-0.41506359 25:0.24434552 26:0.33636442 27:-0.098769397 28:-0.43478909 29:0.19588551 30:0.27329165 31:-0.7637704 32:-0.82083845 33:0.18110928 34:0.28456381 35:-0.04020413 36:-0.0043880525 37:-0.53718525 38:-0.64992148 39:-0.46033314 40:0.28226665 41:-0.72913688 42:-0.20518996 43:0.16337502 44:-0.39143226 45:-0.094706923 46:-0.031286705 47:0.26639876 48:-0.15889025 49:0.039190017 50:-0.022993386 51:0.12730381 52:-0.41042995 53:0.23311917 54:0.15098602 55:0.02116636 56:0.12731932 57:0.12481887 58:0.19910228 59:0.10648496 60:0.17767385  |EV| 
1  |BT| (ROOT (S (SBAR (IN (Because))(S (NP (NP (JJ (concomitant))(NN (administration)))(PP (IN (of))(NP (NP (NN (gliclazide)))(PP (IN (with))(NP (NP (NN (provastatin))(CC (and))(NN (gemfibrozil)))(PP (IN (in))(NP (NN (diabetes)))))))))(VP (VBZ (is))(VP (VBN (associated))(PP (IN (with))(NP (NNS (atherosclerosis))))))))(, (,))(NP (PRP (it)))(VP (MD (should))(VP (VB (be))(VP (VBN (contraindicated))(CC (or))(VBN (used))(PP (IN (with))(NP (NN (caution)))))))(. (.)))) |ET|  |BV| 1:-0.64380205 2:-0.0097835716 3:-0.56415755 4:0.66292429 5:0.92432618 6:1.6463505 7:-1.1863612 8:-1.2141163 9:-0.026554083 10:0.15865059 11:0.42958203 12:0.72791225 13:0.71058089 14:-0.80931681 15:-0.10776296 16:0.25698867 17:-1.2558001 18:-0.19377108 19:1.4803429 20:0.2470232 21:-0.5694164 22:-0.53439766 23:-0.26903683 24:1.1534308 25:1.0153744 26:0.27208284 27:-0.18659815 28:-0.41079745 29:-0.037070502 30:0.25957331 31:-0.37007791 32:0.03575949 33:0.28977156 34:-0.53668118 35:-1.1458126 36:0.43316948 37:-0.36870492 38:-0.41678375 39:0.637227 40:-0.064219132 41:-0.31541291 42:-0.11154027 43:0.082977079 44:0.088117301 45:-0.21187115 46:-0.33728549 47:-0.16462645 48:-0.65265858 49:-0.14764537 50:0.031930529 51:0.29476666 52:0.45563793 53:-0.092066631 54:-0.047118578 55:0.14745778 56:0.20787767 57:0.66203606 58:-0.142664 59:0.048430484 60:-0.65778691  |EV| 
0.7553857384803247532190084712056  |BT| (ROOT (S (NP (NP (NNP (Cinacalcet)))(, (,))(PP (IN (for))(NP (NN (example))))(, (,)))(VP (VBZ (is))(NP (NP (DT (a))(NN (drug)))(SBAR (SBAR (WHNP (WDT (that)))(S (ADVP (RB (allosterically)))(VP (VBZ (modifies))(NP (DT (the))(NN (receptor)))(ADVP (RB (so))(RB (as)))(S (VP (TO (to))(VP (VB (increase))(NP (PRP$ (its))(NN (sensitivity)))(PP (TO (to))(S (VP (VBG (circulating))(NP (NN (calcium))))))(PRN (-LRB- (-LRB-))(ADVP (RB (thus))(NP (DT (the))(NN (name))))(ADJP (`` (``))(JJ (calcimimetic))('' ('')))(-RRB- (-RRB-)))))))))(CC (and))(SBAR (IN (in))(S (NP (DT (this))(NN (way)))(VP (VBZ (decreases))(NP (JJ (parathyroid))(NN (hormone))(NN (secretion)))))))))(. (.)))) |ET|  |BV| 1:-0.73004878 2:-1.031927 3:-0.19360065 4:-0.0095260581 5:-0.15709367 6:-0.15227628 7:-0.79149169 8:0.4239842 9:-0.079996921 10:1.0777498 11:0.058074117 12:-0.14017753 13:0.099841915 14:0.2298121 15:-0.8900969 16:0.85412562 17:-0.43766207 18:0.19068843 19:0.22167738 20:-0.43719614 21:-0.76733154 22:0.2460794 23:-0.36372909 24:-0.26238525 25:-0.33067521 26:-0.33500141 27:-0.089534409 28:0.13414255 29:0.37700409 30:0.26008978 31:-0.075949982 32:-0.24670501 33:0.17961161 34:-0.15187471 35:-1.0580264 36:-0.25400683 37:-0.31937048 38:0.033552781 39:0.48308486 40:-0.69982004 41:-0.095457762 42:-0.119698 43:0.13229862 44:-0.070296139 45:0.1005244 46:0.30357286 47:-0.14314541 48:-0.14556548 49:-0.08461044 50:0.31633195 51:-0.17051397 52:0.11074489 53:0.048266828 54:-0.3887338 55:-0.071701817 56:0.2325535 57:0.14667387 58:0.08313635 59:-0.036476303 60:0.17199352  |EV| 
-0.7030222125192412407912456728809  |BT| (ROOT (S (NP (JJ (Rizatriptan))(CD (10))(NN (mg)))(VP (VBZ (has))(VP (VBN (demonstrated))(, (,))(PP (IN (in))(NP (NP (DT (a))(JJ (head-to-head))(NN (study)))(, (,))(NP (JJR (higher))(NN (response))(NNS (rates)))(CC (and))(NP (NP (DT (a))(ADJP (RBR (more))(JJ (rapid)))(NN (onset)))(PP (IN (of))(NP (NP (NN (action)))(PP (IN (than))(NP (NN (sumatriptan))(CD (100))(NN (mg)))))))))(, (,))(ADVP (RB (together)))(PP (IN (with))(NP (DT (a))(JJ (favorable))(NN (tolerability))(NN (profile))))))(. (.)))) |ET|  |BV| 1:-0.32797492 2:-0.94069475 3:-0.60456753 4:-0.65981048 5:0.7500115 6:-0.10764538 7:-0.48857605 8:-1.0108658 9:0.41849396 10:-0.75902396 11:-0.3341133 12:-0.64211088 13:0.10719255 14:-0.20691954 15:-0.52022511 16:-0.76019633 17:0.59634751 18:0.12651819 19:0.92679298 20:-0.52777058 21:0.47001791 22:-0.62756586 23:1.0812582 24:-0.81703526 25:0.64208084 26:-0.74925143 27:-0.18517151 28:-0.39398289 29:-0.31712973 30:0.6180594 31:0.18569587 32:1.3691579 33:0.2923626 34:-1.2151914 35:-0.51034468 36:-0.34254208 37:-0.095466524 38:0.10040471 39:0.055905849 40:-0.58425546 41:0.09560924 42:0.17644545 43:0.2682246 44:-0.30543253 45:0.65958643 46:0.33287817 47:0.023871539 48:-0.28657869 49:-0.34527224 50:0.12421337 51:0.22246784 52:0.11028741 53:-0.30035987 54:0.23523124 55:0.0048748953 56:0.051284734 57:0.37455076 58:-0.08612404 59:0.22434585 60:0.24387553  |EV| 
-0.59487830784963957597710759728216  |BT| (ROOT (S (NP (NP (JJ (Recent))(NNS (initiatives)))(VP (VBG (using))(NP (NP (NP (JJR (lower))(NNS (doses)))(PP (IN (of))(NP (NN (capecitabine))(CC (and))(NN (irinotecan)))))(, (,))(CONJP (RB (as))(RB (well))(IN (as)))(NP (JJ (alternative))(NN (dosing))(NNS (schedules))))))(, (,))(VP (VBP (have))(VP (VBN (resulted))(PP (PP (IN (in))(NP (NP (ADJP (RBR (more))(JJ (favorable)))(NNS (outcomes)))(PRN (-LRB- (-LRB-))(NP (JJ (efficacy))(CC (and))(JJ (tolerability)))(-RRB- (-RRB-)))))(, (,))(RB (even))(PP (IN (in))(NP (NN (combination)))))(PP (IN (with))(NP (NP (NNS (targeted-agents)))(PP (JJ (such))(IN (as))(NP (NN (bevacizumab))))))))(. (.)))) |ET|  |BV| 1:-0.46881801 2:-0.46444795 3:-0.26888451 4:-0.1521796 5:1.5136513 6:0.85400742 7:1.0441439 8:-0.89196044 9:-0.14930846 10:0.63301414 11:0.40352672 12:0.23101969 13:0.76615053 14:0.1099057 15:-0.71746057 16:1.3965064 17:-0.45881772 18:-0.66644859 19:-0.70927691 20:-0.94010508 21:-1.3908824 22:-0.11869227 23:0.231677 24:0.20158879 25:0.51931131 26:0.15928105 27:-0.94721961 28:-0.71603251 29:0.53037298 30:0.30137166 31:-1.0751276 32:0.034899134 33:0.29326963 34:0.06090232 35:-0.11565398 36:0.021296026 37:0.44529137 38:-0.70981979 39:-0.15477675 40:-1.3002903 41:-0.42334145 42:0.053204302 43:0.14373149 44:0.098878093 45:0.50184149 46:0.24694282 47:-0.10846069 48:0.045926113 49:-0.027187824 50:0.26369774 51:0.34348264 52:-0.14971417 53:-0.11164189 54:0.21436319 55:0.21167266 56:-0.033072136 57:0.056870934 58:-0.19191745 59:0.047568329 60:-0.08281666  |EV| 
-0.68507297428924385229720428469591  |BT| (ROOT (S (NP (NP (NNS (CONCLUSIONS)))(: (:))(NP (NP (NNP (Administration)))(PP (IN (of))(NP (JJ (oral))(NN (cholecalciferol))))(UCP (PP (TO (to))(NP (JJ (HIV-infected))(NNS (children))))(CC (and))(VP (VBG (adolescents))(PP (IN (at))(NP (NP (DT (a))(NN (dosage)))(PP (IN (of))(NP (CD (100,000))(NN (IU)))))))(NP (DT (every))(CD (2))(NNS (months)))(, (,))(ADVP (RB (together))(PP (IN (with))(NP (CD (1))(JJ (g/day))(NN (calcium)))))))(, (,)))(VP (VP (VBZ (is))(ADJP (JJ (safe))))(CC (and))(VP (VBZ (results))(PP (IN (in))(NP (NP (JJ (significant))(NNS (increases)))(PP (IN (in))(NP (JJ (serum))(JJ (25-hydroxyvitamin))(NNP (D))(NNS (concentrations))))))))(. (.)))) |ET|  |BV| 1:-0.76733154 2:0.2460794 3:-0.36372909 4:-0.26238525 5:-0.33067521 6:-0.33500141 7:-0.089534409 8:0.13414255 9:0.37700409 10:0.26008978 11:-0.075949982 12:-0.24670501 13:0.17961161 14:-0.15187471 15:-1.0580264 16:-0.25400683 17:-0.31937048 18:0.033552781 19:0.48308486 20:-0.69982004 21:-0.096292295 22:-1.555195 23:-0.98769671 24:0.35432729 25:0.84567106 26:-0.51499337 27:-0.18037847 28:-0.6457147 29:0.15408337 30:0.8962456 31:0.17549346 32:0.44203722 33:-0.59305567 34:0.53062898 35:-0.32494697 36:1.089808 37:-0.023833916 38:-0.084314443 39:1.4496329 40:-0.97434145 41:0.1874679 42:0.10865168 43:-0.2795662 44:0.30078739 45:0.18772158 46:0.43481719 47:-0.29426977 48:-0.29693085 49:-0.42093197 50:0.24895035 51:-0.0053882585 52:-0.17340101 53:0.35578895 54:0.094016381 55:0.16182128 56:-0.098656625 57:-0.0032122619 58:0.54385775 59:0.30633852 60:-0.044400193  |EV| 
0.8024737374108963372520975099178  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (PRP$ (Our))(NNS (results)))(VP (VBP (suggest))(SBAR (IN (that))(S (NP (NN (aspirin)))(VP (VP (VBZ (inhibits))(NP (NP (DT (the))(NN (proliferation)))(PP (IN (of))(NP (JJ (gemcitabine-resistant))(JJ (pancreatic))(NN (cancer))(NNS (cells))))))(CC (and))(VP (VBZ (augments))(NP (NP (DT (the))(JJ (antisurvival))(NN (effect)))(PP (IN (of))(NP (NN (gemcitabine))))))(, (,))(PP (ADVP (RB (probably)))(IN (by))(S (VP (VBG (suppressing))(NP (NP (DT (the))(NN (activity)))(PP (IN (of))(NP (NP (NNS (GSK-3beta)))(CC (and))(NP (PRP$ (its))(JJ (downstream))(NN (gene))(NNS (products))))))))))))))(. (.)))) |ET|  |BV| 1:-1.0761337 2:-0.72653055 3:-0.047030564 4:-0.095044218 5:0.87921143 6:0.14182645 7:0.56299537 8:0.30437505 9:0.050402731 10:0.29846507 11:-0.081354752 12:0.20232107 13:0.73375541 14:-0.26733202 15:-0.23603797 16:0.81133437 17:-0.32434905 18:-1.4542429 19:-0.4224728 20:-0.82956928 21:-0.45031631 22:0.15654109 23:-0.14055742 24:0.57517284 25:0.1998097 26:-0.003260914 27:-0.33045915 28:-0.79845482 29:0.2162341 30:-0.19117653 31:-0.26789901 32:0.13184972 33:0.5689823 34:-0.53675497 35:-0.25804719 36:0.65332514 37:-0.48971584 38:-0.86091042 39:0.14939134 40:-0.01000188 41:-0.096336924 42:-0.027791424 43:0.039164212 44:0.2517575 45:-0.13067243 46:-0.096702948 47:-0.49028218 48:0.26716644 49:0.2047739 50:0.40549722 51:0.10614941 52:0.43307978 53:0.20852001 54:-0.16296774 55:0.17101906 56:0.39294994 57:-0.20900437 58:-0.28422031 59:0.13200566 60:-0.072639398  |EV| 
0.8222438359212024261424289761635  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (S (NP (NNP (Nicotine)))(VP (VBZ (enhances))(NP (NP (DT (the))(NN (migration))(CC (and))(NN (invasion)))(PP (IN (of))(NP (DT (the))(JJ (esophageal))(NNS (squamous))(NN (carcinoma))(NN (cell))(NN (line)))))))(, (,))(CC (and))(S (NP (NN (nimesulide)))(ADVP (RB (partly)))(VP (VBZ (blocks))(NP (NP (DT (the))(NN (effect)))(PP (IN (of))(NP (NP (JJ (nicotine-enhanced))(ADJP (JJ (esophageal))(JJ (squamous)))(NN (carcinoma))(NN (cell))(NN (migration)))(CC (and))(NP (NN (invasion)))))))))(. (.)))) |ET|  |BV| 1:-0.31161079 2:-0.36281344 3:0.18907669 4:0.085704744 5:-0.025418209 6:-0.14755964 7:0.024619143 8:-0.21351071 9:1.1228068 10:0.1944949 11:0.71831656 12:-0.64764792 13:-0.3232435 14:-0.11913425 15:-0.39324352 16:1.1804386 17:0.10067534 18:0.44076952 19:-0.1683571 20:0.32567781 21:-0.60680348 22:-0.42775238 23:0.61553919 24:-0.26859996 25:1.1707163 26:1.5227534 27:0.65517157 28:0.37978908 29:1.1509615 30:-0.42484179 31:-1.1956306 32:0.5912714 33:0.2327998 34:0.30807802 35:-0.51293838 36:0.95876044 37:-0.11718958 38:-0.72043502 39:0.26086608 40:0.47095519 41:-0.091401286 42:-0.20811839 43:-0.23443471 44:-0.11267611 45:0.064704627 46:0.10087411 47:0.0054497705 48:-0.32332611 49:-0.13627668 50:0.78882611 51:0.446859 52:0.35039237 53:-0.16746172 54:-0.1468253 55:-0.084831379 56:0.073958255 57:-0.25757048 58:-0.23169948 59:0.27435941 60:0.025395276  |EV| 
0.84446248796458833751898964692373  |BT| (ROOT (S (NP (PRP (We)))(VP (VBP (propose))(SBAR (IN (that))(S (NP (NP (JJR (earlier))(NN (introduction)))(PP (IN (of))(NP (NN (rituximab)))))(VP (MD (may))(VP (VB (reduce))(S (NP (DT (the))(NN (side))(NNS (effects)))(ADJP (VBN (related))(PP (TO (to))(NP (NP (JJ (other))(JJ (cytotoxic))(NN (therapy)))(ADJP (RB (mainly))(JJ (steroids))(CC (and))(JJ (cyclophosphamide))))))))))))(. (.)))) |ET|  |BV| 1:-0.8092041 2:-0.19329149 3:-0.70447874 4:0.16662487 5:0.29772061 6:-0.64029855 7:-0.70728737 8:-0.16949117 9:-0.54650426 10:1.4144824 11:-0.060322113 12:0.17590384 13:-0.13637727 14:0.23657389 15:-0.57702953 16:1.4925574 17:0.57485455 18:-0.11306486 19:0.70975369 20:-1.2286081 21:-0.25624138 22:-0.26062015 23:0.16864459 24:0.1016928 25:0.09441454 26:0.40387216 27:0.81406814 28:-0.69259363 29:-0.25558886 30:0.54672831 31:-0.46322447 32:-0.027425131 33:-0.035071287 34:0.21702953 35:0.44882351 36:0.77333432 37:-0.46913329 38:-0.64461929 39:0.30856243 40:0.097931087 41:0.16633591 42:0.065021738 43:0.17110889 44:0.17646554 45:-0.091481015 46:-0.10278995 47:0.024598153 48:-0.5407055 49:-0.05047391 50:0.57116812 51:0.21961136 52:0.1560477 53:0.032716319 54:0.37944219 55:0.020566043 56:0.0012731787 57:0.014923286 58:0.22276877 59:0.27619025 60:-0.11370695  |EV| 
-1  |BT| (ROOT (S (NP (PRP (We)))(VP (VBD (showed))(SBAR (IN (that))(S (NP (NN (vanadium)))(VP (VP (VBZ (accelerates))(NP (NP (NN (transfer)))(PP (IN (of))(NP (NP (NP (DT (the))(JJ (tetracycline))(NN (resistance))(NN (gene))(NN (tet)))(PRN (-LRB- (-LRB-))(NP (NNP (M)))(-RRB- (-RRB-))))(PP (IN (from))(NP (NNP (Photobacterium)))))))(PP (TO (to))(NP (NNP (Escherichia))(NNS (coli)))))(, (,))(CC (and))(VP (VBD (found))(NP (NP (DT (a))(JJ (positive))(NN (correlation)))(PP (IN (between))(NP (NP (DT (the))(NN (concentration)))(PP (IN (of))(NP (NP (NP (NN (vanadium)))(PP (IN (in))(NP (JJ (natural))(JJ (marine))(NN (sediment)))))(CC (and))(NP (NP (DT (the))(NN (rate)))(PP (IN (of))(NP (JJ (oxytetracycline))(NN (resistance)))))))))))))))(. (.)))) |ET|  |BV| 1:-0.63782364 2:1.0624148 3:0.045017537 4:0.26631644 5:0.16656385 6:-0.44899556 7:0.61517125 8:-0.17606387 9:0.44340757 10:0.81548345 11:0.11764482 12:0.068545155 13:0.045241877 14:1.037433 15:0.19346681 16:-0.47470611 17:-0.16642 18:0.63013065 19:0.11350364 20:0.87358379 21:-1.0853487 22:1.5168384 23:-0.87191224 24:0.52222228 25:-0.30203065 26:-0.2098964 27:0.39682025 28:-0.28059399 29:0.22387348 30:0.59591073 31:0.61155295 32:1.9145528 33:-0.1840205 34:0.6337775 35:0.99932468 36:-0.02000815 37:-0.89096725 38:0.86428571 39:-0.0050041401 40:-0.17774805 41:-0.088618167 42:0.43587509 43:-0.039854843 44:-0.47982305 45:-0.53028309 46:-0.16205473 47:-0.07508745 48:-0.64378512 49:0.35403571 50:0.11403154 51:0.33243772 52:0.33273461 53:-0.21982794 54:0.081220709 55:0.45193362 56:0.24719366 57:0.17658286 58:-0.043427121 59:-0.31201085 60:0.37575802  |EV| 
-0.99936810556397992488797399346367  |BT| (ROOT (S (NP (NP (NNP (Pretreatment)))(PP (IN (of))(NP (NP (NNS (rats)))(PP (IN (with))(NP (NN (hexamethonium))(PRN (-LRB- (-LRB-))(NP (CD (20))(NN (mg/kg/day)))(-RRB- (-RRB-)))(S (VP (TO (to))(VP (VB (antagonize))(NP (JJ (peripheral))(JJ (nicotinic))(NNS (receptors)))(PP (IN (except))(PP (IN (for))(NP (NP (JJ (a7))(JJ (nicotinic))(NN (acetylcholine))(NN (receptor)))(PRN (-LRB- (-LRB-))(ADJP (JJ (a7-nAChR)))(-RRB- (-RRB-))))))))))))))(VP (VBD (had))(NP (NP (DT (no))(NN (effect)))(PP (IN (on))(NP (NP (DT (the))(NN (insulin))(VBG (sensitizing))(NN (effect)))(PP (IN (of))(NP (NN (nicotine))))))))(. (.)))) |ET|  |BV| 1:-0.6964218 2:0.36328217 3:0.839136 4:-0.91466933 5:-0.27204117 6:-0.37875962 7:0.44033417 8:0.29511434 9:0.8904736 10:-0.26710111 11:0.88625318 12:-0.29589823 13:0.97394598 14:-0.12877832 15:-0.10586167 16:0.56494546 17:0.2942304 18:0.2748687 19:0.5583688 20:-0.16265568 21:-0.31161079 22:-0.36281344 23:0.18907669 24:0.085704744 25:-0.025418209 26:-0.14755964 27:0.024619143 28:-0.21351071 29:1.1228068 30:0.1944949 31:0.71831656 32:-0.64764792 33:-0.3232435 34:-0.11913425 35:-0.39324352 36:1.1804386 37:0.10067534 38:0.44076952 39:-0.1683571 40:0.32567781 41:-0.42557269 42:-0.44162837 43:0.070636481 44:-0.14707261 45:0.4170531 46:0.21429317 47:-0.14757098 48:0.1515376 49:-0.73837423 50:0.67230415 51:0.044768557 52:-0.10559467 53:0.085499734 54:-0.0026796774 55:-0.25354201 56:0.13665839 57:-0.072767481 58:0.066548817 59:0.32274595 60:0.11894938  |EV| 
-0.98327272543691102146823368457262  |BT| (ROOT (S (NP (NP (NNP (Riboflavin)))(PRN (-LRB- (-LRB-))(NP (NN (vitamin))(NN (B2)))(-RRB- (-RRB-))))(VP (VBZ (is))(NP (NP (NP (DT (the))(JJ (universal))(NN (precursor)))(PP (IN (of))(NP (DT (the))(JJ (coenzymes))(NN (flavin))(NN (mononucleotide))(CC (and))(NN (flavin))(NN (adenine))(NN (dinucleotide)))))(: (--))(NP (NP (NNS (cofactors)))(SBAR (WHNP (WDT (that)))(S (VP (VBP (are))(ADJP (JJ (essential))(PP (IN (for))(NP (NP (DT (the))(NN (activity)))(PP (IN (of))(NP (NP (DT (a))(JJ (wide))(NN (variety)))(PP (IN (of))(NP (NP (JJ (metabolic))(NNS (enzymes)))(PP (IN (in))(NP (NNS (animals))(, (,))(NNS (plants))(, (,))(CC (and))(NNS (microbes)))))))))))))))))(. (.)))) |ET|  |BV| 1:-1.0573044 2:-0.64755392 3:1.2284371 4:-1.6444205 5:0.064398088 6:0.86615628 7:0.12283108 8:-0.15457146 9:1.1453032 10:-0.40508604 11:-0.60766441 12:-0.44789675 13:-0.3132579 14:0.41718528 15:-0.52481818 16:0.016087865 17:1.2331976 18:-0.25023434 19:0.42599061 20:-0.02892465 21:-0.98417938 22:0.41805446 23:0.35911784 24:-0.89342439 25:-0.28451303 26:-0.78242135 27:-0.58465123 28:0.97099948 29:0.19545634 30:-1.8243748 31:-0.0024916052 32:0.65486383 33:0.1811683 34:1.1890516 35:-0.096406184 36:-0.96060628 37:-0.53619105 38:-0.27410814 39:-0.029814117 40:-1.4676652 41:-0.42625639 42:-0.42338812 43:0.46504939 44:0.072148435 45:0.14118558 46:-0.0083054807 47:-0.13131417 48:-0.22267748 49:0.10933387 50:0.053466953 51:0.83714551 52:0.48635641 53:0.016989956 54:0.009752267 55:0.30446112 56:-0.10523754 57:-0.0068945372 58:-0.15791787 59:-0.25664511 60:0.41441447  |EV| 
0.87506073763690794820035989687312  |BT| (ROOT (S (PP (IN (On))(NP (DT (the))(JJ (other))(NN (hand))))(, (,))(NP (NP (CD (1))(NN (microM))(NN (cimetidine)))(PP (IN (at))(NP (DT (the))(JJ (basolateral))(NN (side)))))(VP (VP (ADVP (RB (moderately)))(VBD (decreased))(S (NP (NP (DT (the))(JJ (basolateral-to-apical))(NN (transport)))(PP (IN (of))(NP (NNP (-LSB-))(PRN (-LRB- (-LRB-))(NP (CD (14)))(-RRB- (-RRB-)))(NNP (C)))))(ADJP (RB (-RSB-))(JJ (metformin)))))(CC (and))(VP (ADVP (RB (significantly)))(VBD (increased))(NP (NP (DT (the))(NN (intracellular))(NN (accumulation)))(PP (IN (of))(NP (NNP (-LSB-))))(PRN (-LRB- (-LRB-))(NP (CD (14)))(-RRB- (-RRB-)))(NP (NP (NNP (C))(NNP (-RSB-)))(VP (VBN (metformin))(PP (IN (from))(NP (DT (the))(JJ (basolateral))(NN (side)))))))(, (,))(S (VP (VBG (suggesting))(SBAR (IN (that))(S (NP (NP (NN (cimetidine)))(PP (IN (at))(NP (DT (a))(JJ (low))(NN (concentration)))))(VP (VBZ (inhibits))(NP (NP (JJ (apical))(NNS (hMATE1)))(, (,))(CONJP (RB (rather))(IN (than)))(NP (JJ (basolateral))(NNS (hOCT2)))))))))))(. (.)))) |ET|  |BV| 1:-0.72917187 2:-0.43784007 3:0.11291414 4:-0.1686371 5:-0.028862542 6:-0.74388736 7:-0.63631111 8:-0.1496412 9:0.082612067 10:0.62254179 11:0.084620066 12:-0.22390963 13:0.23155889 14:0.69729364 15:-0.023859221 16:-0.039339174 17:-0.18612586 18:-0.67083597 19:0.021638148 20:-0.06030333 21:-0.68697548 22:0.0967035 23:-0.11480934 24:-0.28948942 25:-0.42214116 26:-0.340745 27:-0.036100358 28:-0.33836946 29:-0.2955496 30:0.42614302 31:-0.42998114 32:-0.20018318 33:0.0093365954 34:-0.58310562 35:0.081080563 36:-0.29948404 37:0.23485571 38:0.23559245 39:0.52771729 40:-0.37726155 41:-0.0075099412 42:-0.20610012 43:0.90185982 44:-0.5861463 45:0.01409817 46:-0.26846722 47:-0.126803 48:-0.39803523 49:-0.15482537 50:-0.037867222 51:0.35997832 52:-0.089244798 53:-0.16821414 54:-0.62669241 55:-0.044446278 56:-0.31414622 57:-0.26391244 58:0.3666639 59:0.30231008 60:0.15227282  |EV| 
0.85947298406393080050236221723026  |BT| (ROOT (S (ADVP (RB (Also)))(, (,))(S (NP (NN (starch)))(ADVP (RB (unexpectedly)))(VP (VBN (conditioned))(NP (DT (the))(JJR (stronger))(NN (flavor))(NN (preference)))(, (,))(SBAR (IN (although))(S (NP (DT (this)))(VP (MD (can))(VP (VB (be))(VP (VBN (explained))(PP (IN (by))(NP (NP (DT (the))(NN (differential))(NN (post-oral)))(VP (VBG (reinforcing))(NP (NP (NNS (actions)))(PP (IN (of))(NP (NN (starch))(CC (and))(NN (sucrose)))))))))))))))(, (,))(CC (and))(S (NP (NN (naltrexone)))(VP (VBD (blocked))(NP (NP (NP (DT (the))(NN (expression)))(, (,))(CONJP (CC (but))(RB (not)))(NP (DT (the))(NN (acquisition)))(, (,)))(PP (IN (of))(NP (DT (this))(NN (preference)))))))(. (.)))) |ET|  |BV| 1:-0.27463067 2:-0.91500187 3:-0.21062799 4:-0.80729401 5:0.75264245 6:-0.25265709 7:0.50812238 8:0.20771764 9:0.71180749 10:0.92224193 11:0.66304022 12:0.29768577 13:0.93442696 14:-0.63969117 15:-0.16151166 16:0.83217007 17:-0.069254249 18:-0.27093816 19:0.50270307 20:-0.37011161 21:-0.93499321 22:-0.84000343 23:-0.41635552 24:-0.38887846 25:-0.25315806 26:-0.15392397 27:0.025107415 28:0.56973457 29:0.38532907 30:0.37857184 31:0.66472489 32:0.96014047 33:0.74786615 34:-0.18957825 35:-0.72223562 36:-0.079844475 37:-0.32539806 38:0.89657247 39:0.50971693 40:0.36139879 41:-0.51399136 42:-0.17479488 43:0.0458887 44:-0.04103617 45:0.30380768 46:0.36483827 47:-0.33177465 48:0.13461648 49:0.2719641 50:0.43453917 51:0.57531822 52:0.20079257 53:-0.14913259 54:-0.42960742 55:0.21288674 56:0.44449803 57:0.19205268 58:-0.0029294007 59:-0.46648878 60:0.070295535  |EV| 
0.83747952952967219530933107307646  |BT| (ROOT (S (S (NP (DT (This))(NN (study)))(VP (VBZ (suggests))(SBAR (IN (that))(S (NP (DT (the))(JJ (haloperidol-induced))(JJ (interoceptive))(NN (drug))(NN (state)))(VP (VBZ (is))(ADJP (RB (directly))(VBN (involved))(PP (IN (in))(NP (PRP$ (its))(JJ (antiavoidance))(NN (action))))))))))(, (,))(CC (and))(S (NP (NN (chlordiazepoxide)))(VP (MD (may))(VP (VB (attenuate))(NP (NP (DT (the))(JJ (antiavoidance))(NN (efficacy)))(PP (IN (of))(NP (NP (NNS (antipsychotics)))(PRN (-LRB- (-LRB-))(ADJP (RB (especially))(JJ (olanzapine)))(-RRB- (-RRB-)))))))))(. (.)))) |ET|  |BV| 1:0.13194823 2:0.34916896 3:-0.7530095 4:-0.43338528 5:0.26798153 6:1.1201754 7:0.013825226 8:-0.61208022 9:0.21881662 10:0.5256815 11:0.8308621 12:1.0212096 13:0.50689417 14:0.013927326 15:-0.75837433 16:-0.09899047 17:0.54053074 18:-0.78683519 19:0.3812432 20:0.087259933 21:-1.1399069 22:-0.051731899 23:-1.3472413 24:-0.11247903 25:0.35895267 26:-0.78500241 27:-1.8944215 28:0.49661213 29:1.8387921 30:0.36294636 31:-0.65767848 32:0.029336948 33:0.013183736 34:0.34426984 35:-0.32096601 36:-0.17584008 37:0.018173909 38:0.39964738 39:0.34451035 40:0.53582203 41:0.3678374 42:-0.13182457 43:-0.058484748 44:-0.61339414 45:0.31494701 46:0.1335351 47:-0.081001848 48:0.12900026 49:0.11893929 50:0.61827773 51:-0.32562399 52:-0.058520108 53:-0.0079880757 54:0.026817579 55:0.30697981 56:0.39717978 57:-0.047811665 58:-0.16747265 59:0.13505782 60:0.18526416  |EV| 
-0.7051337229970076059260009060381  |BT| (ROOT (S (NP (PRP (They)))(VP (VBP (have))(ADVP (RB (also)))(VP (VBN (been))(VP (VBN (shown))(S (VP (TO (to))(VP (VB (reduce))(NP (NP (NN (alcohol))(NN (consumption)))(, (,))(NP (NP (JJ (suppress))(NN (reward)))(VP (VBN (induced))(PP (IN (by))(NP (NN (alcohol))(, (,))(NN (cocaine))(CC (and))(NN (amphetamine)))))))))))))(. (.)))) |ET|  |BV| 1:0.04645972 2:-0.243412 3:-0.12847507 4:-0.020735495 5:0.046708986 6:-0.63118833 7:-0.37865597 8:-0.77093482 9:0.74587637 10:-0.46059707 11:0.0066282842 12:-0.22267382 13:-0.17692463 14:-0.36518228 15:-0.20190102 16:0.29322821 17:-0.080923498 18:-0.18870497 19:0.15922587 20:0.54918379 21:-0.51009583 22:-0.56838346 23:0.018959643 24:-0.80733913 25:-0.028113127 26:-0.51623201 27:0.14834246 28:-0.50347131 29:0.91042084 30:0.16682194 31:0.37457371 32:-0.095307551 33:0.23110786 34:-0.50809145 35:-0.5548557 36:-0.40123346 37:0.65094382 38:-0.02916215 39:0.42906675 40:1.1775618 41:-0.26822233 42:-0.45637035 43:0.31215826 44:-0.10864807 45:0.9119668 46:-0.066393852 47:0.044901386 48:-0.31448659 49:0.058841076 50:0.068024352 51:0.24292949 52:0.14088732 53:-0.11221211 54:-0.21386984 55:0.20427245 56:0.12289384 57:0.57200038 58:-0.11666305 59:0.16181985 60:0.30399641  |EV| 
-0.62584677435225732899937156616943  |BT| (ROOT (FRAG (NP (NNP (CONCLUSIONS)))(: (:))(S (NP (NP (JJ (Mucosal))(NN (injury)))(PP (IN (with))(NP (JJ (diclofenac-K))(JJ (liquid))(CD (25))(NN (mg))(JJ (liquid))(NNS (capsules)))))(VP (VP (VBD (was))(ADJP (JJ (similar))(S (VP (TO (to))(VP (VB (diclofenac-K))(NP (NP (CD (25))(NN (mg))(NNS (tablets)))(, (,))(NP (ADJP (ADJP (RB (significantly))(JJR (lower)))(PP (IN (than))(NP (NNP (ASA))(CD (1)))))(NN (g))(NNS (tablets)))))))))(CC (and))(VP (VBD (showed))(NP (DT (some))(NN (superiority)))(PP (IN (over))(NP (NP (JJ (ibuprofen))(ADJP (NP (CD (400))(NNS (mg)))(JJ (liquid)))(NNS (capsules)))(PRN (-LRB- (-LRB-))(NP (NNP (EudraCT))(NNP (Number))(NNP (2009-011278-14)))(-RRB- (-RRB-))))))))(. (.)))) |ET|  |BV| 1:0.20548551 2:-0.35148144 3:-0.40011621 4:0.40772349 5:0.97159827 6:0.96807027 7:0.39033049 8:0.26300904 9:-0.043818988 10:0.9472447 11:0.0028803297 12:0.20844343 13:0.25706103 14:-0.13688749 15:-1.4772656 16:0.59102124 17:-0.74126548 18:-0.33666137 19:1.1327502 20:-0.02149684 21:0.24906121 22:-0.99049872 23:-0.41239464 24:-0.044612978 25:0.39299873 26:0.28446469 27:0.38468862 28:-0.28248656 29:0.67045301 30:0.52617681 31:-0.2217478 32:0.2344217 33:-0.71098858 34:-0.73123658 35:-0.32787028 36:0.053887159 37:0.38661277 38:0.071346872 39:0.66734159 40:0.38040379 41:0.059913151 42:0.26468921 43:-0.20027205 44:-0.24251381 45:0.032195982 46:-0.070126399 47:-0.061050329 48:-0.45855877 49:0.079036959 50:-0.20999974 51:0.60368371 52:-0.11027312 53:0.2444479 54:0.19429779 55:0.17067111 56:-0.2064845 57:-0.10443541 58:-0.25243422 59:-0.22681965 60:0.63085324  |EV| 
-0.64815774957308081027917978644837  |BT| (ROOT (S (PP (IN (In))(NP (NN (contrast))))(, (,))(NP (DT (the))(JJ (chromogenic))(NN (antifactor))(NN (Xa)))(ADVP (RB (assay)))(VP (VBD (proved))(S (VP (TO (to))(VP (VB (be))(ADJP (JJ (sensitive))(PP (TO (to))(NP (NP (JJR (lower))(NNS (amounts)))(PP (IN (of))(NP (NN (rivaroxaban))(CC (and))(NN (apixaban)))))))(PP (IN (with))(NP (JJR (less))(NN (variability))))))))(. (.)))) |ET|  |BV| 1:-0.63687938 2:-0.82367885 3:-0.065637842 4:-0.35780254 5:0.60219276 6:-0.13255666 7:-0.33090624 8:-0.14652449 9:0.76032281 10:0.47847584 11:0.054607507 12:1.1422564 13:0.020491388 14:-1.2595913 15:-0.39662492 16:0.89241385 17:-1.4477484 18:0.89069349 19:-0.64151692 20:-0.78322566 21:-1.0708463 22:-1.0190002 23:-0.37221909 24:-0.79612762 25:1.1188668 26:0.86109793 27:0.14011246 28:-0.33982381 29:0.23061365 30:0.8240155 31:-0.16274263 32:1.4762937 33:-0.018853454 34:-1.4313775 35:-0.30922985 36:0.23932619 37:-1.4855354 38:1.1207211 39:-0.090681009 40:-0.46252665 41:-0.41603047 42:-0.15366942 43:-0.039533544 44:0.25971389 45:0.083582051 46:0.2283562 47:0.25811633 48:0.053701136 49:-0.2005575 50:0.1264745 51:0.0032630756 52:0.190842 53:0.23908348 54:-0.37939921 55:-0.12541832 56:0.29845008 57:0.36831132 58:-0.0091973199 59:-0.048603486 60:0.59633225  |EV| 
1  |BT| (ROOT (S (NP (NNP (Dexrazoxane)))(VP (VBZ (is))(NP (NP (DT (a))(NN (cardioprotectant)))(SBAR (WHNP (WDT (that)))(S (ADVP (RB (significantly)))(VP (VBZ (reduces))(NP (NP (DT (the))(NN (incidence)))(PP (IN (of))(NP (NP (JJ (adverse))(JJ (cardiac))(NNS (events)))(PP (IN (in))(NP (NP (NNS (women)))(PP (IN (with))(NP (NP (JJ (advanced))(NN (breast))(NN (cancer)))(VP (VBN (treated))(PP (IN (with))(NP (JJ (doxorubicin-containing))(NNS (regimens)))))))))))))))))(. (.)))) |ET|  |BV| 1:-0.1789027 2:-0.41120195 3:-0.25580734 4:-0.22398032 5:-0.27193514 6:-0.1810323 7:0.51285189 8:-0.62322861 9:0.047982849 10:0.37694168 11:-0.20004165 12:-0.14829116 13:0.25701633 14:0.23248774 15:0.10704896 16:-0.29212648 17:-0.10906627 18:-1.2593999 19:-0.37454131 20:0.28424814 21:-1.4529216 22:0.61657375 23:-0.59227073 24:-0.75131005 25:0.73869932 26:0.0021804129 27:-0.47875696 28:-0.68373328 29:-0.24201699 30:-0.20682798 31:-0.013879195 32:0.44672984 33:0.59701431 34:-0.16675036 35:-0.66908795 36:1.002424 37:-0.17960155 38:0.2225728 39:-0.67672402 40:-0.38899297 41:-0.27464476 42:0.21355717 43:0.068614274 44:0.40517893 45:-0.067771442 46:0.0458951 47:-0.24671526 48:-0.44378817 49:0.21875574 50:-0.095017873 51:0.24357021 52:0.35755214 53:-0.053961013 54:0.16573529 55:-0.1684579 56:-0.20387162 57:0.77704012 58:-0.16534935 59:0.28079897 60:-0.25592068  |EV| 
0.70393879967642869477373324116343  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(S (NP (NNP (Diosmin)))(VP (VP (VBZ (inhibits))(NP (JJ (platelet))(NN (aggregation))))(CC (and))(VP (VBZ (prolongs))(NP (NP (DT (the))(NN (effect)))(PP (IN (of))(NP (NN (norepinephrine)))))(PP (IN (on))(NP (JJ (venous))(NN (tone)))))(, (,))(S (VP (VBG (leading))(PP (TO (to))(NP (VBN (increased))(NN (venoconstriction))))))))(. (.)))) |ET|  |BV| 1:-1.0374453 2:0.85880065 3:-0.24367349 4:-1.0123558 5:0.14853026 6:0.064390242 7:0.82503897 8:0.057420235 9:0.23259422 10:0.22073723 11:0.8552382 12:-0.631019 13:0.38975126 14:-0.6101191 15:0.14520936 16:0.39410061 17:-0.23449533 18:0.13932607 19:0.37582126 20:-0.08262825 21:-0.84905618 22:-0.38242501 23:-1.3305421 24:0.063795418 25:-0.48764706 26:-1.2378488 27:-0.37567493 28:0.32431534 29:-0.47060958 30:-0.091480948 31:-0.42965943 32:0.20810635 33:0.77424395 34:0.49745879 35:0.91372198 36:1.9166695 37:0.79609305 38:1.2478442 39:0.84441906 40:0.12838127 41:-0.1270657 42:0.19763693 43:0.054239631 44:-0.054814838 45:-0.1175506 46:-0.25290683 47:-0.26520777 48:-0.073643744 49:-0.03985028 50:0.2937369 51:0.34242412 52:-0.2447518 53:-0.12332889 54:-0.29979074 55:-0.047245692 56:0.25683197 57:0.55559826 58:-0.037195664 59:0.36413044 60:0.10089979  |EV| 
0.68745394410435478604881609498989  |BT| (ROOT (S (NP (NP (DT (An))(NN (increase)))(PP (IN (in))(NP (NP (DT (the))(NN (dose)))(PP (IN (of))(NP (NN (quinine)))))))(VP (MD (may))(VP (VB (be))(ADJP (JJ (necessary)))(SBAR (WHADVP (WRB (when)))(S (NP (DT (the))(NN (drug)))(VP (VBZ (is))(ADJP (JJ (co-administered))(PP (IN (with))(NP (NN (nevirapine))))))))))(. (.)))) |ET|  |BV| 1:0.57349074 2:-0.62114441 3:0.1373312 4:-0.73294896 5:0.9415558 6:0.42877951 7:-0.40418941 8:1.1755209 9:0.16499816 10:-0.062251404 11:-0.092863604 12:-0.43411082 13:0.85699159 14:-0.18656024 15:-1.3612603 16:1.4078653 17:-0.13748874 18:-0.29962924 19:1.3479723 20:0.8356809 21:0.069912061 22:-0.10778003 23:-0.88023275 24:0.29654455 25:-0.059729181 26:-0.49629134 27:0.47862133 28:0.022943072 29:0.58010441 30:0.01228845 31:-0.18734775 32:-0.036213595 33:-0.25611776 34:-0.91316807 35:-0.33024159 36:-0.21044041 37:0.23369637 38:0.029738568 39:0.29810676 40:-0.48655638 41:-0.3004795 42:0.39136875 43:0.30683371 44:-0.019175682 45:0.057783317 46:-0.13880754 47:0.31635532 48:-0.2154997 49:-0.58690673 50:0.26825139 51:-0.043800626 52:-0.09825433 53:0.36857939 54:-0.060938723 55:-0.066977113 56:-0.02944928 57:-0.16560057 58:0.32706708 59:0.2795074 60:0.20782381  |EV| 
-0.7025112823401779005294542912452  |BT| (ROOT (S (S (NP (NP (NNS (Analogues)))(PP (IN (with))(NP (JJ (9-deazaguanine))(NN (aglycone)))))(VP (VBP (have))(NP (NP (JJR (better))(NN (anti-leukaemic))(CC (and))(NN (anti-lymphoma))(NNS (activities)))(PP (VBN (compared))(PP (TO (to))(NP (DT (the))(NN (guanine))(CC (and))(NN (hypoxanthine))(NNS (analogues))))))))(, (,))(CC (and))(S (S (VP (VBN (applied))(PP (IN (in))(NP (NP (DT (the))(NN (concentration)))(PP (IN (of))(NP (NP (CD (100))(NN (mum)))(, (,))(VP (VBN (caused))(NP (NP (DT (a))(ADJP (RB (statistically))(JJ (significant)))(NN (decrease)))(PP (IN (in))(NP (DT (the))(NN (cell))(NN (viability)))))(PP (IN (in))(NP (NP (DT (all))(JJ (human))(NN (leukaemia)))(CC (and))(NP (NN (lymphoma))(NNS (cells))))))))))))(VP (VBD (used))))(. (.)))) |ET|  |BV| 1:-0.89806104 2:-0.88740349 3:0.6684531 4:-0.72632658 5:-1.6517493 6:-0.36108562 7:0.26906854 8:1.6386491 9:0.22852036 10:0.079020485 11:0.19047874 12:0.77491361 13:0.37403876 14:0.77928269 15:-0.82996875 16:0.47676581 17:-0.69418496 18:0.11014714 19:-0.58469981 20:-0.93877232 21:-0.50943935 22:-0.73875523 23:0.061298322 24:-0.25966427 25:-0.96637291 26:-1.0542109 27:0.51872665 28:1.7673639 29:0.42409813 30:-0.25641692 31:-0.3561087 32:1.2766526 33:0.54846913 34:0.23720847 35:-1.082846 36:0.2394647 37:-1.0329642 38:0.35627651 39:-0.28181463 40:-0.57772297 41:-0.22328578 42:0.23710315 43:0.085840218 44:0.056551639 45:-0.14368555 46:0.042310908 47:-0.042670321 48:0.059921462 49:0.045837134 50:0.48710594 51:0.46052864 52:0.1620905 53:0.089402355 54:-0.18688795 55:-0.29084203 56:0.16001715 57:0.19617473 58:0.10502163 59:0.12059479 60:0.73291677  |EV| 
-0.76103387669141109306281123281224  |BT| (ROOT (S (ADVP (RB (Secondly)))(, (,))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (NP (NP (JJ (targeted))(NN (therapy))(NNS (drugs)))(PP (JJ (such))(IN (as))(NP (NNP (Cetuximab))(CC (and))(NNP (Erlotinib)))))(, (,))(CC (or))(NP (NP (NN (non)))(: (-))(NP (NP (JJ (targeted))(NNS (agents)))(PP (JJ (such))(IN (as))(NP (NN (temozolomide))(CC (and))(NN (nitrosourea)))))))))(VP (VBZ (has))(VP (VBN (been))(VP (VBN (influenced))(PP (IN (by))(NP (NP (DT (the))(NN (presence)))(PP (IN (of))(NP (JJ (certain))(JJ (genetic))(CC (or))(JJ (epigenetic))(NNS (markers))))))(PP (IN (in))(NP (NNS (tumors)))))))(. (.)))) |ET|  |BV| 1:-0.69214302 2:0.21240491 3:0.0008037737 4:0.36204693 5:-0.15223251 6:-0.30088231 7:1.2508336 8:0.25733453 9:1.3072095 10:0.98745745 11:-0.83434856 12:0.40237793 13:-0.078595594 14:0.077269964 15:-0.65975505 16:1.6260929 17:-0.99955791 18:-0.53161037 19:1.0515879 20:-0.45317563 21:-0.28991279 22:0.37629354 23:0.42804348 24:-0.22335902 25:0.28749895 26:0.58985078 27:0.8052637 28:-0.19434102 29:1.3410344 30:0.66071439 31:0.48423976 32:0.22147802 33:0.35671246 34:-0.28302619 35:-0.63071799 36:1.5842505 37:-0.47079864 38:0.025771931 39:0.47316387 40:-1.2745491 41:0.13066009 42:0.11461355 43:-0.24673337 44:0.24634486 45:-0.16579489 46:-0.27172568 47:-0.09005148 48:-0.12256122 49:0.24209523 50:0.43269047 51:0.70043033 52:0.32129848 53:0.21017855 54:0.32587168 55:0.043249562 56:0.20948215 57:0.20467678 58:0.41391915 59:0.24450508 60:0.2613984  |EV| 
-0.68194643871730076245540885793162  |BT| (ROOT (S (ADVP (RB (Recently)))(NP (PRP (it)))(VP (VBZ (has))(VP (VBN (been))(VP (VBN (demonstrated))(SBAR (IN (that))(S (NP (NP (NNS (mutations)))(PP (IN (in))(NP (NNP (KRAS)))))(VP (VBP (predict))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (NN (panitumumab))(CC (and))(NN (cetuximab)))))(, (,))(S (VP (VP (VBG (limiting))(NP (PRP$ (their))(NN (use))(S (VP (TO (to))(VP (VB (CRC))(NP (NNS (patients)))(PP (IN (with))(NP (JJ (wild-type))(NNS (KRAS)))))))))(, (,))(CC (and))(VP (VBG (moving))(NP (NP (DT (the))(JJ (clinical))(NN (field)))(PP (IN (towards))(NP (VBN (personalized))(NN (cancer))(NN (care))))))))))))))(. (.)))) |ET|  |BV| 1:0.60125124 2:-0.76545882 3:1.1888238 4:0.45946464 5:0.6342001 6:-0.044119511 7:0.73391873 8:0.13165164 9:0.66971922 10:0.8942911 11:-0.68757224 12:0.64582759 13:0.27450234 14:1.3237469 15:-0.39306837 16:0.21697031 17:-0.37259692 18:-0.66445273 19:0.44825962 20:-0.88031834 21:-0.28161815 22:-0.68261337 23:0.44740391 24:0.2930876 25:0.58377028 26:0.37423158 27:0.70943683 28:-0.085498527 29:0.86710089 30:0.58071637 31:0.063820101 32:-0.0067333668 33:0.26994082 34:0.39133662 35:-0.33628094 36:1.5841424 37:-0.76286179 38:-0.42525661 39:-0.71097696 40:-0.94073945 41:0.17530411 42:-0.14159285 43:0.10548896 44:-0.18714178 45:-0.094075002 46:-0.13974254 47:0.095271334 48:-0.31400967 49:0.37932444 50:0.38600287 51:0.097688533 52:0.08405342 53:-0.035385132 54:0.40623608 55:0.017745996 56:0.10302187 57:-0.046429336 58:0.41667458 59:-0.062408935 60:0.13697022  |EV| 
0.65473347853803254281501722289249  |BT| (ROOT (S (S (VP (VBG (Using))(NP (JJ (zebrafish))(NNS (embryos)))(PP (IN (as))(NP (DT (the))(NN (model))))))(, (,))(NP (PRP (we)))(VP (VBP (demonstrate))(SBAR (IN (that))(S (NP (NN (morphine)))(VP (VBZ (decreases))(NP (JJ (miR-133b))(NN (expression))))))(, (,))(S (ADVP (RB (hence)))(VP (VBG (increasing))(NP (NP (DT (the))(NN (expression)))(PP (IN (of))(NP (NP (PRP$ (its))(NN (target)))(, (,))(NP (NNS (Pitx3)))(, (,)))))(NP (NP (DT (a))(NN (transcription))(NN (factor)))(SBAR (WHNP (WDT (that)))(S (VP (VBZ (activates))(NP (JJ (tyrosine))(ADJP (JJ (hydroxylase))(CC (and))(JJ (dopamine)))(NN (transporter))))))))))(. (.)))) |ET|  |BV| 1:-0.45263946 2:-0.44811127 3:-0.4024395 4:-0.35953194 5:0.29140186 6:-0.31026688 7:-0.16002285 8:0.027013453 9:0.46951276 10:0.70688903 11:0.51139504 12:-0.31645745 13:0.28384194 14:-0.14880067 15:-0.087615728 16:-0.37213057 17:0.33573028 18:0.14914471 19:-0.2827695 20:0.36941594 21:-0.52288628 22:0.064634569 23:0.43291721 24:-0.5993492 25:0.067319103 26:-0.54065132 27:0.75569421 28:0.22499478 29:0.7509374 30:0.50299102 31:0.66871351 32:-0.46396655 33:0.70376694 34:0.35963044 35:0.027474603 36:0.40848967 37:0.32412928 38:-0.051923949 39:0.47423962 40:0.30214891 41:-0.22579339 42:-0.30025807 43:0.11974526 44:-0.12639363 45:0.49724901 46:0.10903224 47:0.39655098 48:-0.30314425 49:-0.09243574 50:0.25542712 51:0.6907146 52:-0.038867123 53:0.21896365 54:-0.53824127 55:-0.26528144 56:0.077603109 57:0.20276619 58:-0.087801449 59:0.062777109 60:-0.10763332  |EV| 
0.58331293304953724110362145438557  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(S (NP (NNP (Genistein)))(VP (MD (can))(VP (VP (VB (reduce))(NP (NP (DT (the))(NN (expression)))(PP (IN (of))(NP (NNS (TGF-beta1))))))(CC (and))(VP (VB (block))(NP (NP (DT (the))(NN (accumulation)))(PP (IN (of))(NP (NP (NN (intracellular))(JJ (free))(NN (calcium)))(VP (VBN (induced))(PP (IN (by))(NP (NN (growth))(NNS (factors))))))))))))(. (.)))) |ET|  |BV| 1:-0.76733154 2:0.2460794 3:-0.36372909 4:-0.26238525 5:-0.33067521 6:-0.33500141 7:-0.089534409 8:0.13414255 9:0.37700409 10:0.26008978 11:-0.075949982 12:-0.24670501 13:0.17961161 14:-0.15187471 15:-1.0580264 16:-0.25400683 17:-0.31937048 18:0.033552781 19:0.48308486 20:-0.69982004 21:-0.88100749 22:-0.82609057 23:-1.0307251 24:-0.55634868 25:-0.26797688 26:-0.3145192 27:0.50074118 28:0.95685005 29:-1.1553111 30:0.057921607 31:0.56989318 32:-0.15794641 33:1.2393218 34:0.034051262 35:0.38033518 36:1.0104743 37:0.24098912 38:-0.43851969 39:0.26584595 40:-0.64438432 41:0.16321167 42:-0.28958035 43:-0.059644565 44:0.0074298442 45:0.30851322 46:-0.50210363 47:-0.029710406 48:-0.0061491807 49:-0.08498773 50:0.258744 51:-0.31173491 52:-0.29327375 53:-0.031276263 54:0.016536172 55:-0.088501006 56:0.29832447 57:0.66238058 58:0.039773043 59:-0.022565685 60:0.2259912  |EV| 
0.41220809884475839712791866986663  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(S (NP (JJ (Chronic))(JJ (low-dose))(JJ (oral))(NN (amiodarone)))(VP (VBZ (attenuates))(NP (NP (DT (the))(JJ (proarrhythmic))(NNS (effects)))(PP (IN (of))(NP (NN (dobutamine)))))(, (,))(S (VP (VBG (increasing))(NP (NP (DT (the))(NN (safety)))(PP (IN (of))(NP (JJ (ambulatory))(NNP (IDI)))))))))(. (.)))) |ET|  |BV| 1:0.60882604 2:-0.23329782 3:-1.6974742 4:-0.35691172 5:-0.29879364 6:-0.13806401 7:0.25545862 8:-0.36142683 9:0.17044505 10:-0.5944435 11:0.24077468 12:-0.20301823 13:0.18099 14:-0.18655179 15:0.019401098 16:0.23374529 17:-0.54920375 18:-0.50025564 19:-1.1375816 20:0.18487531 21:-0.16469966 22:0.022516429 23:-0.73193413 24:0.045193154 25:0.4222194 26:0.036796849 27:0.2352435 28:-0.27031907 29:0.41419598 30:0.20313478 31:-0.29296407 32:-0.33279586 33:0.23716505 34:-0.20832293 35:-0.14375141 36:-0.043305229 37:-0.10976048 38:-0.43185729 39:0.685583 40:0.18347895 41:-0.36709806 42:0.08908315 43:0.1374606 44:0.21745056 45:-0.037434354 46:0.24936189 47:0.43517515 48:-0.45619708 49:-0.12915017 50:-0.17014076 51:0.11554941 52:-0.18325271 53:-0.090026043 54:0.06297379 55:0.010368944 56:0.07810808 57:0.39527619 58:0.00020494645 59:0.27816376 60:-0.25906739  |EV| 
-0.70409872699550768437859460391337  |BT| (ROOT (FRAG (NP (NNP (BACKGROUND)))(: (:))(S (PP (JJ (Due))(TO (to))(NP (NP (DT (the))(JJ (limited))(NNS (data)))(ADJP (JJ (available))(PP (IN (in))(NP (NN (literature)))))))(, (,))(NP (NP (DT (the))(NN (aim)))(PP (IN (of))(NP (DT (this))(JJ (multi-centre))(NN (study)))))(VP (VBD (was))(S (VP (TO (to))(ADVP (RB (prospectively)))(VP (VB (compare))(PP (IN (in))(NP (JJ (thalassemia))(JJ (major))(PRN (-LRB- (-LRB-))(NP (NNP (TM)))(-RRB- (-RRB-)))(NNS (patients))))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (NP (NP (VBN (combined))(NN (deferiprone)))(PRN (-LRB- (-LRB-))(NP (NNP (DFP)))(-RRB- (-RRB-))))(CC (and))(NP (NP (JJ (deferoxamine))(PRN (-LRB- (-LRB-))(NP (NNP (DFO)))(-RRB- (-RRB-)))(NN (regimen)))(PP (IN (versus))(NP (DT (either))(NNP (DFP))(CC (and))(NNP (DFO))))(PP (IN (in))(NP (NN (monotherapy)))))))))))(PP (IN (by))(NP (NP (NP (JJ (cardiovascular))(JJ (magnetic))(NN (resonance)))(PRN (-LRB- (-LRB-))(NP (NNP (CMR)))(-RRB- (-RRB-))))(PP (IN (over))(NP (NP (DT (a))(VBG (follow))(RP (up)))(PP (IN (of))(NP (CD (18))(NNS (months))))))))))(. (.)))) |ET|  |BV| 1:-0.59635317 2:-0.73754424 3:-0.22736442 4:-0.18584974 5:0.40085682 6:-0.26287535 7:0.23012421 8:-0.55766994 9:-0.70827299 10:0.7536903 11:-0.59109914 12:0.4312039 13:-0.069738187 14:-0.2155562 15:0.36373171 16:0.44060203 17:-0.78674418 18:-0.53757834 19:0.086989902 20:-0.66096216 21:-0.29204905 22:-0.77387869 23:-0.23356922 24:-0.8799926 25:0.30062583 26:0.50936383 27:0.74580115 28:-0.86730087 29:0.00043346902 30:0.56914258 31:0.090854265 32:0.19427791 33:-0.84593165 34:0.0020033068 35:0.53567261 36:0.33451828 37:-1.2774867 38:-1.3302456 39:-0.56758267 40:-1.3697481 41:0.27192444 42:-0.34477407 43:-0.036144745 44:-0.028823452 45:0.33378315 46:-0.21708131 47:-0.26402315 48:-0.14676255 49:0.25586542 50:-0.099953227 51:0.40094534 52:-0.033874787 53:-0.27203816 54:0.64172727 55:-0.12642813 56:-0.11062916 57:0.36570272 58:0.18812627 59:0.40082106 60:-0.53635865  |EV| 
-0.45064243619206012514410986113944  |BT| (ROOT (S (NP (NP (NP (JJ (Specific))(NNS (activities)))(PP (IN (of))(NP (NNP (SOD))(, (,))(NNP (CAT))(, (,))(NNP (GPX))(, (,))(NNP (GR))(CC (and))(NNP (GST)))))(CC (and))(NP (NP (NN (serum)))(ADJP (JJ (testosterone))(CC (and))(JJ (progesterone)))))(VP (VBD (were))(VP (ADVP (RB (significantly)))(VBN (decreased))(, (,))(SBAR (IN (while))(S (NP (NNP (H2O2))(, (,))(NNP (LPO))(CC (and))(NNP (serum)))(ADVP (RB (FSH)))(VP (VBD (was))(VP (VBN (increased))(PP (IN (in))(NP (NP (JJ (50-parts)))(PP (IN (per))(NP (NP (CD (million))(-LRB- (-LRB-))(NN (ppm))(-RRB- (-RRB-)))(CC (and))(NP (CD (200))(JJ (ppm-treated))(NNS (rats)))))))(PP (IN (in))(NP (DT (an))(JJ (age-dependent))(NN (manner))))))))))(. (.)))) |ET|  |BV| 1:-0.21002722 2:0.69389272 3:0.5572148 4:0.14590901 5:-0.43242931 6:-0.65587527 7:0.2527782 8:-0.98675036 9:-0.13765194 10:0.4820973 11:0.71145684 12:0.001813069 13:-0.090216413 14:0.2304763 15:0.26433235 16:0.22392234 17:-0.078052655 18:0.13959673 19:0.5426532 20:0.34579405 21:-0.70291984 22:0.10596521 23:0.40353924 24:-0.0082024643 25:0.51516557 26:-0.4248296 27:0.15003122 28:0.1239915 29:0.20275137 30:0.48732561 31:0.47781709 32:-0.14894189 33:0.51152009 34:0.33163288 35:-0.5908134 36:0.57499492 37:0.029747412 38:0.11391607 39:0.40241897 40:0.6374259 41:-0.73575509 42:-0.52072817 43:-0.13551107 44:0.11380048 45:-0.024229728 46:-0.10147609 47:-0.16631822 48:0.051990826 49:0.03252105 50:-0.049800087 51:0.85123843 52:-0.25786796 53:0.12621595 54:-0.91563308 55:0.082193032 56:-0.070582598 57:0.38757965 58:-0.040254798 59:0.1011998 60:0.10898614  |EV| 
-0.33499163529702419284106440500182  |BT| (ROOT (S (NP (NP (NNP (Ribavirin)))(CC (and))(NP (JJ (6-aza-uridine))))(VP (VBD (were))(ADJP (JJ (able))(S (VP (TO (to))(VP (VP (VB (delay)))(CC (but))(RB (not))(VP (VB (prevent))(NP (JJ (NiV-induced))(NN (mortality)))(PP (IN (in))(NP (NNS (hamsters))))))))))(. (.)))) |ET|  |BV| 1:-0.16825023 2:-0.17732142 3:-0.11057193 4:0.47006825 5:0.55146331 6:-0.91474909 7:-0.12150086 8:-0.21713793 9:-0.14340106 10:0.15220863 11:-0.67543906 12:-0.43896741 13:-0.13286592 14:1.2378125 15:-1.2088124 16:0.45170078 17:-0.13367461 18:-1.0689738 19:0.24465796 20:0.28939125 21:-1.1302648 22:-0.87816238 23:0.87777019 24:0.91256285 25:-0.11664556 26:-0.26310652 27:1.294224 28:1.330219 29:0.36540097 30:-0.17028299 31:-1.0839082 32:0.46411005 33:-0.57737273 34:1.5671377 35:0.009030412 36:0.50075418 37:0.95782429 38:1.1311728 39:0.68107182 40:0.7444005 41:0.0037732667 42:-0.14265953 43:0.032184314 44:0.042804223 45:0.10987251 46:-0.17220221 47:0.26723441 48:-0.15407398 49:-0.13954736 50:-0.00076337677 51:0.19204888 52:0.1135656 53:0.14836071 54:0.3701047 55:0.37077254 56:0.27281705 57:0.32126915 58:0.70471555 59:-0.076927483 60:0.15218115  |EV| 
0.38296867521062649686314216523897  |BT| (ROOT (S (NP (NP (NNP (CONCLUSIONS))(CC (AND))(NNP (POTENTIAL))(NNP (RELEVANCE)))(: (:))(NP (NP (DT (A))(JJ (dexmedetomidine))(NN (CRI)))(PP (IN (at))(NP (DT (the))(VBN (reported))(NN (dose))))))(ADVP (RB (significantly)))(VP (VBZ (reduces))(NP (NP (DT (the))(NX (NNP (MAC))))(PP (IN (of))(NP (NN (sevoflurane))))))(. (.)))) |ET|  |BV| 1:-0.77053291 2:-0.48575148 3:-0.84432662 4:-1.0948236 5:0.79077691 6:-0.38421625 7:-0.094402462 8:-0.76336622 9:-0.38017043 10:0.042292215 11:-0.44345054 12:-0.75959682 13:-0.44020325 14:-0.11750142 15:0.36356458 16:1.1747187 17:0.36346835 18:0.23654294 19:-0.10545375 20:-0.92121631 21:-0.51583421 22:-0.15732002 23:-0.67301118 24:-0.94175428 25:0.24679913 26:-0.6743508 27:-0.21775585 28:0.045891993 29:-0.18093675 30:0.41452351 31:-0.35863405 32:0.2783553 33:0.19278878 34:-1.1857703 35:0.0078831157 36:0.32769522 37:0.64750874 38:0.40576273 39:-0.44038063 40:-0.45647451 41:-0.15608221 42:0.31538296 43:-0.065818056 44:-0.029752484 45:0.3562502 46:0.14041375 47:0.089476928 48:-0.20142746 49:-0.34333619 50:0.41449988 51:0.30833274 52:-0.30665585 53:0.11021344 54:0.26009935 55:-0.46767002 56:0.26406145 57:0.70687705 58:-0.24935602 59:0.37277356 60:-0.016976733  |EV| 
-0.3293552890286277623488331300905  |BT| (ROOT (S (ADVP (RB (Similarly)))(S (VP (TO (to))(VP (VB (paclitaxel))(PRN (-LRB- (-LRB-))(NP (NNP (Taxol)))(-RRB- (-RRB-))))))(, (,))(VP (VP (VBP (epothilone))(NP (DT (A))(JJ (inhibits))(NN (cell))(NN (proliferation))))(CC (and))(VP (VBZ (induces))(NP (NNS (apoptosis)))(PP (IN (by))(NP (VBG (binding))))(PP (TO (to))(NP (NP (NN (tubulin))(CC (and))(VBG (stabilizing)))(PP (IN (of))(NP (NNS (microtubuli))))))))(. (.)))) |ET|  |BV| 1:-0.25381282 2:-0.3905836 3:0.012394076 4:-0.10967423 5:0.096497513 6:-0.41035369 7:0.9284386 8:-0.22448091 9:-0.29918161 10:1.0547025 11:-0.0023328546 12:0.17811078 13:0.36452794 14:-0.053931765 15:0.156688 16:0.72528845 17:-0.048138551 18:-1.1846963 19:-0.578408 20:-0.21507518 21:0.10806209 22:-0.73798895 23:1.6558137 24:0.51094294 25:0.81971055 26:-1.1616857 27:1.1428647 28:-0.11010087 29:-0.050751615 30:-0.44537079 31:1.1681331 32:0.33287895 33:-0.79483718 34:0.0312462 35:0.29051206 36:0.28662109 37:-0.33912843 38:-1.6960806 39:-0.73355275 40:-0.3957302 41:0.041133687 42:-0.36123791 43:-0.26177749 44:0.042678516 45:0.051704448 46:-0.4234786 47:-0.23021887 48:-0.21198164 49:0.063752249 50:0.50839698 51:0.40498763 52:-0.031887345 53:0.059205145 54:-0.24146071 55:-0.059601292 56:0.069364294 57:0.1582569 58:-0.068043143 59:-0.027889766 60:0.50526166  |EV| 
-0.26944282336872721339560143860581  |BT| (ROOT (S (PP (IN (In))(NP (NP (JJ (vitro))(NNS (chemosensitivities)))(PP (IN (of))(NP (NP (JJ (pancreatic))(NN (carcinoma))(NNS (cells)))(PP (TO (to))(NP (CD (5-FU))))))))(, (,))(NP (NN (gemcitabine))(CC (and))(NN (oxaliplatin)))(VP (VBD (were))(ADJP (JJR (lower)))(PP (IN (than))(NP (NP (DT (those)))(PP (IN (of))(NP (JJ (gastrointestinal))(NN (carcinoma)))))))(. (.)))) |ET|  |BV| 1:-0.9649387 2:-0.22778067 3:0.24806629 4:0.35060078 5:1.663449 6:0.54817027 7:0.32789484 8:-0.13410074 9:-0.49568343 10:0.29095802 11:0.32065418 12:-0.11118594 13:1.0687401 14:0.40582746 15:-0.49732971 16:0.93356448 17:-0.5627355 18:-0.61297697 19:-1.0885471 20:-0.65223277 21:-1.0761337 22:-0.72653055 23:-0.047030564 24:-0.095044218 25:0.87921143 26:0.14182645 27:0.56299537 28:0.30437505 29:0.050402731 30:0.29846507 31:-0.081354752 32:0.20232107 33:0.73375541 34:-0.26733202 35:-0.23603797 36:0.81133437 37:-0.32434905 38:-1.4542429 39:-0.4224728 40:-0.82956928 41:0.034843843 42:-0.17812763 43:-0.19747502 44:0.081864744 45:0.017517984 46:-0.48645061 47:-0.24189919 48:-0.22510134 49:-0.07895121 50:0.37073612 51:0.27127957 52:0.20653842 53:-0.42993429 54:0.0025436913 55:-0.081034549 56:0.10166813 57:-0.071511105 58:-0.18758696 59:0.470404 60:0.54819953  |EV| 
-0.21069468621219250570320014048775  |BT| (ROOT (FRAG (NP (NNP (CONCLUSIONS)))(: (:))(S (NP (NP (NNP (Rituximab)))(CC (and))(NP (NP (JJR (lower))(NNS (doses)))(PP (IN (of))(NP (NN (prednisone))(CC (and))(NN (calcineurin))(NNS (inhibitors))))))(VP (VP (VBP (are))(ADJP (JJ (noninferior))(PP (TO (to))(NP (NP (JJ (standard))(NN (therapy)))(PP (IN (in))(S (VP (VBG (maintaining))(S (NP (NP (JJ (short-term))(NN (remission)))(PP (IN (in))(NP (NP (NNS (children)))(PP (IN (with))(NP (NNP (INS)))))))(ADJP (JJ (dependent))(PP (IN (on))(NP (DT (both))(NNS (drugs)))))))))))))(CC (and))(VP (VBP (allow))(NP (PRP$ (their))(JJ (temporary))(NN (withdrawal))))))(. (.)))) |ET|  |BV| 1:-0.8092041 2:-0.19329149 3:-0.70447874 4:0.16662487 5:0.29772061 6:-0.64029855 7:-0.70728737 8:-0.16949117 9:-0.54650426 10:1.4144824 11:-0.060322113 12:0.17590384 13:-0.13637727 14:0.23657389 15:-0.57702953 16:1.4925574 17:0.57485455 18:-0.11306486 19:0.70975369 20:-1.2286081 21:-0.21683902 22:-0.58271813 23:-0.3773798 24:0.31495053 25:-0.075841524 26:-0.13666572 27:-0.077723585 28:-0.39503255 29:0.06788633 30:0.4634937 31:-0.58181411 32:0.057384633 33:0.24518061 34:0.18402077 35:-0.60698193 36:-0.26682448 37:0.12457526 38:-0.7255078 39:0.078947604 40:-0.59980386 41:0.18605465 42:0.178432 43:0.066185363 44:0.30255163 45:0.036192015 46:-0.18028609 47:-0.076101005 48:-0.26996738 49:0.43288186 50:-0.11217209 51:0.067644887 52:-0.22861063 53:-0.29629922 54:-0.034416966 55:-0.032504879 56:-0.14814775 57:0.00098714139 58:0.50184435 59:0.32549354 60:-0.17926866  |EV| 
0.14353951310859380807727347928449  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(S (NP (NNP (Topiramate)))(VP (MD (could))(VP (VB (prevent))(NP (JJ (olanzapine))(JJ (induced))(NN (weight))(NN (gain))(CC (and))(JJ (adverse))(NN (metabolic))(NNS (effects))))))(. (.)))) |ET|  |BV| 1:0.13194823 2:0.34916896 3:-0.7530095 4:-0.43338528 5:0.26798153 6:1.1201754 7:0.013825226 8:-0.61208022 9:0.21881662 10:0.5256815 11:0.8308621 12:1.0212096 13:0.50689417 14:0.013927326 15:-0.75837433 16:-0.09899047 17:0.54053074 18:-0.78683519 19:0.3812432 20:0.087259933 21:-0.60522342 22:0.27817166 23:-0.90040553 24:-0.31354764 25:0.31086519 26:-0.032624342 27:-0.59054387 28:-0.83233339 29:1.3101377 30:0.5389362 31:0.28208524 32:0.10082465 33:1.5436033 34:0.41065362 35:0.59445727 36:0.13318267 37:0.30581635 38:-1.0496583 39:0.307877 40:0.63569981 41:-0.022051398 42:-0.19173475 43:0.27052844 44:0.18240513 45:0.61012048 46:-0.16928996 47:0.067366391 48:-0.25596905 49:-0.0062662228 50:0.030988824 51:-0.11297582 52:0.12557976 53:0.11082303 54:0.45737624 55:-0.093955308 56:0.21011567 57:0.49456543 58:0.046179846 59:-0.18107736 60:0.49071524  |EV| 
0.10226171623123020415491168932931  |BT| (ROOT (S (NP (PRP$ (Our))(NNS (results)))(VP (VBP (suggest))(SBAR (IN (that))(S (NP (NN (sertraline)))(VP (MD (may))(VP (VB (reduce))(NP (DT (the))(JJ (membrane))(NN (conduction)))(PP (IN (through))(NP (NP (NN (inhibition)))(PP (IN (of))(NP (JJ (ionic))(NNS (channels))))(SBAR (WHNP (WDT (which)))(S (VP (VB (decrease))(NP (JJ (ouabain-induced))(NN (arrhythmia)))))))))))))(. (.)))) |ET|  |BV| 1:0.075778112 2:0.3366892 3:-1.1316298 4:-0.38793954 5:1.1202346 6:0.089918151 7:-0.58620197 8:0.83895719 9:0.38686207 10:0.49496409 11:0.45256186 12:0.37516338 13:1.4813621 14:0.1288348 15:-0.43844366 16:0.67904538 17:0.031936709 18:-0.041735757 19:0.98866665 20:-0.61810493 21:0.062594734 22:-0.75768083 23:-1.4813035 24:-0.89769107 25:-0.58773482 26:0.55305028 27:-0.47477198 28:-0.38279101 29:0.86100966 30:-0.23867407 31:0.83104825 32:-0.8110435 33:-0.065309875 34:0.060984265 35:0.051138829 36:-0.71780908 37:0.19032373 38:-0.26659429 39:0.0085575059 40:0.75624537 41:-0.12971602 42:0.17198081 43:0.26141033 44:-0.068379015 45:-0.2540879 46:-0.29883716 47:0.090436451 48:0.16198991 49:-0.17000487 50:0.42197618 51:-0.19756621 52:-0.069918364 53:0.21237314 54:0.0031382905 55:0.0093994159 56:0.11187522 57:0.37786776 58:0.57812023 59:-0.21400197 60:0.10244197  |EV| 
0.20754934141849523676626176893478  |BT| (ROOT (S (NP (DT (These))(NNS (data)))(VP (VBP (suggest))(SBAR (IN (that))(S (NP (NN (nalbuphine)))(VP (VBZ (attenuates))(NP (NP (DT (the))(NN (development)))(PP (IN (of))(NP (NN (sensitization)))))(PP (TO (to))(NP (NP (DT (the))(JJ (behavioral))(NNS (effects)))(PP (IN (of))(NP (NN (cocaine))))))))))(. (.)))) |ET|  |BV| 1:0.04645972 2:-0.243412 3:-0.12847507 4:-0.020735495 5:0.046708986 6:-0.63118833 7:-0.37865597 8:-0.77093482 9:0.74587637 10:-0.46059707 11:0.0066282842 12:-0.22267382 13:-0.17692463 14:-0.36518228 15:-0.20190102 16:0.29322821 17:-0.080923498 18:-0.18870497 19:0.15922587 20:0.54918379 21:0.63292617 22:-0.50982553 23:-0.25642928 24:-0.45444 25:-0.97684413 26:0.11316805 27:-0.59628713 28:-0.051975127 29:1.1963233 30:0.45435756 31:-0.31040189 32:-0.37512559 33:0.60222888 34:0.99032032 35:1.4206415 36:0.1277096 37:1.2034942 38:0.7174831 39:0.39829654 40:0.54056239 41:-0.18912211 42:-0.29835558 43:0.10612609 44:-0.1124513 45:0.25890234 46:-0.18938741 47:0.07281708 48:-0.19818535 49:-0.021192284 50:0.075320274 51:0.091683634 52:0.037943937 53:0.23385087 54:0.01202534 55:0.037880037 56:0.15107051 57:0.33303729 58:-0.057089638 59:0.077604711 60:0.035212219  |EV| 
0.065111604599145403438065216050745  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(S (NP (NNP (Data)))(VP (VBP (have))(VP (VBN (shown))(SBAR (IN (that))(S (NP (NP (NN (hyperprolactinemia)))(VP (VBN (induced))(PP (IN (by))(NP (NN (metoclopramide))))))(VP (VP (VBZ (determines))(NP (JJ (endometrial))(NN (proliferation))))(CC (and))(VP (VBZ (interferes))(PP (IN (with))(NP (NP (DT (the))(NN (ovarian))(NN (function)))(, (,))(ADVP (RB (mainly)))))(PP (IN (in))(NP (DT (the))(JJ (progesterone))(NN (production)))))))))))(. (.)))) |ET|  |BV| 1:-0.70291984 2:0.10596521 3:0.40353924 4:-0.0082024643 5:0.51516557 6:-0.4248296 7:0.15003122 8:0.1239915 9:0.20275137 10:0.48732561 11:0.47781709 12:-0.14894189 13:0.51152009 14:0.33163288 15:-0.5908134 16:0.57499492 17:0.029747412 18:0.11391607 19:0.40241897 20:0.6374259 21:-0.18249138 22:-0.10426323 23:-0.17040956 24:-0.23240829 25:1.2175658 26:0.12161294 27:-0.0248219 28:-0.48099515 29:0.19091956 30:-0.18165459 31:0.62016201 32:-0.12164176 33:0.44775671 34:0.30970037 35:-0.55052608 36:0.18322083 37:-0.037191644 38:0.17589921 39:0.13660975 40:-0.067096911 41:-0.1174462 42:-0.21725926 43:-0.35735837 44:-0.11957736 45:0.36556014 46:-0.19346571 47:-0.35283735 48:0.042394653 49:0.095075138 50:0.77397537 51:0.18151984 52:-0.26641375 53:-0.0087483572 54:-0.19381598 55:0.20818299 56:0.22266564 57:0.47187969 58:-0.36918333 59:0.04851548 60:0.464174  |EV| 
